Sentence,class,file
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/4b/civ1024.PMC4787604.pdf
Available at: http://apps.who.int/ebola/ebola-situation-reports .,Non-OADS,/arxiv_data1/oa_pdf/a2/4b/civ1024.PMC4787604.pdf
Available at: http://www.cdc.gov/vhf/ebola/transmission/qas.html .,OADS,/arxiv_data1/oa_pdf/a2/4b/civ1024.PMC4787604.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/83/civ1198.PMC4787605.pdf
Available at: http://www.clinicaltrials.gov/ct2/show/NCT01103063?term= NCT01103063&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/ec/83/civ1198.PMC4787605.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/7d/civ1214.PMC4787606.pdf
Available at: http://www.hpa.org.uk/SMI/pdf .,Non-OADS,/arxiv_data1/oa_pdf/ba/7d/civ1214.PMC4787606.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/b9/civ1222.PMC4787608.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/fa/ciw007.PMC4787609.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/4f/ciw027.PMC4787611.pdf
Available at: http://www.cdc.gov/pertussis/outbreaks/trends.html .,Non-OADS,/arxiv_data1/oa_pdf/a8/4f/ciw027.PMC4787611.pdf
Available at: http://www.dh.gov.uk/health/2012/09/whooping-cough/ .,Non-OADS,/arxiv_data1/oa_pdf/a8/4f/ciw027.PMC4787611.pdf
Available at: http://www.fda.gov/ucm/groups/fdagov-public/@ fdagov-drugs-gen/documents/document/ucm202140.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a8/4f/ciw027.PMC4787611.pdf
"This is an Open Access article, freely available through Biology of Reproduction’s Authors’ Choice option, and is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described athttp://creativecommons.org/licenses/by-nc/4.0/.eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 34",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/i0006-3363-94-2-34.PMC4787626.pdf
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/i0006-3363-94-2-34.PMC4787626.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 41",Non-OADS,/arxiv_data1/oa_pdf/6d/c0/i0006-3363-94-2-41.PMC4787627.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 44",Non-OADS,/arxiv_data1/oa_pdf/ec/be/i0006-3363-94-2-44.PMC4787628.pdf
"Parmbsc0 ( 88)+p a r m χOL4(89)+p a r m /epsilon1ζOL1(90)v e r - sion(bsc0 χOL4/epsilon1ζOL1)oftheCornell etal.forcefield( 91,92) wasusedinalmostallsimulations(forparameters,seeAm-berTools15 May 2015 update or http://fch.upol.cz/en/ff ol/ index.php ).",OADS,/arxiv_data1/oa_pdf/19/57/gkv994.PMC4787745.pdf
Our software implementation is freely available from the project website http://www.bio.iﬁ.lmu.de/software/lfc .,Non-OADS,/arxiv_data1/oa_pdf/70/78/gkv696.PMC4787746.pdf
"Global miRISC dynamic modes from the elastic network model (ENM)theory To model global dynamics of Ago and miRISC structures, weusedthe elNemoimplementationofENM( 31,35),avail- able athttp://www.sciences.univ-nantes.fr/elnemo/ .Default parameters were used except for the displacement param- eter which was varied between 100 and 800.",OADS,/arxiv_data1/oa_pdf/76/31/gkv990.PMC4787751.pdf
"Nuclearcaseinkinaseandcyclin-dependentkinasessub- strate1(NUCKS1)isanuclearandhighlyphosphorylatedprotein (15–17) which also is acetylated, methylated, ubiq- uitylated and formylated (( 18);http://www.phosphosite.",Non-OADS,/arxiv_data1/oa_pdf/71/98/gkv859.PMC4787752.pdf
"Trained species-specific miRNAprediction systems and all training and test data are freely available at http://bioinf.sce.carleton.ca/SMIRP .A sp r e v i - ously mentioned, this approach is particularly useful forniche species that are of important model organisms of study, but suffer from being phylogenetically distant from themodelorganismsthataretypicallyusedtocreatesingle-speciesor multi-speciespooled training data.",Non-OADS,/arxiv_data1/oa_pdf/64/c7/gkv698.PMC4787757.pdf
"The microPred train- ing dataset, available at http://www.cs.ox.ac.uk/people/ manohara.rukshan.batuwita/microPred.htm , has become ade-factostandard for the training of miRNA prediction methods, having been used in numerous studies since itwas introduced in 2009 ( 40,29,31–32,37–38).",Non-OADS,/arxiv_data1/oa_pdf/64/c7/gkv698.PMC4787757.pdf
"Thefourpre-trainedmicroPred-likeandHeteroMirPred- like species-specific miRNA prediction systems evaluated in this study are available as SMIRP, at http://bioinf.sce.",OADS,/arxiv_data1/oa_pdf/64/c7/gkv698.PMC4787757.pdf
"Additionally, previous methods have been used to track sites of extensive read pile-up capable of generatingartifact peak calls, known as ‘blacklisted’ regions ( 1) (http://www.broadinstitute.org/ ∼anshul/projects/encode/ rawdata/blacklists/hg19-blacklist-README.pdf ).",OADS,/arxiv_data1/oa_pdf/4f/d6/gkv671.PMC4787761.pdf
"PAGE3OF8 NucleicAcidsResearch,2015,Vol.43,No.20 e133 we used available ‘posmap’ data tables that reference each WGS read assignment to published contig assemblies: ftp://ftp.jcvi.org/pub/data/huref/h6.posmap.frgctg.gz .I n total, our initial HuRef WGS sponge database represents246 Mb of unmapped sequences, or roughly 8.2% of the genome ( 7),described below: Satellite DNAs.",OADS,/arxiv_data1/oa_pdf/4f/d6/gkv671.PMC4787761.pdf
Alignment files and significant peaks were initially evaluated by intersecting with BED files provided for three separate blacklists (Descriptionavailable http://www.broadinstitute.org/ ∼anshul/projects/ encode/rawdata/blacklists/hg19-blacklist-README.pdf ; Blacklist based on RepeatMasker annotation: ftp:// encodeftp.cse.ucsc.edu/users/akundaje/rawdata/blacklists/ hg19/Duke Hg19SignalRepeatArtifactRegions.bed.gz ; Merged Consensus blacklist: ftp://encodeftp.cse.,OADS,/arxiv_data1/oa_pdf/4f/d6/gkv671.PMC4787761.pdf
ucsc.edu/users/akundaje/rawdata/blacklists/hg19/ wgEncodeHg19ConsensusSignalArtifactRegions.bed.gz and Ultra-high signal artifacts: ftp://encodeftp.cse.,OADS,/arxiv_data1/oa_pdf/4f/d6/gkv671.PMC4787761.pdf
"Com- parisons between bigWig alignment files used a base-by- base Pearson correlation with bigWigCorrelation software (version2),developedinhousetoenablecorrelationvalues between full genome bigWig files (commonly involving up to3billiondatapointseach)andalsoconverttoabedgraphformatnecessaryfordownstreamanalyses.Thistoolispub- lically available through the UCSC applications /software code release (v316; with procedure to obtain the userapplication tool set and how to build the tools is in this README: http://genome-source.cse.ucsc.edu/gitweb/ ?p=kent.git;a=blob;f=src/userApps/README ).",OADS,/arxiv_data1/oa_pdf/4f/d6/gkv671.PMC4787761.pdf
These tools arealsoavailablethroughtheUCSCapplications /software code release (v316; with procedure to obtain the user ap- plication tool set and how to build the tools is in this README: http://genome-source.cse.ucsc.edu/gitweb/?p= kent.git;a=blob;f=src/userApps/README ).,OADS,/arxiv_data1/oa_pdf/4f/d6/gkv671.PMC4787761.pdf
"Coverslips were finally mounted in Vectashield mounting medium with DAPI (H-1500; Vector Laborato- ries,Burlingame,CA,USA).Resultingfluorescencewasvi-sualized using a Nikon Eclipse T200 microscope equipped withaHamamatsuOrcaERcameraandtheVolocity3.6.1 (Improvision,Cambridge,UK)software.Pictureswerefur-ther processed using Image J software ( http://rsbweb.nih.",Non-OADS,/arxiv_data1/oa_pdf/13/c8/gkv835.PMC4787776.pdf
Image J software ( http://rsbweb.nih.gov/ij/ )was used to process images and quantify protein band intensitieson thewestern blots.,OADS,/arxiv_data1/oa_pdf/13/c8/gkv835.PMC4787776.pdf
Chemical structures of HygA and relevant compounds were depicted using Mar- vinSketch(ChemAxon: http://www.chemaxon.com ).Coor- dinates and restraints of the drug suitable for refinementwere obtained using the GRADE server ( 42) and eLBOW (43).,OADS,/arxiv_data1/oa_pdf/53/45/gkv975.PMC4787777.pdf
"(2011)GRADE,version 1.2.7.Cambridge,UnitedKingdom,GlobalPhasingLtd.,http://www.globalphasing.com .",Non-OADS,/arxiv_data1/oa_pdf/53/45/gkv975.PMC4787777.pdf
2013. http://www.r-project.org ).,Non-OADS,/arxiv_data1/oa_pdf/0d/06/gkv1053.PMC4787788.pdf
"Finally, the program computes statistics forallframes.Thesoftware,manualandserverareavailableat http://mint.cent.uw.edu.pl .",OADS,/arxiv_data1/oa_pdf/53/f7/gkv559.PMC4787793.pdf
"Single-conformation analysis mode To analyze a single .pdbfile, we also provide the MINT web server at http://mint.cent.uw.edu.pl .",Non-OADS,/arxiv_data1/oa_pdf/53/f7/gkv559.PMC4787793.pdf
"To extend the impact and usage of mRNA related ceRNA–ceRNAlandscapeacrosscancers,Pan-ceRNADB( http://www.bio- bigdata.com/pan-cernadb/ orhttp://www.bio-bigdata.net/ pan-cernadb/ ), a convenient and available resource is fur- ther constructed for biomedical scientists.",OADS,/arxiv_data1/oa_pdf/e8/bb/gkv853.PMC4787795.pdf
"Moreover, to provide a conve-nientandavailableresourceaboutmRNArelatedceRNA– ceRNA landscape across cancers for biomedical scien- tists, Pan-ceRNADB, a free and web-accessible database,is further constructed ( http://www.bio-bigdata.com/pan- cernadb/ orhttp://www.bio-bigdata.net/pan-cernadb/ ).",OADS,/arxiv_data1/oa_pdf/e8/bb/gkv853.PMC4787795.pdf
"(2006)NetworkWorkbenchTool.IndianaUniversity; NortheasternUniversityandUniversityofMichigan,http://nwb.slis.indiana.edu .",Non-OADS,/arxiv_data1/oa_pdf/e8/bb/gkv853.PMC4787795.pdf
"We selected all the genes with highly mutated TSSes, promoters or UTRs (adjusted P-valuesaftercorrections ≤0.05)andperformedGOanaly- sis (http://amigo.geneontology.org ,(52)).",OADS,/arxiv_data1/oa_pdf/60/69/gkv803.PMC4787796.pdf
GeneontologyanalysiswasdoneusingFunspecprogram (GOBiological Process; http://funspec.med.utoronto.ca/) .,OADS,/arxiv_data1/oa_pdf/1b/d7/gkv765.PMC4787798.pdf
Secondary structure predictions The secondary structure predictions were carried out with the ViennaRNA ( http://rna.tbi.univie.ac.at/ )(29)a n d /or Mfold (http://mfold.rna.albany.edu )(30) web servers.,OADS,/arxiv_data1/oa_pdf/5c/79/gkv786.PMC4787799.pdf
The structures were drawn using VARNA ( http://varna.lri.fr/ ) (31).,OADS,/arxiv_data1/oa_pdf/5c/79/gkv786.PMC4787799.pdf
"For blots, RNA wastransferredtonylonmembrane,hybridizedinSigmaPerfec- tHyb buffer ( https://www.sigmaaldrich.com/ ) and stripped with boiling0.1% SDSsolution.",Non-OADS,/arxiv_data1/oa_pdf/5d/fd/gkv753.PMC4787800.pdf
RNA wasisolated using RNeasy Plant Mini Kit from QIA- GEN ( https://www.qiagen.com ).,OADS,/arxiv_data1/oa_pdf/5d/fd/gkv753.PMC4787800.pdf
cDNA were gen- erated form 1 /H9262g of total RNA using the first strand cDNA kit from Thermo Fisher Scientific (http://www.lifetechnologies.com ) using the specific primer RT ASGUS Linker: CGACTGGAGCACGAG- GACACTGA GACTGGCATGAACTTCGGTGAA (bold letters represent linker sequence).,OADS,/arxiv_data1/oa_pdf/5d/fd/gkv753.PMC4787800.pdf
"done using a primer containing the Linker sequence, LK: CGACTGGAGCACGAGGACACTGA, and a primerspecific to the RbcS region, RbcS1Rev: TCACAGTTC- GATAGCGAAAACCGA.SsoAdvancedUniversalSYBR Green Supermix from Biorad ( http://www.bio-rad.com/ ) wasusedintheMastercycler R/circlecopyrteprealplexfromEppendorf (www.eppendorf.com ).eIF1aexpression was used has amplification control since unspecific annealing of RTprimer produces cDNAfrom highly abundant RNA ( 36).",OADS,/arxiv_data1/oa_pdf/5d/fd/gkv753.PMC4787800.pdf
"Surprisingly, although it would constitute a simple, modular and widely applicable labeling method, the di- rect incorporation of ‘clickable’ nucleotides into DNAby TdT has been restricted to a variation of the termi- nal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay ( 42), where DNA strand-breaks in cells are detected by incorporation of 5-ethynyl-deoxyuridine (5-E-dU), conversion with an azido-dye and fluorescence detection ( https://www.lifetechnologies.com/order/catalog/ product/C10245 archived at http://www.webcitation.org/ 6YcrIwgCX ).",Non-OADS,/arxiv_data1/oa_pdf/e2/57/gkv544.PMC4787804.pdf
http://www.graphpad.com/ support/faq/whats-new-in-prism-mac-60e/ .,Non-OADS,/arxiv_data1/oa_pdf/7d/b4/gkv801.PMC4787806.pdf
"These mutated sequences give rise to the same protein sequences but fold into different RNAstructures than the native S1 /S2 and S3 /S4 sequences, ac- cording to the mfold program ( http://helix.nih.gov/apps/ bioinfo/mfold.html ).",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/gkv801.PMC4787806.pdf
Data were processed using the lo-calapplicationFOXTROT( http://www.synchrotron-soleil.,OADS,/arxiv_data1/oa_pdf/e5/e7/gkv792.PMC4787810.pdf
Additional workflow and analysis scripts are available at https://github.com/hesselberthlab/5OH .Processeddatacan be visualized on the UCSC Genome Browser in the trackhub athttps://github.com/hesselberthlab/trackhub .,OADS,/arxiv_data1/oa_pdf/54/7a/gkv536.PMC4787814.pdf
RNAcop is available as web server and stand-alone software viahttp://rth.dk/resources/rnacop .,OADS,/arxiv_data1/oa_pdf/04/07/gkv813.PMC4787817.pdf
Web serverand availability RNAcop is available as a web server at http://rth.dk/ resources/rnacop and stand alone command-line version.,OADS,/arxiv_data1/oa_pdf/04/07/gkv813.PMC4787817.pdf
( C) A pie chart presenting the percentage of AlgR targets with functional categories defined in the Pseudomonas database ( http://pseudomonas.com ).,OADS,/arxiv_data1/oa_pdf/39/bc/gkv747.PMC4787818.pdf
The MIN antibody are available via http://human.bio.,Non-OADS,/arxiv_data1/oa_pdf/fd/42/gkv550.PMC4787826.pdf
AllconstructsdescribedinthisstudyareavailableviaAd- dgeneorvia http://human.bio.lmu.de/ webtools/MINtool/ .,OADS,/arxiv_data1/oa_pdf/fd/42/gkv550.PMC4787826.pdf
All cell lines are available at http://human.bio.lmu.de/ webtools/MINtool/cell lines.html .,OADS,/arxiv_data1/oa_pdf/fd/42/gkv550.PMC4787826.pdf
"Data correction, normalization andquantitativeevaluationswereperformedbyautomatedpro- cessing with ImageJ ( http://rsb.info.nih.gov/ij/ )u s i n gas e t of newly developed macros followed by calculations in Ex-cel.",OADS,/arxiv_data1/oa_pdf/fd/42/gkv550.PMC4787826.pdf
"To simplify the distribution of MIN-tagged cell lines and the MIN-tag toolbox as well as to assist with the design of targeting strategies, we have developed a web-tool that is accessibleathttp://human.bio.lmu.de/ webtools/MINtool/ .A se n t r y linescanbesharedandthegenetictoolboxeasilyexpanded with new functional modules, the MIN-tag strategy repre-sents a dynamic flexible open platform and facilitates sys- tematic functional studies with direct biological compara- bility.",OADS,/arxiv_data1/oa_pdf/fd/42/gkv550.PMC4787826.pdf
"The surveyed IESs were extracted from files stored in the Paramecium genome database at the URL: http://paramecium.cgm.cnrs-gif.fr/ ; file names: ‘ptetraurelia CDSv1pt51.gff3.gz’, ‘parame- ciumDB.gff3.gz’, ‘Ptetraurelia genescur.fasta’, and ‘Ptetraurelia geneswithIEScur.fasta’ ( 22,23).",OADS,/arxiv_data1/oa_pdf/bf/d5/gkv843.PMC4787833.pdf
"Statisticsand comparative study of differently-sizedIESs Statistical analyses were carried out in the R environment (http://www.R-project.org/ ).Beforeweperformedcompar- ative analyses, e.g., intergenic versus intragenic IESs, we systematically controlled for possible size-differences be-tween the surveyed IES categories.",OADS,/arxiv_data1/oa_pdf/bf/d5/gkv843.PMC4787833.pdf
"Validation of NA12878 SVs using long-read sequencing datasets WevalidatedtheSVcallsoflaSVinanindividualwithEu- ropeanancestryusingthelong-readsequencingdatasetsfor thesameindividualprovidedbyMoleculoandPacBio.The datasets were downloaded from the 1000 Genomes ProjectFTP site: ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/phase3/ integrated svmap/supporting/NA12878/moleculo/ ,a n d ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/phase3/ integrated svmap/supporting/NA12878/pacbio/ .",OADS,/arxiv_data1/oa_pdf/60/59/gkv831.PMC4787836.pdf
The FASTQ raw sequence reads of genomic DNA were downloaded fromCGHub( https://cghub.ucsc.edu/ )andtranscriptomeRNA- seq data were obtained from the Data Portal of TCGA (https://tcga-data.nci.nih.gov/tcga/ ).,OADS,/arxiv_data1/oa_pdf/60/59/gkv831.PMC4787836.pdf
WealignedallthecontigsassembledfromCESCsamplestothegenomesofall175HPVstrainsdownloadedfromPaVE (http://pave.niaid.nih.gov/ )usingtheBLATalgorithm( 31).,OADS,/arxiv_data1/oa_pdf/60/59/gkv831.PMC4787836.pdf
" Case Rep Oncol  2015;8:536 –539  DOI: 10.1159/000442148   Published online: November 27, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0536$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/51/9b/cro-0008-0536.PMC4787896.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/52/ddw018.PMC4787905.pdf
"Seven ﬁelds per coverslip were imaged using the 320 objective and were analyzed using ImageJ (http://imagej.nih.gov/ij/; provid- ed in the public domain by the National Institutes of Health,Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/b1/e7/i1552-5783-57-3-1038.PMC4788093.pdf
"Primers (Supplementary Table S1) weredesigned by using the PRIMER3 program (http://frodo.wi.mit.edu/; provided in the public domain by the WhiteheadInstitute for Biomedical Research, Cambridge, MA, USA).",OADS,/arxiv_data1/oa_pdf/c5/8e/i1552-5783-57-3-940.PMC4788094.pdf
* Data obtained from http://www.retina-international.org/ﬁles/sci-news/rhomut.htm (provided in the public domain by Retina International).RHO Mutations in Autosomal Dominant RP IOVSjMarch 2016 jVol.,OADS,/arxiv_data1/oa_pdf/c5/8e/i1552-5783-57-3-940.PMC4788094.pdf
At least 20 amino acids in the rhodopsin protein sequence are affected by different multiple mutations (http://www.retina-international.org/ﬁles/sci-news/rhomut.htm; provided inthe public domain by Retina International); it is therefore notsurprising that ﬁve of the mutations identiﬁed here are located in such positions.,Non-OADS,/arxiv_data1/oa_pdf/c5/8e/i1552-5783-57-3-940.PMC4788094.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/0e/ndt-12-609.PMC4788357.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 609–610Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  609LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10426 1Identification of a seasonal pattern to brain  metastases Minas Sakellakis1 Angelos Koutras1 Maria Pittaka2 Dimitrios Kardamakis2 Melpomeni Kalofonou1 Haralabos P Kalofonos1 Despina Spyropoulou2 1Division of Oncology, Department  of Medicine, 2Department of Radiation  Oncology, University Hospital, Patras  Medical School, Rion, Patras, GreeceDear editor We have previously tested our hypothesis that there is a seasonality in the incidence  of carcinomatous meningitis.1 Although further validation is needed in a larger cohort,  we found that leptomeningeal metastasis occurred more often during warm months of  the year which, in the case of Greece, is the period generally marked with the larger  daytime length.1 Carcinomatous meningitis is closely related to brain metastasis, and  a logical question is whether warm season is marked by a greater propensity also for  brain metastasis.2 We conducted a single-center retrospective review of the medical records of  patients with brain metastases that received whole brain irradiation from 2008 to  2013 (6 years).",Non-OADS,/arxiv_data1/oa_pdf/32/0e/ndt-12-609.PMC4788357.pdf
"Thus far, no studies have been widely published or reported (including our insti - tution) on the observation of higher cancer diagnosis during warm months.4 What is Correspondence: Minas Sakellakis Division of Oncology, Department of  Medicine, University Hospital, Patras  Medical School, Rion 26504, Patras,  Greece Tel +30 26 1099 9535 Fax +30 26 1099 4645 email doctorsakellakis@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Sakellakis et al Running head recto: Identification of a seasonal pattern to brain metastases DOI: http://dx.doi.org/10.2147/NDT.S104261",Non-OADS,/arxiv_data1/oa_pdf/32/0e/ndt-12-609.PMC4788357.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/32/0e/ndt-12-609.PMC4788357.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/0e/ndt-12-609.PMC4788357.pdf
Available from:  http://www.hnms.gr/hnms/english/climatology/ climatology _region_  diagrams_html?dr_city =Patra.,Non-OADS,/arxiv_data1/oa_pdf/32/0e/ndt-12-609.PMC4788357.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/86/70/cia-11-279.PMC4788358.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 279–284submit your manuscript | www.dovepress.co m Dove press  279 http: //dx.doi.org/10.2147/CIA.S9475 0Dove press OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article legal medical consideration of Alzheimer’s disease  patients’ dysgraphia and cognitive dysfunction:  a 6 month follow up emanuela Onofri1 Marco Mercuri1 Trevor Archer2 Max rapp-ricciardi2 serafino ricci1 1Department of Anatomy, histology,   legal Medicine and Orthopaedics,   sapienza University of rome, rome,   Italy; 2Department of Psychology,   University of gothenburg,   gothenburg, swedenBackground:  The purpose of this study was to investigate the ability of Alzheimer’s disease  (AD) patients to express intentions and desires, and their decision-making capacity.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cia-11-279.PMC4788358.pdf
"Thus, even if a person has AD, diagnosis  cannot be equated with decisional incapacity.11 Nevertheless, it is essential to distinguish  between patients and episodes on the basis of functionality and nonfunctionality.Correspondence: emanuela Onofri Department of Anatomy, histology,  legal Medicine and Orthopaedics,  sapienza University of rome, Viale regina  elena 336, rome 00100, Italy email emanuela.onofri@uniroma1.i t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Onofri et al Running head recto: Legal medical consideration of Alzheimer’s disease patients’ dysgraphia DOI: http://dx.doi.org/10.2147/CIA.S94750",Non-OADS,/arxiv_data1/oa_pdf/86/70/cia-11-279.PMC4788358.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cia-11-279.PMC4788358.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/86/70/cia-11-279.PMC4788358.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/42/ndt-12-603.PMC4788359.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 603–607Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  603OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10386 9Validity and test–retest reliability of the Persian  version of the Montgomery–asberg Depression  rating scale Mohammad ahmadpanah1 Meisam sheikhbabaei1 Mohammad haghighi1 Fatemeh roham1 leila Jahangard1 amineh akhondi2 Dena sadeghi Bahmani3 hafez Bajoghli4 edith holsboer-Trachsler3 serge Brand3,5 1Behavioral Disorders and substances  abuse research center, hamadan  University of Medical sciences,   hamadan, iran; 2hamadan educational  Organization, Ministry of education,   hamadan, iran; 3center for affective,   stress, and sleep Disorders,   Psychiatric clinics of the University  of Basel, Basel, switzerland; 4iranian  National center for addiction studies  (iNcas), T ehran University of Medical  sciences, T ehran, iran; 5Department of  sport, exercise and health science,   sport science section, University of  Basel, Basel, switzerlandBackground and aims:  The Montgomery–Asberg Depression Rating Scale (MADRS) is an  expert’s rating tool to assess the severity and symptoms of depression.",Non-OADS,/arxiv_data1/oa_pdf/9b/42/ndt-12-603.PMC4788359.pdf
"Although diagnoses are strictly based on internationally accepted classifications  such as the International Classification of Diseases-10 (ICD-10) or the Diagnostic and  Statistical Manual of Mental Disorders , 5th Edition, to assess symptoms of MDD and  illness severity, the scientific community essentially relies on two tools, the Hamilton  Depression Rating Scale (HDRS)5 consisting of 21 items, and the Montgomery– Asberg Depression Rating Scale (MADRS).6 The ten items forming the latter scale  assess the following symptoms: 1) apparent sadness; 2) reported sadness; 3) inner  tension; 4) reduced sleep; 5) reduced appetite; 6) concentration difficulties; 7) lassitude; correspondence: serge Brand center for affective, stress, and sleep  Disorders, Psychiatric clinics of the  University of Basel,  Wilhelm Klein- strasse 27, 4012 Basel, switzerland Tel +41 61 325 5114 Fax +41 61 325 5513 email serge.brand@upkbs.c h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Ahmadpanah et al Running head recto: Validation of the Farsi MADRS DOI: http://dx.doi.org/10.2147/NDT.S103869",Non-OADS,/arxiv_data1/oa_pdf/9b/42/ndt-12-603.PMC4788359.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9b/42/ndt-12-603.PMC4788359.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/42/ndt-12-603.PMC4788359.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 361–372Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  361Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S9810 0Allergic diseases among children: nutritional  prevention and intervention Mohamed A Hendaus1,2 Fatima A Jomha3 Mohammad ehlayel2,4 1Department of Pediatrics, Section of  Academic General Pediatrics, Hamad  Medical Corporation, 2weill Cornell  Medical College, Doha, Qatar; 3School  of Pharmacy, Lebanese international  University, Khiara, Lebanon;   4Department of Pediatrics, Section of  Pediatric Allergy- immunology, Hamad  Medical Corporation, Doha,  QatarAbstract:  Allergic diseases comprise a genetically heterogeneous group of chronic,  immunomediated diseases.",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"Worldwide, respiratory allergic diseases alone, namely asthma and allergic rhinitis,  affect nearly 700 million subjects.3 It has been clearly reported that the prevalence  of these diseases has been on the rise for the last few decades, but at different rates,  in various areas of the world.3,4 Currently, bronchial asthma is considered the most  common chronic, noninfectious condition among children.4 In some industrialized  countries, the prevalence of asthma is close to 35%–40%, whereas it is less than 5% in  other communities;5 furthermore, relatively new reports have shown that the prevalence  of asthma is increasing in many low- and middle-income nations.4,6Correspondence: Mohamed A Hendaus Department of Pediatrics, Section of  Academic General Pediatrics, Hamad  Medical Corporation, PO Box 3050,  Doha, Qatar Tel +974 4439 2239 Fax +974 4443 9571 email mhendaus@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Hendaus et al Running head recto: Preventing allergies in children DOI: http://dx.doi.org/10.2147/TCRM.S98100",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"Available from: http://www.ginasthma.org/local/uploads/files/ GINABurdenReport_1.pd f. Accessed July 17, 2015.",OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"Available from: http://isaac.auckland.ac.nz/ resources/Global_Asthma_Report_2011.pd f. Accessed: January 11,  2016.",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
Available  from: http://www.sopterj.com.br/profissionais/_revista/2012/n_02/03.,Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"Available from: http://www.lung.org/finding-cures/our-research/ trend-reports/asthma-trend-report.pd f. Accessed July 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"Available from: http://www.effca.org/ content/food-cultur e. Accessed January 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
Available from: http://www.ilsi.,Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/2e/tcrm-12-361.PMC4788360.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/d7/opth-10-393.PMC4788361.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 393–404submit your manuscript | www.dovepress.co m Dove press  393 http: //dx.doi.org/10.2147/OPTH.S9939 4Dove press ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article Femtosecond lasers for laser in situ keratomileusis:  a systematic review and meta-analysis Anne Huhtala1 Juhani Pietilä1,2 Petri Mäkinen1,2 Hannu Uusitalo1–3 1Silmäasema Eye Hospital, 2SILK,   Department of Ophthalmology,   School of Medicine, University of  Tampere, 3TAUH Eye Center, Tampere  University Hospital, Tampere, FinlandPurpose:  The aim of this study was  to review and meta-analyze whether there are differences  between reported femtosecond (FS) lasers for laser-assisted in situ keratomileusis (LASIK)  in terms of efficacy, predictability, and safety as primary outcomes and corneal flap thickness  measurements and pre- and postoperative complications as secondary outcomes.",Non-OADS,/arxiv_data1/oa_pdf/f7/d7/opth-10-393.PMC4788361.pdf
"IntraLase, now produced by Abbott Medical  Optics Inc. (Santa Ana, CA, USA), was the first FS laser keratome introduced in the USA  in 2001.6 Technolas Femtosecond Workstation, formerly known as Femtec, by Technolas  Perfect Vision (Munich, Germany), was introduced immediately after the market launch  of IntraLase.7 FEMTO LDV by Ziemer Ophthalmic Systems (Port, Switzerland) was  introduced in the late 2005, and Visumax by Carl Zeiss Meditec AG (Jena, Germany)  in the fall 2006.7 Wavelight FS200 by Alcon Laboratories, Inc. (Fort Worth, TX, USA) Correspondence: Anne Huhtala Silmäasema Eye Hospital Tampere,  Hämeenkatu 6, FIN-33100 Tampere,  Finland Tel +358 50 304 0458 Email annemhuhtala@gmail.co m Journal name: Clinical Ophthalmology Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 10 Running head verso: Huhtala et al Running head recto: Femtosecond lasers for LASIK DOI: http://dx.doi.org/10.2147/OPTH.S99394",Non-OADS,/arxiv_data1/oa_pdf/f7/d7/opth-10-393.PMC4788361.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f7/d7/opth-10-393.PMC4788361.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/d7/opth-10-393.PMC4788361.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/52/ed/ijn-11-905.PMC4788362.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 905–918International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  905OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10035 0effects of copper oxide nanoparticles on  developing zebrafish embryos and larvae Yan sun Gong Zhang Zizi he Yajie Wang Jianlin cui Yuhao Li Department of Pathology, Key  Laboratory of T umor Microenvironment  and Neurovascular Regulation, Nankai  University School of Medicine, Tianjin,   People’s Republic of ChinaAbstract:  Copper oxide nanoparticles (CuO NPs) are used for a variety of purposes in a wide  range of commercially available products.",Non-OADS,/arxiv_data1/oa_pdf/52/ed/ijn-11-905.PMC4788362.pdf
"The ideal features of this organism  include external fertilization, large number of spawn, transparent embryos, and rapid  development.9,10 The liver, a main target for nanomaterial toxicity, is an essential organ Correspondence: Jianlin Cui; Yuhao Li Department of Pathology, Key  Laboratory of Tumor Microenvironment  and Neurovascular Regulation, Nankai  University School of Medicine, 94 Weijin  Road, Tianjin 300071, People’s Republic  of China Tel +86 22 2350 2554 Fax +86 22 2350 2554 email cuijianlin@nankai.edu.c n;   liyuhao@nankai.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Sun et al Running head recto: Effects of CuO NPs on developing zebrafish DOI: http://dx.doi.org/10.2147/IJN.S100350",Non-OADS,/arxiv_data1/oa_pdf/52/ed/ijn-11-905.PMC4788362.pdf
"ImageJ software  (1.49×; NIH, http://rsb.info.nih.gov/ij /) was used to convert  the Western blot gel images to 8-bit grayscale prior to densi - tometric analysis of each band.",OADS,/arxiv_data1/oa_pdf/52/ed/ijn-11-905.PMC4788362.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/52/ed/ijn-11-905.PMC4788362.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/ed/ijn-11-905.PMC4788362.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijn-11-885.PMC4788363.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).international Journal of nanomedicine 2016:11 885–904submit your manuscript | www.dovepress.co m Dove press  885 http: //dx.doi.org/10.2147/IJN.S8854 6simvastatin increases the antineoplastic actions  of paclitaxel carried in lipid nanoemulsions in  melanoma-bearing mice iara F Kretzer1,2 Durvanei a Maria3 Maria c guido1 Thaís c contente1 raul c Maranhão1,2 1laboratory of Metabolism and lipids,   heart institute of the Medical school  hospital, 2Department of clinical  chemistry, Faculty of Pharmaceutical  sciences, University of são Paulo,   3Biochemistry and Biophysics  laboratories, Butantan institute,   são Paulo, BrazilPurpose:  Lipid nanoemulsions (LDEs) that bind to low-density lipoprotein (LDL) receptors  used as carriers of paclitaxel (PTX) can decrease toxicity and increase PTX antitumoral action.",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijn-11-885.PMC4788363.pdf
"In those leukemias and also in  Hodgkin and non-Hodgkin lymphomas, LDL cholesterol levels may decrease, resulting  from the increased removal of LDL from the circulation by the neoplastic tissues.3–6 correspondence: raul c Maranhão laboratório de Metabolismo de lípides,  instituto do coração (incOr) do  hospital das clínicas FMUsP, 44 avenida  Doutor enéas de carvalho aguiar –  Bloco 2, 1ss, são Paulo 05403-900, Brazil Tel +55 11 2661 5951 Fax +55 11 2661 5574 email ramarans@usp.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kretzer et al Running head recto: Simvastatin and paclitaxel carried in lipid nanoemulsions DOI: http://dx.doi.org/10.2147/IJN.S88546",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijn-11-885.PMC4788363.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijn-11-885.PMC4788363.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijn-11-885.PMC4788363.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/54/ijn-11-929.PMC4788364.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 929–940International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  929OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9642 2effects of nanoparticle size on antitumor activity  of 10-hydroxycamptothecin-conjugated gold  nanoparticles: in vitro and in vivo studies hanmei Bao1,2 Qing Zhang2,3 hui Xu1,2 Zhao Yan1,2 1Department of clinical  Pharmacology, 2Key laboratory of  cancer Prevention and Therapy,   National clinical research center for  cancer, 3Department of hematology,   Tianjin Medical University cancer  Institute and hospital, Tianjin, People’s  republic of chinaAbstract:  Gold nanoparticles (AuNPs) have emerged as a promising anticancer drug  delivery scaffold.",Non-OADS,/arxiv_data1/oa_pdf/9a/54/ijn-11-929.PMC4788364.pdf
"A type of size-shrinkable correspondence: Zhao Yan Department of clinical Pharmacology,  Tianjin Medical University cancer  Institute and hospital, huan-hu-Xi  road, Ti-Yuan-Bei, hexi District, Tianjin  300060, People’s republic of china Tel +86 22 2334 0123 (ext 6012) Fax +86 22 2352 4155 email zhao.yan0219@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Bao et al Running head recto: Nanoparticle size and antitumor activity of HCPT-AuNPs DOI: http://dx.doi.org/10.2147/IJN.S96422",Non-OADS,/arxiv_data1/oa_pdf/9a/54/ijn-11-929.PMC4788364.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9a/54/ijn-11-929.PMC4788364.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/54/ijn-11-929.PMC4788364.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6c/08/jmdh-9-103.PMC4788365.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary Healthcare 2016:9 103–109Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  103Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S10069 3improving health-related quality of life through an  evidence-based obesity reduction program: the  Healthy Weights initiative Mark e lemstra1 Marla r rogers2 1alliance Health, Moose Jaw,   2Department of Physical Medicine  and rehabilitation, college of  Medicine, University of saskatchewan,   saskatoon, sK, canada correspondence: Marla rogers   Department of Physical Medicine and  rehabilitation, college of Medicine,  University of saskatchewan,   701 Queen street, saskatoon,   sK s7K 0M7, canada   email marla.rogers@usask.c aAbstract:  When evaluating any health intervention, it is critical to include the impact of the  intervention on health-related quality of life (HRQL).",Non-OADS,/arxiv_data1/oa_pdf/6c/08/jmdh-9-103.PMC4788365.pdf
"Available from:  http://www.statcan.gc.ca/daily-quotidien/140612/dq140612b-eng.ht m.  Accessed December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6c/08/jmdh-9-103.PMC4788365.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/6c/08/jmdh-9-103.PMC4788365.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/08/jmdh-9-103.PMC4788365.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/ec/ott-9-1221.PMC4788366.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1221–1230OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1221Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9721 1integrating subpathway analysis to identify  candidate agents for hepatocellular carcinoma Jiye Wang1 Mi li2 Yun Wang3 Xiaoping liu4 1The criminal science and T echnology  Department, Zhejiang Police college,   hangzhou, Zhejiang Province,   2Department of nursing, shandong  college of Traditional chinese  Medicine college, Yantai, shandong  Province, 3Office Department  of gastroenterology, The First  affiliated hospital of Xi’an Jiao T ong  University, Xi’an, shanxi Province,   4Key laboratory of systems Biology,   shanghai institutes for Biological  sciences, shanghai, People’s  republic of chinaAbstract:  Hepatocellular carcinoma (HCC) is the second most common cause of  cancer-associated death worldwide, characterized by a high invasiveness and resistance to normal  anticancer treatments.",Non-OADS,/arxiv_data1/oa_pdf/1d/ec/ott-9-1221.PMC4788366.pdf
"One example is The Cancer Genome correspondence: Jiye Wang The criminal science and Technology  Department, Zhejiang Police college,  555 Binwen road, Binjiang District,  310000 hangzhou, Zhejiang Province,  People’s republic of china Tel/fax +86 571 8778 7220 email wangjiye_poli@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Identify candidate agents for HCC DOI: http://dx.doi.org/10.2147/OTT.S97211",Non-OADS,/arxiv_data1/oa_pdf/1d/ec/ott-9-1221.PMC4788366.pdf
Materials and methods Microarray data and Deg analysis We downloaded RNA-seq data from liver HCC samples  from the TCGA database ( http://cancergenome.nih.gov /).,OADS,/arxiv_data1/oa_pdf/1d/ec/ott-9-1221.PMC4788366.pdf
"identifying subpathways by  subpathwayMiner HCC-related subpathways were identified using Sub - pathwayMiner an R-based software package that flexibly  identifies subpathways using the Kyoto Encyclopedia of  Genes and Genomes (KEGG) pathway structure information  database.9 KEGG ( http://www.genome.jp/kegg /) is a  collection of online databases containing information on genomes, enzymatic pathways, and biological chemicals.",OADS,/arxiv_data1/oa_pdf/1d/ec/ott-9-1221.PMC4788366.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1d/ec/ott-9-1221.PMC4788366.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/ec/ott-9-1221.PMC4788366.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/b7/ott-9-1251.PMC4788367.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1251–1267OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1251Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9677 2circulating interleukin-10 levels and human  papilloma virus and epstein–Barr virus-associated  cancers: evidence from a Mendelian randomization  meta-analysis based on 11,170 subjects Kai Qu,1,* Qing Pang,1,* Ting lin,1  li Zhang,2 Mingliang gu,3 Wenquan  niu,4 chang liu,1,* Ming Zhang5 1Department of hepatobiliary  surgery, The First affiliated hospital  of Xi’an Jiaotong University  college of Medicine, Xi’an, shaanxi  Province, People’s republic of  china; 2Department of Ultrasound  Diagnostics, Tangdu hospital, Fourth  Military Medical University, Xi’an,   shaanxi Province, People’s republic of  china; 3chinese academy of sciences  Key laboratory of genome sciences  and information, Beijing institute  of genomics, chinese academy of  sciences, Beijing, People’s republic  of china; 4state Key laboratory of  Medical genomics, ruijin hospital,   shanghai Jiaotong University school  of Medicine, shanghai, People’s  republic of china; 5Department of  Otolaryngology, eye, ear, nose and  Throat hospital, Fudan University,   shanghai, People’s republic of china *These authors contributed equally to  this workAbstract:  Recent studies have showed interleukin 10 (IL-10) is a critical cytokine that  determines antiviral immune response and is related to virus-associated cancers.",Non-OADS,/arxiv_data1/oa_pdf/a1/b7/ott-9-1251.PMC4788367.pdf
"For example, EBV is  deemed as a “helper virus” for HPV -induced carcinogenesis.10 Coinfection of HPV and  EBV was observed in 30%–50% of patients with oral cancer11,12 and cervical cancer.13,14  Although the obvious association between HPV/EBV and human papilloma virus and correspondence: Wenquan niu state Key laboratory of Medical  genomics, ruijin hospital, shanghai  Jiaotong University school of Medicine,  ruijin second road 197, new huangpu  District, shanghai 200025, People’s  republic of china Tel +86 21 6437 0045 email niuwenquan_shcn@163.co m Ming Zhang Department of Otolaryngology, eye,  ear, nose and Throat hospital, Fudan  University, 83 Fen Yang road, shanghai  200031, People’s republic of china Tel +86 21 6437 7134 email ent_zhm@126.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Qu et al Running head recto: IL-10 and HPV -/EBV -associated cancers DOI: http://dx.doi.org/10.2147/OTT.S96772",Non-OADS,/arxiv_data1/oa_pdf/a1/b7/ott-9-1251.PMC4788367.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a1/b7/ott-9-1251.PMC4788367.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/b7/ott-9-1251.PMC4788367.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/5d/ppa-10-275.PMC4788368.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and adherence 2016:10 275–282submit your manuscript | www.dovepress.co m Dove press  275 http: //dx.doi.org/10.2147/PPA.S9213 5Better health-related quality of life (mental  component summary), having a higher level of  education, and being less than 75 years of age  are predictors of hospital admission among  cognitively intact nursing home residents: a 5-year  follow-up study correspondence: Jorunn Drageset Department of nursing, Faculty for  health and social science, Bergen  University college, inndalsveien 28,  n-5063 Bergen norway Tel +47 55 585 589 Fax +47 55 585 556 email jorunn.drageset@hib.n o Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Drageset et al Running head recto: Health-related quality of life among NH residents DOI: http://dx.doi.org/10.2147/PPA.S92135 Jorunn Drageset1,2 geir egil eide3,4 anette hylen ranhoff5,6 1Department of nursing, Faculty for  health and social science, Bergen  University college, Bergen, norway;   2Department of Public health and  Primary care, University of Bergen,   Bergen, norway; 3centre for clinical  research, Western norway health  region authority, Bergen, norway;   4research group for lifestyle  epidemiology, Department of Public  health and Primary care, University  of Bergen, Bergen, norway; 5Kavli  research centre for ageing and  Dementia, haraldsplass hospital,   Bergen, norway; 6Department of  clinical science, University of Bergen,   Bergen, norwayObjective:  To study whether health-related quality of life (HRQOL), activities of daily living  (ADL), and anxiety and depression symptoms affect the risk of hospital admission and potential  interactions with having a cancer diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/e6/5d/ppa-10-275.PMC4788368.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e6/5d/ppa-10-275.PMC4788368.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d9/60/ijn-11-919.PMC4788369.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 919–928International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  919OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9227 8Oxidative stress, inflammation, and DNA damage  in multiple organs of mice acutely exposed to  amorphous silica nanoparticles abderrahim Nemmar1 Priya Yuvaraju1 Sumaya Beegam1 Javed Yasin2 Elsadig E Kazzam2 Badreldin H Ali3 1Department of Physiology,   2Department of Internal Medicine,   College of Medicine and Health  sciences, United arab emirates  University, Al Ain, UAE; 3Department  of Pharmacology, College of Medicine  and health sciences, sultan Qaboos  University, Muscat, Al-Khoudh,   sultanate of OmanAbstract:  The use of amorphous silica (SiO2) in biopharmaceutical and industrial fields can  lead to human exposure by injection, skin penetration, ingestion, or inhalation.",Non-OADS,/arxiv_data1/oa_pdf/d9/60/ijn-11-919.PMC4788369.pdf
"Keywords:  amorphous silica nanoparticles, organ toxicity, oxidative stress, inflammation,  DNA damage Introduction Engineered nanomaterials are commonly defined as materials designed and produced  to have structural features with at least one dimension of #100 nm.1 Engineered  nanoparticles display features such as small size, large surface area to mass ratio,  shape, crystallinity, surface charge, reactive surface groups, dissolution rate, state of  agglomeration, and dispersal that give them properties greatly different from larger  particles of the same composition.1 In this context, nanoparticles have been demon - strated to cause greater biological responses and particle-mediated toxicity than larger  particles per given mass.1 Amorphous silica (SiO2) nanoparticles (SiNPs) are nano-sized structures of SiO2  that are used in various areas, such as sunscreen lotions, drug delivery, cosmetics,  food, and chemical industries entailing human exposure during production or use.2  These wide applications of SiNPs have prompted several investigators to perform  in vitro studies on the effect of these nanoparticles in different cell types such as correspondence: abderrahim Nemmar Department of Physiology, College of  Medicine and Health Sciences, United  Arab Emirates University, Tawam Medical  Campus, Khalifa Ibn Zayed Street,  PO Box 17666, Al Ain, UAE Tel +971 3713 7533 Fax +971 3767 1966 email anemmar@uaeu.ac.a e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Nemmar et al Running head recto: SiNPs induce oxidative stress, inflammation, and DNA damage DOI: http://dx.doi.org/10.2147/IJN.S92278",Non-OADS,/arxiv_data1/oa_pdf/d9/60/ijn-11-919.PMC4788369.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d9/60/ijn-11-919.PMC4788369.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/60/ijn-11-919.PMC4788369.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/41/ndt-12-589.PMC4788370.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 589–601Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  589Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10059 7Brain oscillations in bipolar disorder  and lithium-induced changes Murat i˙lhan Atagün Department of Psychiatry, Yıldırım  Beyazıt University Medical School,   Cankaya, Ankara, T urkeyAbstract:  Electroencephalography (EEG) studies in patients with bipolar disorder have revealed  lower amplitudes in brain oscillations.",Non-OADS,/arxiv_data1/oa_pdf/58/41/ndt-12-589.PMC4788370.pdf
"Earlier researches have detected Correspondence: Murat i ˙lhan Atagün Department of Psychiatry, Yıldırım  Beyazıt University Medical School,  Eskişehir Highway No 6, Cankaya 6400,  Ankara, Turkey Tel +90 312 324 1555 Fax +90 312 324 1518 email miatagun@ybu.edu.t rJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Atagün Running head recto: Brain oscillations in bipolar disorder and lithium-induced changes DOI: http://dx.doi.org/10.2147/NDT.S100597",Non-OADS,/arxiv_data1/oa_pdf/58/41/ndt-12-589.PMC4788370.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/58/41/ndt-12-589.PMC4788370.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/41/ndt-12-589.PMC4788370.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ijn-11-873.PMC4788371.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 873–883International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  873OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10090 3apoptosis inducing ability of silver decorated  highly reduced graphene oxide nanocomposites  in a549 lung cancer Merajuddin Khan1 Mujeeb Khan1 abdulhadi h al-Marri1 abdulrahman al-Warthan1 hamad Z alkhathlan1 Mohammed rafiq h  siddiqui1 Vadithe lakshma Nayak2 ahmed Kamal2 syed F adil1 1Department of chemistry, college  of science, King saud University,   riyadh, Kingdom of saudi arabia;   2Department of Medicinal chemistry  and Pharmacology, csIr – Indian  Institute of chemical T echnology,   hyderabad, IndiaAbstract:  Recently, graphene and graphene-based materials have been increasingly used for  various biological applications due to their extraordinary physicochemical properties.",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ijn-11-873.PMC4788371.pdf
"However, the medicinal use of metal-containing  ointments/drugs is also very popular and known to humans since ages as described  in the Papyus Ebers in ∼1550 BC.4 Coordination complex of ligands to a metal is correspondence: ahmed Kamal Department of Medicinal chemistry and  Pharmacology, csIr – Indian Institute of  chemical Technology, hyderabad 500  007, India Tel +91 40 2719 3157 Fax +91 40 2719 3189 email ahmedkamal@iict.res.i n  syed F adil Department of chemistry, college of  science, King saud University, PO Box  2455, riyadh, 11451, Kingdom of  saudi arabia Tel +966 1 146 7043 9 Fax +966 1 146 7425 3 email sfadil@ksu.edu.s a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Khan et al Running head recto: Apoptosis inducing nanocomposites of Ag/HRG in A549 lung cancer DOI: http://dx.doi.org/10.2147/IJN.S100903",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ijn-11-873.PMC4788371.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ijn-11-873.PMC4788371.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/87/ijn-11-873.PMC4788371.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/44/2b/vhrm-12-065.PMC4788372.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/44/2b/vhrm-12-065.PMC4788372.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Vascular Health and Risk Management 2016:12 65–74Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  65ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S8180 7Atrial fibrillation and silent stroke: links, risks, and  challenges Kathrin Hahne¹ Gerold Mönnig2 Alexander Samol¹ ¹Division of Cardiology, 2Division of  Electrophysiology, Department of  Cardiovascular Medicine, University  Hospital Münster, Münster, Germany Correspondence: Alexander Samol   Department of Cardiology and Critical  Care Medicine, Johannes Wesling Hospital  Minden, Hans-Nolte-Str 1, 32429 Minden,  Germany   T el +49 571 7905 3102   Fax +49 571 79029 3100   email Alexander.Samol@ muehlenkreiskliniken.d eAbstract:  Atrial fibrillation (AF) is the most common cardiac arrhythmia, with a projected  number of 1 million affected subjects in Germany.",Non-OADS,/arxiv_data1/oa_pdf/44/2b/vhrm-12-065.PMC4788372.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/44/2b/vhrm-12-065.PMC4788372.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/2b/vhrm-12-065.PMC4788372.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/38/e1/opth-10-405.PMC4788373.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 405–409Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  405Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9538 3Clinical trial comparing autogenous fascia lata  sling and gore-T ex suspension in bilateral  congenital ptosis Mahmoud ahmed  elsamkary1 Maged Maher salib  roshdy1,2 1Ophthalmology Department,   Faculty of Medicine, ain shams  University, Cairo, egypt; 2Pediatric  Ophthalmology Department, al  Watany eye hospital, Cairo, egyptPurpose:  To study the effect of autogenous fascia lata sling (AFLS) versus Gore-Tex suspension  (GTS) regarding the functional and aesthetic outcomes in patients with bilateral congenital  ptosis.",Non-OADS,/arxiv_data1/oa_pdf/38/e1/opth-10-405.PMC4788373.pdf
"The most common surgical approach in  bilateral congenital ptosis with poor levator function of ,4 mm is frontalis suspension  technique.5 Different materials are used as suspensions and can be divided into three  categories: autogenous fascia lata sling (AFLS), allograft fascia lata, and synthetic  materials like Gore-Tex suspension (GTS).Correspondence: Maged Maher salib  roshdy al Watany eye hospital, 211 elhegaz  street, elhegaz square, heliopolis,  Cairo 11361, egypt Tel +20 122 281 1230 Fax +20 2 2624 7474 email dr_maged_roshdy@med.asu.edu.e g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Elsamkary and Roshdy Running head recto: Autogenous fascia lata sling versus Gore-Tex suspension DOI: http://dx.doi.org/10.2147/OPTH.S95383",Non-OADS,/arxiv_data1/oa_pdf/38/e1/opth-10-405.PMC4788373.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/38/e1/opth-10-405.PMC4788373.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/e1/opth-10-405.PMC4788373.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ee/4a/cia-11-285.PMC4788374.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 285Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ee/4a/cia-11-285.PMC4788374.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ee/4a/cia-11-285.PMC4788374.pdf
"2008;   37(3):311–317.Correspondence: Fatih tufan Department of Geriatrics, Istanbul  Faculty of Medicine, Istanbul University,  turgut Ozal Millet Street, PB 34093,  Fatih, Istanbul, turkey tel +90 212 414 2000 email fatihtufan@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: Yilmaz et al Running head recto: Utilization of arm span instead of height in BMI calculation DOI: http://dx.doi.org/10.2147/CIA.S103151 Dove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/ee/4a/cia-11-285.PMC4788374.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/6b/pcv173.PMC4788409.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/a4/pcw020.PMC4788410.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/pcv193.PMC4788412.pdf
"To facilitate the sharing, canalization and choosing of unique gene names in M. polymorpha , a wiki has been established at the National Institute of Genetics at Mishima, Shizuoka, Japan: http://marchantia.info/nomenclature/.",Non-OADS,/arxiv_data1/oa_pdf/5e/bf/pcv193.PMC4788412.pdf
"Ttests were used to evaluate the results.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1500599/DC1According to our agreement with eBay, we cannot use, reproduce, or access the data.",OADS,/arxiv_data1/oa_pdf/dc/2b/1500599.PMC4788474.pdf
"NIH Roadmap for Medical Research: Epigenomics overview, http://www.roadmapepigenomics.",Non-OADS,/arxiv_data1/oa_pdf/f8/08/1501340.PMC4788475.pdf
Our raw observational data will be available on theSubaru-Mitaka Okayama-Kiso Archive System (http://smoka.nao.ac.jp/).,OADS,/arxiv_data1/oa_pdf/1e/79/1500875.PMC4788476.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1500875/DC1Materials and Methods Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/79/1500875.PMC4788476.pdf
The raw observational data will beavailable from the Subaru-Mitaka Okayama-Kiso Archive System (http://smoka.nao.ac.jp/).,OADS,/arxiv_data1/oa_pdf/1e/79/1500875.PMC4788476.pdf
"Similarly, the a ccuracy of the fracture strength in the presence of a sharp crack in an infinite-width plate with respect to a finite-width plate is better than 1%, estimated by substituting theratio ainto the expression for a finite-width plate ( 53) sLEFM f¼KIcﬃﬃﬃﬃﬃpapﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ 1−ap 1−0:5aþ0:326a2/C18/C19 ð9Þ SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1500969/DC1 Note S1.",Non-OADS,/arxiv_data1/oa_pdf/a1/09/1500969.PMC4788477.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1501254/DC1Table S1.,Non-OADS,/arxiv_data1/oa_pdf/30/17/1501254.PMC4788478.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1501130/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/d4/1501130.PMC4788479.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1500975/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/11/b8/1500975.PMC4788480.pdf
"J. Oksanen, F. Guillaume Blanchet, R. Kindt, P. Legendre, P. R. Minchin, R. B. O ’H a r a ,G .L .S i m p s o n , P. Solymos, M. Henry, H. Stevens, H. Wagner, “vegan: Community Ecology Package ”(2013); available at http://cran.r-project.org/package=vegan.",Non-OADS,/arxiv_data1/oa_pdf/11/b8/1500975.PMC4788480.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1501283/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/59/1501283.PMC4788481.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1501333/DC1S1.,Non-OADS,/arxiv_data1/oa_pdf/eb/e9/1501333.PMC4788484.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1501486/DC1Table S1.,Non-OADS,/arxiv_data1/oa_pdf/e8/06/1501486.PMC4788485.pdf
"A. Rambaut, A. J. Drummond, TreeAnnotator (2007); available at http://beast.bio.ed.ac.uk/ TreeAnnotator.",OADS,/arxiv_data1/oa_pdf/e8/06/1501486.PMC4788485.pdf
Images were analyzed with ImageJ open source software (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/ab/b4/1500882.PMC4788486.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1500882/DC1 Table S1.,Non-OADS,/arxiv_data1/oa_pdf/ab/b4/1500882.PMC4788486.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1500445/DC1Table S1.,Non-OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
"RATP, http://data.ratp.fr/ [accessed 20 January 2016].42.",OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
"SNCF, http://files.transilien.com/horaires/gtfs/ [accessed 1 October 2014].43.",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
"MTA, http://web.mta.info/ [accessed 29 November 2014].44.",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
"Google Developers, https://developers.google .com/transit/gtfs/ [accessed 15 January 2014].",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
45. https://en.wikipedia.org/wiki/List_of_New_York_City_Subway_stations_in_Manhattan#Lines_ and_services (see the table “Lines and services ”) [accessed 22 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
"Wikimedia Commons, http://commons.wikimedia.org/wiki/File:NYC_subway-4D.svg [accessed 30 January 2015].",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
"GIS, http://nlftp.mlit.go.jp/ksj-e/gml/datalist/KsjTmplt-P11.html [accessed 1 October 2014].48.",OADS,/arxiv_data1/oa_pdf/5d/d5/1500445.PMC4788487.pdf
"Inclusion criteria for salvage patients included PSA value of 40.1 ng ml −1(http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDe- tails.aspx?study = 0534) and a minimum of three PSA values taken 1 monthapart, in order to calculate doubling time.",Non-OADS,/arxiv_data1/oa_pdf/3d/7c/pcan201536a.PMC4788488.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Prostate Cancer and Prostatic Diseases website (http://www.nature.com/pcan)CTCs in prostate cancer radiotherapy LE Lowes et al 364 Prostate Cancer and Prostatic Diseases (2015), 358 –364 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3d/7c/pcan201536a.PMC4788488.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1500778/DC1Modeling dynamic stiffness controlEq.,Non-OADS,/arxiv_data1/oa_pdf/e1/9f/1500778.PMC4788489.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/2/e1501142/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/5a/70/1501142.PMC4788490.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/53/main.PMC4788499.pdf
http://dx.doi.org/10.1016/j.scog.2015.05.002 2215-0013/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/53/main.PMC4788499.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/53/main.PMC4788499.pdf
Contents lists available at ScienceDirect Schizophrenia Research: Cognition journal homepage: http://www.schizrescognition.com/,Non-OADS,/arxiv_data1/oa_pdf/79/53/main.PMC4788499.pdf
"Life Out- comes 2, 15. http://dx.doi.org/10.1186/1477-7525-2-15 .",Non-OADS,/arxiv_data1/oa_pdf/79/53/main.PMC4788499.pdf
http://dx.doi.org/10.1371/ journal.pone.0083774 .,Non-OADS,/arxiv_data1/oa_pdf/79/53/main.PMC4788499.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.nicl.2015.06.0122213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
Supplementary data related to this article can be found online at http://doi.dx.org/10.1016/j.nicl.2015.06.012 .,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"5 (1), 13 –14.http://dx.doi.org/10.1038/nn77711731802 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.ejphar.,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1038/nrn87512094212 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"345 (1), 41 –51.http://dx.doi.org/10.1124/jpet.112.20114523370795 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1038/ nrd202716604100 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1007/s00213-011- 2580-122205158 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"3, 73 –99.http://dx.doi.org/10.1007/ 7854_2009_1821161750 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0505- 09.200919692603 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1007/s00213-004- 2034-015536545 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1159/00028621520523024 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.neuron.2011.,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1126/science.113707317332411 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/ 10.1038/nn157916251991 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"Psychiatry 2, 43. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1176/appi.ajp.157.11.178911058476 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"580, 1 –6.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"8, 101. http://dx.doi.org/10.3389/fnsys.2014.0010124904322 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1007/s00213- 004-1828-415127179 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.6376-10.201121613500 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0271-06.200616899732 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"Neuropsychopharmacology 35 (1), 4 –26.http://dx.doi.org/10.1038/npp.",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"489 (2), 74 –78.http://dx.doi.org/10.1016/j.neulet.2010.11.",OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1007/s00213- 011-2610-z22234380 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"38, 1 –16.http://dx.doi.org/10.1016/j.neubiorev.2013.10.",OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.neulet.2012.11.05423262077 .,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.neuron.2005.02.00515748840 .,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1007/s10548-012-0267-523208517 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.3758/BF0319278216956107 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.03.,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4177-03.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"168 (1 –2), 57–65.http://dx.doi.org/10.1007/s00213-002-1196-x12845418 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"Synapse39 (3), 193– 200. http://dx.doi.org/10.1002/1098-2396(20010301)39:3 b193::AID- SYN1000 N3.0.CO;2-F11169768 .Rothmond, D.A., Weickert, C.S., Webster, M.J., 2012.",OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"13, 18. http://dx.doi.org/10.1186/1471-2202-13-1822336227 .",Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1097/00004647- 200304000-0001112679724 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1007/s00213-013-3399-824408208 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
"400 (1 –2), 39 –43.http://dx.doi.org/10.1016/j.neulet.2006.02.02216510242 .",OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1038/npp.2013.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.1544-06.200616775146 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1569-05.200516192380 .,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1371-12.,Non-OADS,/arxiv_data1/oa_pdf/a9/ae/main.PMC4788503.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diffusion tensor imagingFree-water corrected DTIMajor depressive disorderTract-based spatial statisticsFractional anisotropyAxial diffusivity 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/61/main.PMC4788504.pdf
http://dx.doi.org/10.1016/j.nicl.2015.11.020 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/61/main.PMC4788504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/61/main.PMC4788504.pdf
DOI of original article: http://dx.doi.org/10.1016/j.amsu.2015.10.007 .,OADS,/arxiv_data1/oa_pdf/28/81/main.PMC4788632.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.12.058 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/28/81/main.PMC4788632.pdf
"Authors Minish M. Jain, She- khar G. Patil, Anand B. Pathak, Chetan D. Deshmukh, Niraj Bhatt, K. Govind Babu, Chiramana Haritha, Shailesh A. Bondarde, Raghu-nadharao Digumarti, Jyoti Bajpai, Ravi Kumar, Smita U. Gupte,Ashish V. Bakshi, Gouri Sankar Bhattacharyya, Poonam Patil, Sun- daram Subramanian, Ashok K. Vaid, Chirag J. Desai, and Poonamalle P. Bapsy received research funding from Sun Pharma AdvancedResearch Co. Ltd. Poonamalle P. Bapsy is employed by Sun Pharma Advanced Research Co. Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/26/d6/10549_2016_Article_3736.PMC4788678.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b8/bc/10549_2016_Article_3727.PMC4788680.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.Breast Cancer Res Treat (2016) 156:57–64 63 123",Non-OADS,/arxiv_data1/oa_pdf/98/5a/10549_2016_Article_3742.PMC4788686.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4c/64/10549_2016_Article_3725.PMC4788691.pdf
IBIS computations are provided by the Risk Web Service developed jointlyby the Hughes RiskApps Group at the Massachusetts GeneralHospital and the BayesMendel Lab at the Dana Farber Cancer Institute http://bayesmendel.dfci.harvard.edu/risk/ .,OADS,/arxiv_data1/oa_pdf/89/1a/10549_2016_Article_3726.PMC4788692.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/89/1a/10549_2016_Article_3726.PMC4788692.pdf
National Institute of Health (NIH) Precision Medicine Initiative (2015) http://www.nih.gov/precisionmedicine/ .,Non-OADS,/arxiv_data1/oa_pdf/89/1a/10549_2016_Article_3726.PMC4788692.pdf
Cancer Australia Advice about familial aspects of breast cancer and epithelial ovarian cancer (2010) https://canceraustralia.gov.,Non-OADS,/arxiv_data1/oa_pdf/89/1a/10549_2016_Article_3726.PMC4788692.pdf
Full guideline June 2013. http://www.nice.org.uk/ guidance/cg164/evidence/full-guideline-190130941 .,Non-OADS,/arxiv_data1/oa_pdf/89/1a/10549_2016_Article_3726.PMC4788692.pdf
https://pluto.srl.cam.ac.uk/ cgi-bin/bd3/v3/bd.cgi .,Non-OADS,/arxiv_data1/oa_pdf/89/1a/10549_2016_Article_3726.PMC4788692.pdf
"Trevena L, Zikmund-Fisher FB, Edwards A et al (2012) Pre- senting probabilities: update of the International Patient DecisionAids Standards (IPDAS) Collaboration’s background document, chap C. http://ipdas.ohri.ca/IPDAS-Chapter-C.pdf .",OADS,/arxiv_data1/oa_pdf/89/1a/10549_2016_Article_3726.PMC4788692.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/73/95/10549_2016_Article_3737.PMC4788694.pdf
"Each dilution curve was ﬁtted with a logistic model (‘‘Supercurve Fitting’’ developed by the Department ofBioinformatics and Computational Biology in MD Anderson Cancer Center, http://bioinformatics.mdander son.org/OOMPA ).",OADS,/arxiv_data1/oa_pdf/1f/46/10549_2016_Article_3729.PMC4788696.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1f/46/10549_2016_Article_3729.PMC4788696.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/29/main.PMC4788701.pdf
"Oral pre-cancer is clinically diverse and includes various lesions (leukoplakia, erythroplakia and palatal lesions in reverse smokers) http://dx.doi.org/10.1016/j.oraloncology.2015.11.012 1368-8375/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/12/29/main.PMC4788701.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: Centre of Chronic Conditions and Injuries, Public Health Foundation of India, 4th Floor, Plot No.",Non-OADS,/arxiv_data1/oa_pdf/12/29/main.PMC4788701.pdf
Available from: http://globocan.iarc.fr [accessed on 30th April 2015].,Non-OADS,/arxiv_data1/oa_pdf/12/29/main.PMC4788701.pdf
Available from: http://globocan.iarc.fr [accessed on 30th April 2015].,Non-OADS,/arxiv_data1/oa_pdf/12/29/main.PMC4788701.pdf
"5-8Nephrectomy before, concomi- tant with, or after transplant has various advantages and dis- advantages ( Table S1, SDC , http://links.lww.com/TXD/A20).",Non-OADS,/arxiv_data1/oa_pdf/49/5b/txd-1-e43.PMC4788702.pdf
"The type and timing of n ephrectomies according to the nephrectomy and transplant years are shown in Supplemen-taryFigures S1 ,a n d S2(SDC, http://links.lww.com/TXD/A20).",Non-OADS,/arxiv_data1/oa_pdf/49/5b/txd-1-e43.PMC4788702.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.004 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/d0/8c/main.PMC4788703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/main.PMC4788703.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.002 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/5f/e4/main.PMC4788704.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/e4/main.PMC4788704.pdf
"Based on these promising results of preclinical studies, PEGPH20 is now being tested in a clinical trial (NCT01839487) to determine its ef ﬁcacy when used in combination with nab- paclitaxel plus gemcitabine in patients with metastatic PDAC (https://clinicaltrials.gov/show/NCT01839487 ).",Non-OADS,/arxiv_data1/oa_pdf/5f/e4/main.PMC4788704.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/06/main.PMC4788705.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.001 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/bc/20/main.PMC4788706.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: CFDA, China Food and Drug Administration; HPLC, high performance liquid chromatography; HQT, Huangqin Tang; ICH, International Conference on Harmonization; LC –MSn, liquid chromatography –tandem mass spectrometer; LLOD, linearity, lower limit of detection; LLOQ, lower limit of quanti ﬁcation; PCA, principal component analysis; RSD, relative standard deviation; S/N, signal-to-noise ratio; TCM, traditional Chinese medicine.",Non-OADS,/arxiv_data1/oa_pdf/bc/20/main.PMC4788706.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.009 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/36/57/main.PMC4788707.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/57/main.PMC4788707.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.006 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/a8/a5/main.PMC4788709.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/a5/main.PMC4788709.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.003 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/e6/4d/main.PMC4788710.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/4d/main.PMC4788710.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.008 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/01/82/main.PMC4788711.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/82/main.PMC4788711.pdf
Available from: http://dx.doi.org/10.1155/2012/247597 .,Non-OADS,/arxiv_data1/oa_pdf/01/82/main.PMC4788711.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.10.002 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/dd/fb/main.PMC4788712.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/fb/main.PMC4788712.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AABA, α-aminobutyric acid; AccQ, 6-aminoquinolyl- N-hydroxysuccinimidyl carbamate; AMQ, 6-aminoquinoline; AQC, 6-aminoqui- nolyl- N-hydrosysuccinimidyl carbamate; DPPH, 1,1-diphenyl-2-picryl-hydrazyl; EA, essential amino acid; EDTA, ethylene diamine tetraacetic acid; FAA s, free amino acids; F-C, Folin-Ciocalteu; GABA, γ-aminobutyric acid; GAE, gallic acid equivalents; HCA, hierarchical cluster analysis; HEA, half-essential amino acid; NEA, non-essential amino acid; PCA, principal component analysis; RSD, relative standard deviation; Thea, theanine; UHPLC, ultra-hig h performance liquid chromatography nCorresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/ff/76/main.PMC4788713.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/76/main.PMC4788713.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.11.005 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/6c/27/main.PMC4788714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/27/main.PMC4788714.pdf
Felix Oswald and Aravindan Varadarajan contributed equally to this work.Erwin Peterman and Yves J. M. Bollen contributed equally to this work.Editor: Amitabha Chattopadhyay./C2112016 The Authors 0006-3495/16/03/1139/11 http://dx.doi.org/10.1016/j.bpj.2016.01.010 Biophysical Journal Volume 110 March 2016 1139–1149 1139,Non-OADS,/arxiv_data1/oa_pdf/d4/00/main.PMC4788719.pdf
"The TMP radius in the plane of the membrane was measured from the PDB model using PyMol (DeLano Scientiﬁc, http://www.pymol.org ).",OADS,/arxiv_data1/oa_pdf/d4/00/main.PMC4788719.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.12.012 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/19/main.PMC4788754.pdf
The HOMER (Hypergeometric Optimization of Motif EnRichment) suite of tools ( http://homer.salk.edu/homer/ ) was used to deter- mine the enrichment of individual ontology terms and create GO maps in the groups of differentially methylated genes.,OADS,/arxiv_data1/oa_pdf/e8/19/main.PMC4788754.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, Supplemental data, Supplemental appendices, threeﬁgures, and eight tables and can be found with this article onlineathttp://dx.doi.org/10.1016/j.stemcr.2015.12.012 .",OADS,/arxiv_data1/oa_pdf/e8/19/main.PMC4788754.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.01.002 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/03/main.PMC4788760.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and one table andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.01.002 .,Non-OADS,/arxiv_data1/oa_pdf/ba/03/main.PMC4788760.pdf
"Stem Cell Reports Report MicroRNAs for Fine-T uning of Mouse Embryonic Stem Cell Fate Decision through Regulation of TGF- bSignaling Christiana Hadjimichael,1,2Christoforos Nikolaou,2Joseph Papamatheakis,1,2and Androniki Kretsovali1,* 1Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology – Hellas (FORTH), 70013 Heraklion, Crete, Greece 2Department of Biology, University of Crete, 71409 Heraklion, Crete, Greece *Correspondence: kretsova@imbb.forth.gr http://dx.doi.org/10.1016/j.stemcr.2016.01.004 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3f/ce/main.PMC4788761.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and three tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/3f/ce/main.PMC4788761.pdf
"Stem Cell Reports Report Extracellular Vesicles Derived from Osteogenically Induced Human Bone Marrow Mesenchymal Stem Cells Can Modulate Lineage Commitment Margarida Martins,1,2Diana Ribeiro,1,2Albino Martins,1,2Rui Luı ´s Reis,1,2and Nuno Meleiro Neves1,2,* 13B’s Research Group-Biomaterials, Biodegradable and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Ti ssue Engineering and Regenerative Medicine, Avepark, Barco, 4805-017 Guimara ˜es, Portugal 2ICVS/3B’s PT Government Associated Laboratory, Braga/Guimara ˜es, Portugal *Correspondence: nuno@dep.uminho.pt http://dx.doi.org/10.1016/j.stemcr.2016.01.001 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/76/5b/main.PMC4788762.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, two ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/76/5b/main.PMC4788762.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.01.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/22/main.PMC4788763.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and three tablesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c4/22/main.PMC4788763.pdf
"Stem Cell Reports Article GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis Xin Gao,1Tongyu Wu,1Kirby D. Johnson,1Jamie L. Lahvic,2Erik A. Ranheim,3Leonard I. Zon,2 and Emery H. Bresnick1,* 1UW-Madison Blood Research Program, Department of Cell and Regenerative Biology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA 2Stem Cell Program and Division of Hematology/Oncology, Children’s Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA 02114, USA 3Department of Pathology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA *Correspondence: ehbresni@wisc.edu http://dx.doi.org/10.1016/j.stemcr.2016.01.008 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4788764.pdf
"Only Gpr65 resembled Gata2 , both being expressed in HSPCs and mast cells ( Figure S2 )(http://biogps.org ).",Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4788764.pdf
"B, basophilic erythroblast; O, polyorthochromatic eryth- roblast; P, proerythroblast; R, reticulocyte ( http://www.cbil.upenn.edu/ErythronDB/ ).",Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4788764.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and ﬁve ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2016.01.008 .,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4788764.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"Variables statistically significantlyassociated with seropositivity in the univariable analysisincluded age, education level, working in the garden,Seroepidemiology of toxoplasmosis in rural and urban communities Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"bOffice or indoor type of occupation as the reference category.Seroepidemiology of toxoplasmosis in rural and urban communities Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"Toxoplasma and reaction time: role of toxoplas- mosis in the origin, preservation and geographical distributionSeroepidemiology of toxoplasmosis in rural and urban communities Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"Vet Parasitol 2006; 140: 76 /C182.Seroepidemiology of toxoplasmosis in rural and urban communities Citation: Infection Ecology and Epidemiology 2016, 6: 30597 - http://dx.doi.org/10.3402/iee.v6.30597 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3f/da/IEE-6-30597.PMC4788768.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 30173 - http://dx.doi.org/10.3402/iee.v6.30173 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/97/ca/IEE-6-30173.PMC4788769.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30173 - http://dx.doi.org/10.3402/iee.v6.30173",Non-OADS,/arxiv_data1/oa_pdf/97/ca/IEE-6-30173.PMC4788769.pdf
"Distributions for prior information of known variables (Se /C30sensitivity, Sp /C30speciﬁcity) Parameter Most likely value (mode) Percentile Percentile’s value Beta distribution Reference SpSCT 0.9999 1 0.99 Beta(5836, 1.584) (15) SeSCT 0.8360 10 0.76 Beta(45.24, 9.68) (10, 16) SpMC-PCR 0.9900 5 0.95 Beta(88.28, 1.882) (6)Detection of Echinococcus multilocularis by MC-PCR Citation: Infection Ecology and Epidemiology 2016, 6: 30173 - http://dx.doi.org/10.3402/iee.v6.30173 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/97/ca/IEE-6-30173.PMC4788769.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30173 - http://dx.doi.org/10.3402/iee.v6.30173",Non-OADS,/arxiv_data1/oa_pdf/97/ca/IEE-6-30173.PMC4788769.pdf
"Vet Parasitol 2015; 213: 162 /C171.Detection of Echinococcus multilocularis by MC-PCR Citation: Infection Ecology and Epidemiology 2016, 6: 30173 - http://dx.doi.org/10.3402/iee.v6.30173 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/97/ca/IEE-6-30173.PMC4788769.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30173 - http://dx.doi.org/10.3402/iee.v6.30173",Non-OADS,/arxiv_data1/oa_pdf/97/ca/IEE-6-30173.PMC4788769.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.01.011 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/23/main.PMC4788774.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.01.",OADS,/arxiv_data1/oa_pdf/dd/23/main.PMC4788774.pdf
"Olufs,1,3Khoa A. Tran,1Nur Zaﬁrah Zaidan,1and Rupa Sridharan1,2,* 1Epigenetics Theme, Wisconsin Institute for Discovery, University of Wisconsin, 330 North Orchard Street, Room 2118, Madison, WI 53715, USA 2Department of Cell and Regenerative Biology, University of Wisconsin, 1111 Highland Avenue, Madison, WI 53715, USA 3Co-ﬁrst author *Correspondence: rsridharan@discovery.wisc.edu http://dx.doi.org/10.1016/j.stemcr.2016.01.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/71/66/main.PMC4788781.pdf
Primers used in this study SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and two tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.01.009 .,OADS,/arxiv_data1/oa_pdf/71/66/main.PMC4788781.pdf
"Stem Cell Reports Report Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-MatchedNon-human Primates Takuji Kawamura,1Shigeru Miyagawa,1Satsuki Fukushima,1Akira Maeda,2Noriyuki Kashiyama,1 Ai Kawamura,1Kenji Miki,3Keisuke Okita,3Yoshinori Yoshida,3Takashi Shiina,4Kazumasa Ogasawara,5 Shuji Miyagawa,2Koichi Toda,1Hiroomi Okuyama,2and Yoshiki Sawa1,* 1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan 2Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan 3Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Kyoto 606-8507, Japan 4Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa 259-1143, Japan 5Department of Pathology, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan *Correspondence: sawa-p@surg1.med.osaka-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.01.012 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/db/0f/main.PMC4788782.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, two tables, and two movies and can befound with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/db/0f/main.PMC4788782.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.01.014 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d3/main.PMC4788784.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/86/d3/main.PMC4788784.pdf
"Stem Cell Reports Article BMP and Hedgehog Regulate Distinct AGM Hematopoietic Stem Cells Ex Vivo Mihaela Crisan,1,2Parham Solaimani Kartalaei,1,3Alex Neagu,1Soﬁa Karkanpouna,1 Tomoko Yamada-Inagawa,1Caterina Purini,1Chris S. Vink,1,3Reinier van der Linden,1Wilfred van Ijcken,4 Susana M. Chuva de Sousa Lopes,5Rui Monteiro,6Christine Mummery,5and Elaine Dzierzak1,3,* 1Department of Cell Biology, Erasmus Medical Center, Erasmus MC Stem Cell Institute, 3000 CA Rotterdam, the Netherlands 2BHF Centre for Cardiovascular Science, Scottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4TJ, UK 3Centre for Inﬂammation Research, Queens Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK 4Center for Biomics, Erasmus Medical Center, 3000 CA Rotterdam, the Netherlands 5Department of Anatomy and Embryology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands 6Molecular Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK *Correspondence: elaine.dzierzak@ed.ac.uk http://dx.doi.org/10.1016/j.stemcr.2016.01.016 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/56/ed/main.PMC4788785.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes one ﬁgure and two tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.01.016 .,Non-OADS,/arxiv_data1/oa_pdf/56/ed/main.PMC4788785.pdf
"Stem Cell Reports Article Higher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability Kurt Jacobs,1,2Filippo Zambelli,1Afroditi Mertzanidou,1Ilse Smolders,3Mieke Geens,1Ha Thi Nguyen,1,4 Lise Barbe ´,1Karen Sermon,1and Claudia Spits1,* 1Research Group Reproduction and Genetics, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Be lgium 2Institute of Molecular Cancer Research, University of Zurich (UZH), Winterthurerstrasse 190, 8057 Zurich, Switzerland 3Research Group Experimental Neuropharmacology, Center for Neurosciences C4N, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels , Belgium 4Center for Molecular Biology, Institute of Research and Development, Duy Tan University, K7/25 Quang Trung, Danang 550000, Vietnam *Correspondence: claudia.spits@vub.ac.be http://dx.doi.org/10.1016/j.stemcr.2016.01.015 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/6a/main.PMC4788786.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and four tablesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8b/6a/main.PMC4788786.pdf
"Recognition of drusen and RPE defects, believed to represent  stressed and/or dying RPE cells, can be accomplished with  slit-lamp biomicroscopy on clinical examination, but the Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> Received 10 December 2015 | Accepted 25 February 2016 | Published 27 February 2016© 2016 Molecular Vision 189Regulation of signaling events involved in the pathophysiology of  neovascular AMD Haibo Wang, M. Elizabeth Hartnett The John A. Moran Eye Center, University of Utah, Salt Lake City, UT Neovascular age-related macular degeneration (AMD) is a complex disease in which an individual’s genetic  predisposition is affected by aging and environmental stresses, which trigger signaling pathways involving inflam - mation, oxidation, and/or angiogenesis in the RPE cells and choroidal endothelial cells (CECs), to lead to vision  loss from choroidal neovascularization.",Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
"Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  190thickened extracellular matrix that makes up basal linear or  laminar deposits is difficult to detect even on retinal imaging  studies, such as optical coherence tomography (OCT),  infrared imaging, and fluorescein angiography (FA) [ 19].",Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
"Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  191[10,12,20,38,39], imaging and genetic studies to develop  hypotheses related to biologic events in AMD followed by  a combination of culture techniques, including relevant  coculture models, and genetically modified mice exposed to  external stresses to model outcomes representative of forms  of AMD.",Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
"Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  192The Wnt signaling pathway has been implicated in  neovascular AMD and in models of laser-induced CNV  [49,50].",Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
"Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  193is the formation of a fibrovascular scar with loss of the archi - tecture of the RPE monolayer and the outer retina [ 22,23].",Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  194grown within the insert.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  195multiple pathways involved based on also crosstalk between  pathways.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
"Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  196age-related and diet-affected deposition of oxidized lipo - proteins within Bruch’s membrane, which trigger activation  of microglia to release TNF-α.",Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
"Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  197to the choriocapillaris, there is evidence that cholesterol can  be produced in the retina [ 112].",Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  19811.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  199cell precursors via platelet-derived growth factor-BB and  heterotypic cell contact.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  20060.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  201for RAP diagnosis: a multicenter study.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
Molecular Vision  2016; 22:189-202 <http://www.molvis.org/molvis/v 22/189> © 2016 Molecular Vision  202108.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/mv-v22-189.PMC4789180.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ad/33/10029_2015_Article_1423.PMC4789196.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2d/77/10620_2015_Article_3972.PMC4789226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/13/main.PMC4789324.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2015.12.003 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/35/13/main.PMC4789324.pdf
Available from: http://www.un.org/esa/population/publications/worldageing19502050/ .,Non-OADS,/arxiv_data1/oa_pdf/35/13/main.PMC4789324.pdf
BMC Cancer 2013;13:263. http://dx.doi.org/10.1186/1471- 2407-13-263.,Non-OADS,/arxiv_data1/oa_pdf/35/13/main.PMC4789324.pdf
Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_ 2010-06-14_QuickReference_5x7.pdf .,OADS,/arxiv_data1/oa_pdf/35/13/main.PMC4789324.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.10.012,Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8–16 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/31/43/main.PMC4789325.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/main.PMC4789329.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2015.12.001 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/1e/e1/main.PMC4789329.pdf
RadiatOncol 2013;8:118. http://dx.doi.org/10.1186/1748-717X-8-118.,OADS,/arxiv_data1/oa_pdf/1e/e1/main.PMC4789329.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MPS IIIB Mucopolysaccharidosis type III B Gene therapyAdeno-associated virusAAVLysosomal storage disease 1.,Non-OADS,/arxiv_data1/oa_pdf/be/e3/main.PMC4789330.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.11.006 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e3/main.PMC4789330.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/e3/main.PMC4789330.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/bc/main.PMC4789331.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2015.12.002 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/1f/bc/main.PMC4789331.pdf
Low Urin Tract Symptoms 2014. http://dx.doi.org/10.1111/luts.12083.Prostate Int 4 (2016) 30 e35 34,Non-OADS,/arxiv_data1/oa_pdf/1f/bc/main.PMC4789331.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/89/main.PMC4789332.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2015.11.002 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/2f/89/main.PMC4789332.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/40/main.PMC4789333.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2015.10.016 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/6c/40/main.PMC4789333.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/2a/main.PMC4789335.pdf
Both active sites have deviating substrateContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.02.006 2213-2317/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/93/2a/main.PMC4789335.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AGEs, advanced glycation end products; Glo1, glyoxalase 1; Glo2, glyoxalase 2; GSH, reduced glutathione; GSSG, glutathione disul ﬁde; MG, methyl- glyoxal; Pf,Plasmodium falciparum nCorrespondence to: Department of Parasitology, Ruprecht-Karls University, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany E-mail address: marcel.deponte@gmx.de (M. Deponte).",Non-OADS,/arxiv_data1/oa_pdf/93/2a/main.PMC4789335.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inborn errors of metabolismPhenylketonuriaNutritional statusBody compositionBioelectrical impedance 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/bb/main.PMC4789337.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.12.003 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/bb/main.PMC4789337.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/bb/main.PMC4789337.pdf
"E-mail address: miroslaw.bik-multanowski@uj.edu.pl Ewa Jamroz School of Medicine in Katowice, Department of Paediatrics and Developmental Age Neurology, Medical University of Silesia, Katowice, Poland Lukasz Kaluzny Department of Pediatric Gastroenterology and Metabolism, Medical University, Poznan, PolandMolecular Genetics and Metabolism Reports 6 (2016) 5 –7 http://dx.doi.org/10.1016/j.ymgmr.2015.12.002 2214-4269/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3c/0f/main.PMC4789339.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/0f/main.PMC4789339.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/95/main.PMC4789340.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2015.11.001 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/f2/95/main.PMC4789340.pdf
Available from: http://www.mbsonline.gov.au .,Non-OADS,/arxiv_data1/oa_pdf/f2/95/main.PMC4789340.pdf
Avail- able from: http://www.abs.gov.au/ .,Non-OADS,/arxiv_data1/oa_pdf/f2/95/main.PMC4789340.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/6c/main.PMC4789341.pdf
"Cell culture and radiation Normal human skin ﬁbroblasts AG 1522, which were usedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.03.002 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/4f/6c/main.PMC4789341.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/6c/main.PMC4789341.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.03.002 .,OADS,/arxiv_data1/oa_pdf/4f/6c/main.PMC4789341.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.11.002 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"97 (10) (2008) 1420 –1425, http://dx.doi.org/10.1111/j.1651-2227.2008.00952.x .",Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"94 (4) (2008) 397 –402, http://dx.doi.org/10.1016/j.ymgme.2008.05.004 .",OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"30 (6) (2007) 880 –887, http://dx.doi.org/10.1007/s10545-007-0718-4 .",Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"21 (4 Suppl) (2005) S27 –S35, http://dx.doi.org/10.1016/j.ccc.2005.08.003 .",OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"113 (12) (2013) 1683 –1694, http://dx.doi.org/10.1016/j.jand.2013.06.001 .",Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"162 (6) (2013) 1228 –1234, http://dx.doi.org/10.1016/j.jpeds.2012.11.084 (34 e1).",Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"Krivitzky, M. Mokhtarani, et al., Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate, Hepatology 57 (6) (2013) 2171 –2179, http://dx.doi.org/10.1002/hep.26058 .",Non-OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"112 (1) (2014) 17 –24,http://dx.doi.org/ 10.1016/j.ymgme.2014.02.007 .",OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
"161 (2) (2012) 328–332, http://dx.doi.org/10.1016/j.jpeds.2012.02.006 .40 D. Hook et al.",OADS,/arxiv_data1/oa_pdf/3d/b9/main.PMC4789342.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/d3/main.PMC4789344.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2015.08.001 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/45/d3/main.PMC4789344.pdf
Mediators In ﬂ amm 2010;2010:823486. http://dx.doi.org/10.1155/2010/ 823486 .,OADS,/arxiv_data1/oa_pdf/45/d3/main.PMC4789344.pdf
J Endocrinol Invest 2014;2014:329456. http://dx.doi.org/ 10.1155/2014/329456 .,Non-OADS,/arxiv_data1/oa_pdf/45/d3/main.PMC4789344.pdf
J Obes 2013;2013:291546. http://dx.doi.org/10.1155/2013/291546 .,OADS,/arxiv_data1/oa_pdf/45/d3/main.PMC4789344.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Bland –Altman Amino acid analyzerPhenylalanine analytical methods Newborn screening 1.,Non-OADS,/arxiv_data1/oa_pdf/52/95/main.PMC4789345.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.01.001 2214-4269/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/52/95/main.PMC4789345.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/95/main.PMC4789345.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.001,Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,2 0–27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
The LALIGN program (European Bioinformatics Institute; http://www.ebi.ac.uk/Tools/psa/lalign/ nucleotide.html ) was used for pairwise alignment and calcula- tion of identity between two ebpS sequences.,OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,2 0–27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,2 0–27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,2 0–27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,2 0–27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,2 0–27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,2 0–27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/a0/20/main.PMC4789347.pdf
"Taking into account the recent evidences, it was decided to study if the use of the MLN4924 neddylation pathway inhibitor could induce Nrf2 accumulation and prevent the hydrogen peroxide(H 2O2) induced neurotoxicity in primary cultures of cerebellar granule neurons (CGNs).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.02.008 2213-2317/ &2016 Published by Elsevier B.V.Abbreviations: CGNs, Cerebellar granule neurons; Cul3, Cullin 3; DHE, Dihy- droethidium; DIV, Days in vitro ; FBS, Fetal bovine serum; FDA, Fluorescein diace- tate; H 2O2, Hydrogen deroxide; MLN4924, Selective inhibitor of NAE; MTT, 3-[4,5- dimethylthiazol-2-yl)]-2,5-diphenyl-tetrazolium bromide; NAE, Nedd8-activatingenzyme; Nedd8, Neural precursor cell expressed developmentally down-regulatedprotein 8; Nrf2, Nuclear factor E2-related factor 2; PCNA, Proliferating cell nuclear antigen; ROS, Reactive oxygen species nCorrespondence to: Laboratory 209, Building F, Faculty of Chemistry, Depart- ment of Biology, National Autonomous University of Mexico (UNAM), UniversityCity, 04510 D.F., Mexico, Mexico.",Non-OADS,/arxiv_data1/oa_pdf/db/32/main.PMC4789348.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/03/main.PMC4789349.pdf
Proteasomal system is a crucial degradation pathway for the oxidatively modi ﬁed proteins that makes it important for theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.03.001 2213-2317/ &2016 Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/75/03/main.PMC4789349.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ARE, Antioxidant Response Element; DNPH, 2,4-Dinitrophenylhy- drazine; GAPDH, Glyceraldehyde 3-Phosphate Dehydrogenase; GCL, GlutamateCysteine Ligase; GST, Glutathione S-Transferase; HDAC, Histone Deacetylase; HO-1,Heme Oxygenase 1; HSP, Heat Shock Protein; HT, Hyperthermia; MCA, Methyl-coumarin; NQO1, NAD (P) H Quinone Oxidoreductase 1; Keap1, Kelch-like ECH- Associated Protein 1; Nrf2, NF-E2-Related Factor 2; PARP, Poly ADP Ribose Poly- merase; TBST, Tris-Buffered Saline and Tween 20; UPS, Ubiquitin –Proteasome System nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/75/03/main.PMC4789349.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/c5/main.PMC4789350.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.12.001 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/c5/main.PMC4789350.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/c5/main.PMC4789350.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Prenatal diagnosisMitochondrial trifunctional protein (TFP)Acylcarnitine analysisFatty acid oxidation HADHA gene GenBank and other databases: HADHA OMIM: 600890, GDB: 434026, GenBank: NM_000182HADHB OMIM: 143450, GDB: 344953, GenBank: NM_000183 1.",Non-OADS,/arxiv_data1/oa_pdf/0e/76/main.PMC4789351.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2015.11.005 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/76/main.PMC4789351.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/76/main.PMC4789351.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PNPOPyridoxineNeonatalEpilepsyPyridoxal-phosphateAntiquitin 1.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/main.PMC4789384.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.01.004 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/main.PMC4789384.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/main.PMC4789384.pdf
A full list of contributing groups can be found at http://exac.broadinstitute.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/main.PMC4789384.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cobalamin C defectInborn error of metabolism Hydroxycobalamin Intrauterine treatmentHomocysteine 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/ab/main.PMC4789385.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.01.005 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/ab/main.PMC4789385.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/ab/main.PMC4789385.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keyword: Biotinidase Biotinidase de ﬁciency MicrodeletionDeletionMutationMicroarray 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/a6/main.PMC4789387.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.02.006 2214-4269/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/4d/a6/main.PMC4789387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/a6/main.PMC4789387.pdf
"Crockett, R. Mao, The biotinidase variants registry: a para- digm public database, Genes Genomics Genetics (2013), http://dx.doi.org/10.1534/ g3.113.005835 pii: g3.113.005835v1.",OADS,/arxiv_data1/oa_pdf/4d/a6/main.PMC4789387.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mitochondrial diseasesCPEOHuntington disease mtDNA tRNA 1.,Non-OADS,/arxiv_data1/oa_pdf/03/45/main.PMC4789388.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2016.02.001 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/45/main.PMC4789388.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/45/main.PMC4789388.pdf
"23 (12) (2015) 1735 –1738, http://dx.doi.org/10.1038/ejhg.2015.73 .",Non-OADS,/arxiv_data1/oa_pdf/03/45/main.PMC4789388.pdf
"5 (2014), http://dx.doi.org/10.3389/ fphys.2014.00380 380.",Non-OADS,/arxiv_data1/oa_pdf/03/45/main.PMC4789388.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/5c/rjw035.PMC4789537.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/b2/ofw027.PMC4789539.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/81/ofw021.PMC4789540.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs164/en/ .,Non-OADS,/arxiv_data1/oa_pdf/f8/81/ofw021.PMC4789540.pdf
Available at: http://www.cdc.gov/ hepatitis/hcv/hcvfaq.htm .,Non-OADS,/arxiv_data1/oa_pdf/f8/81/ofw021.PMC4789540.pdf
Labo- ratory Tests and Hepatitis C. Available at: http://www.hepatitis.va.gov/provider/ reviews/laboratory-tests.asp .,Non-OADS,/arxiv_data1/oa_pdf/f8/81/ofw021.PMC4789540.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/df/ehv660.PMC4789593.pdf
ORCID ID: http://orcid.org/0000-0001-6058-9521.,OADS,/arxiv_data1/oa_pdf/b7/0c/AIM-24-25.PMC4789622.pdf
"The IMPACT  (IMProving Access to Clinical Trial Data)   Observatory is an international study funded by the New - FelPro fellowship (Marie Sklodowska-Curie and Croatian Government) ( http://ottawagroup.ohri.ca/disclosure.html ,  accessed 24 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/be/78/MSM-28-74.PMC4789626.pdf
"CONCLUSION Authors hope that this event will become established,  and soon harvest more cooperation in disseminating and contribution in the production of evidence, and reduc - ing waste in research ( https://twitter.com/monalisa1n/ status/672448827421495297 , accessed Jan 24, 2016), (12).",Non-OADS,/arxiv_data1/oa_pdf/be/78/MSM-28-74.PMC4789626.pdf
"We  also hope that Mona Nasser’s prediction will come true:  “By adopting this practice researchers in BH can bring their system in line with the best in the world and compete for  global funding:” ( http://www.the-dentist.co.uk/article/4108/ cochrane-principles-in-bosnia-herzegovina , accessed Jan  24, 2016).",Non-OADS,/arxiv_data1/oa_pdf/be/78/MSM-28-74.PMC4789626.pdf
http://hrcak.srce.hr/index.,Non-OADS,/arxiv_data1/oa_pdf/be/78/MSM-28-74.PMC4789626.pdf
"http://orcid.org/0000-0002-9080-5456), E-mail: imasic@lol.ba; izetmasic@gmail.com doi: 10.5455/aim.2016.24.4-11 ACTA INFORM MED.",OADS,/arxiv_data1/oa_pdf/ce/bf/AIM-24-4.PMC4789627.pdf
"ORCID ID: http://orcid.org/0000-0003-2054-3830 E-mail:  toksikourgentna@gmail.com ABSTRACT Introduction: Acute intoxications with corrosive substances can cause severe chemical injuries of the upper gastrointestinal tract,  most often located in the mouth, pharynx, esophagus, stomach and duodenum.",Non-OADS,/arxiv_data1/oa_pdf/bd/67/MSM-28-66.PMC4789631.pdf
ORCID ID: http://orcid.org/0000-0002-6013-2940.,OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
http://dx.doi.org/10.1590/S0042-96862009000200015.3.,Non-OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
Available from: http://data.worldbank.org/indicator/SH.DYN.NMRT.,OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
Available from: http://data.unicef.org/child-mor-tality/neonatal.,Non-OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
"[cited Jun 15, 2015]; http://dx.doi.org/10.1590/S0102-311X2009000900018  9.",OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
http://dx.doi.org/10.1590/S0034-89102002000700005  10.,Non-OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
http://dx.doi.org/10.1590/S0100-879X2004000500018  12.,Non-OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
http://dx.doi.org/10.1016/0010-4825 (94)90013-2 13.,OADS,/arxiv_data1/oa_pdf/5f/04/AIM-24-34.PMC4789632.pdf
"Hyattsville, MD, 2006. http://www.cdc.gov/ nchs/products/pubs/pubd/hestats/prelimbirths05/prelimbirths05.",Non-OADS,/arxiv_data1/oa_pdf/30/4e/MSM-28-32.PMC4789633.pdf
ORCID ID: http://orcid.org/0000-0003-4746-1114 E-mail: d.roshani@muk.ac.ir   doi: 10.5455/aim.2016.24.38-41 ACTA INFORM MED.,Non-OADS,/arxiv_data1/oa_pdf/17/9c/AIM-24-38.PMC4789637.pdf
Available from:  http://www.ncbi.nlm.nih.gov/Pubmed/17911719 4.,Non-OADS,/arxiv_data1/oa_pdf/6d/54/AIM-24-51.PMC4789654.pdf
Available from: https://oa.doria.fi/bitstream/handle 6.,OADS,/arxiv_data1/oa_pdf/6d/54/AIM-24-51.PMC4789654.pdf
Available from: http://www.uow.edu.au/ ~ ping/ publication/Yu2009b.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/6d/54/AIM-24-51.PMC4789654.pdf
Available from: http://perspectives.ahima.org/index.php?option=com_content&view=article&id=164:- factorsinfluencing-acceptance-of-electronic-health-re- cords-in-hospitals&catid=42:electronic-records&Itemid=88 8.,Non-OADS,/arxiv_data1/oa_pdf/6d/54/AIM-24-51.PMC4789654.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17064955 14.,Non-OADS,/arxiv_data1/oa_pdf/6d/54/AIM-24-51.PMC4789654.pdf
"Available from: http://www.nap.edu,  Qods Razavi; 2004.",Non-OADS,/arxiv_data1/oa_pdf/71/94/AIM-24-56.PMC4789678.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 W orld Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/90/4e/bmjinnov-2015-000087.PMC4789684.pdf
2011. http://www.who.int/substance_abuse/publications/global_alcohol_report/msbgsruprofiles.pdf(accessed 22 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/90/4e/bmjinnov-2015-000087.PMC4789684.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ bmjinnov-2015-000098).,Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
20Each approach (described further in see online supplementary materials) provided potentiallyinterested participants a link to our custom study website (http://www.brightenstudy.com).,Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
Procedure Screening Potential participants were directed to a website (http://www.brightenstudy.com) explaining the studypurpose and procedures.,Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 devices UFaDAM.,Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
http://www.fda.gov/ medicaldevices/productsandmedicalprocedures/connectedhealth/mobilemedicalapplications/default.htm 2 Campbell KR.,Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
"A Therapist in One ’s Pocket: mHealth to Improve Access to Mental Health Care, 2015. http://www.nimh.nih.gov/about/strategic-planning-reports/highlights/highlight-a-therapist-in-ones-pocket-mhealth-to-improve-access-to-mental-health-care.shtml 5 Insel T .",Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
"Secondary Something Interesting is Happening, 2015. http://www.nimh.nih.gov/about/director/2015/something-interesting-is-happening.shtml 6 Price M, Yuen EK, Goetter EM, et al.",Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
"2012. http://www.dailyyonder.com/how-rural-are-states/2012/04/03/3847/ 30 Head BF , Dean E, Flanigan T , et al.",Non-OADS,/arxiv_data1/oa_pdf/73/4e/bmjinnov-2015-000098.PMC4789688.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2015-207345).,OADS,/arxiv_data1/oa_pdf/de/82/annrheumdis-2015-207345.PMC4789689.pdf
"Department of Rheumatology and Clinical Immunology,Charité UniversitätsmedizinBerlin, Berlin, Germany Correspondence to Dr Sarah Ohrndorf, Departmentof Rheumatology and ClinicalImmunology, Charité Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117,Germany;sarah.ohrndorf@charite.de Received 22 January 2015 Revised 24 June 2015 Accepted 14 July 2015Published Online First26 August 2015 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-207315▸http://dx.doi.org/10.1136/ annrheumdis-2015-208399 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-208661 To cite: Glimm A-M, Werner SG, Burmester GR, et al .Ann Rheum Dis 2016; 75:566–570.ABSTRACT Background In rheumatoid arthritis (RA), hand synovitis appears especially in wrist, metacarpophalangeal(MCP) and proximal interphalangeal (PIP) joints.",Non-OADS,/arxiv_data1/oa_pdf/de/82/annrheumdis-2015-207345.PMC4789689.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Combe B, Landewe R, Lukas C, et al .",Non-OADS,/arxiv_data1/oa_pdf/de/82/annrheumdis-2015-207345.PMC4789689.pdf
"To view please visit the journal online (http://dx.doi.org/10.1136/ bmjspcare-2015-000959) 1Department of Learning, Informatics, Management and Ethics, Medical ManagementCentre, Karolinska Institutet, Stockholm, Sweden 2Department of Nursing, Umeå University, Umeå, Sweden 3Department of Health Sciences, Lund University, Lund, Sweden 4The Institute for Palliative Care, Lund University and Skåne Regional Council, Lund, Sweden 5Karolinska University Hospital, Innovation Centre, Stockholm, Sweden Correspondence to Dr Olav Lindqvist, LIME/MedicalManagement Centre, Karolinska Institutet, Stockholm SE-171 77, Sweden; olav.lindqvist@ki.se Received 24 June 2015 Revised 9 November 2015Accepted 17 December 2015 Published Online First 18 January 2016 To cite: Lindqvist O, Rasmussen BH, Fürst CJ, et al .",Non-OADS,/arxiv_data1/oa_pdf/16/51/bmjspcare-2015-000959.PMC4789691.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Tinetti ME.,Non-OADS,/arxiv_data1/oa_pdf/16/51/bmjspcare-2015-000959.PMC4789691.pdf
http://www.who.int/healthpromotion/conferences/ previous/ottawa/en/ (Last accessed 9 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/16/51/bmjspcare-2015-000959.PMC4789691.pdf
http://www.openaccessweek.org/ page/about (Last accessed 9 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/16/51/bmjspcare-2015-000959.PMC4789691.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2014-206897).,OADS,/arxiv_data1/oa_pdf/c1/9f/annrheumdis-2014-206897.PMC4789692.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 El Hachmi M, Jadoul M, Lefèbvre C, et al.",Non-OADS,/arxiv_data1/oa_pdf/c1/9f/annrheumdis-2014-206897.PMC4789692.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ bmjspcare-2013-000593).,Non-OADS,/arxiv_data1/oa_pdf/24/c1/bmjspcare-2013-000593.PMC4789693.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/REFERENCES 1 Starkweather AR, Sherwood P , Lyon DE, et al.",Non-OADS,/arxiv_data1/oa_pdf/24/c1/bmjspcare-2013-000593.PMC4789693.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Partdrige AH, Seah DS, King T , et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/db/bmjspcare-2014-000841.PMC4789694.pdf
http://www.kingsfund.org.uk/ sites/files/kf/field/field_publication_file/providing-integrated-care-for-older-people-with-complex-needs-kingsfund-jan14.pdf(accessed 12 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/b5/db/bmjspcare-2014-000841.PMC4789694.pdf
"WHA67.19,http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf?ua=1 (accessed 20 Nov 2015).",OADS,/arxiv_data1/oa_pdf/b5/db/bmjspcare-2014-000841.PMC4789694.pdf
http://www.insup-c.eu (accessed 6 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/b5/db/bmjspcare-2014-000841.PMC4789694.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Almuzaini T, Sammons H, Choonara I. Substandard and falsi ﬁed medicines in the UK: a retrospective review of drug alerts (2001 –2011).",Non-OADS,/arxiv_data1/oa_pdf/00/17/ejhpharm-2015-000750.PMC4789696.pdf
"http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/ general_content_000186.jsp 4 Newton PN, Tabernero P, Dwivedi P, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/17/ejhpharm-2015-000750.PMC4789696.pdf
http://www.rpharms.com/promoting-pharmacy-pdfs/falsi ﬁed-medicines-sept-2013.pdf 6 WHO Medicines: spurious/falsely-labeled/ falsi ﬁed/counterfeit (SFFC) medicines.,Non-OADS,/arxiv_data1/oa_pdf/00/17/ejhpharm-2015-000750.PMC4789696.pdf
"http://www.who.int/mediacentre/factsheets/fs275/en/ 7 Attaran A, Barry D, Basheer S, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/17/ejhpharm-2015-000750.PMC4789696.pdf
http://ec.europa.eu/ growth/tools-databases/tbt/en/search/?tbtaction=search.detail&num=306&Country_ ID=EU&dspLang=EN&BASDATEDEB=&basdatedeb=&basdate ﬁn=&baspays= EU&basnotifnum=306&basnotifnum2=306&bastypepays=EU&baskeywords(accessed 3 Sep 2015).,OADS,/arxiv_data1/oa_pdf/00/17/ejhpharm-2015-000750.PMC4789696.pdf
http://www.eahp.eu/news/EU-monitor/eahp-eu-monitor-25-august-2015 (accessed 3Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/00/17/ejhpharm-2015-000750.PMC4789696.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015-207315).,Non-OADS,/arxiv_data1/oa_pdf/5d/ef/annrheumdis-2015-207315.PMC4789697.pdf
"Correspondence to Dr M van Onna, Departmentof Clinical Immunology andRheumatology, Academic Medical Center, F4-105, PO Box 2260, Amsterdam 1100DD, The Netherlands;m.vanonna@amc.uva.nl Received 20 January 2015 Revised 9 September 2015 Accepted 20 September 2015Published Online First9 October 2015 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-207345▸http://dx.doi.org/10.1136/ annrheumdis-2015-208399 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-208661 To cite: van Onna M, Ten Cate DF, Tsoi KL, et al.Ann Rheum Dis 2016; 75: 511 –518.ABSTRACT Objectives In rheumatoid arthritis (RA), treat-to-target strategies require instruments for valid detection of jointinﬂammation.",Non-OADS,/arxiv_data1/oa_pdf/5d/ef/annrheumdis-2015-207315.PMC4789697.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Schoels M, Knevel R, Aletaha D, et al.",Non-OADS,/arxiv_data1/oa_pdf/5d/ef/annrheumdis-2015-207315.PMC4789697.pdf
This report presents independent research bythe NIHR CLAHRC YH (http://www.clahrc-yh.nir.ac.uk).,Non-OADS,/arxiv_data1/oa_pdf/66/0f/bmjqs-2015-004386.PMC4789698.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 The Health Foundation.,Non-OADS,/arxiv_data1/oa_pdf/66/0f/bmjqs-2015-004386.PMC4789698.pdf
2006. http://www.lancs.ac.uk/shm/ research/nssr/research/dissemination/publications (accessed 4 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/66/0f/bmjqs-2015-004386.PMC4789698.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Center for Advancing Health.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/bmjqs-2015-004006.PMC4789699.pdf
"W ashington DC: CFAH, 2010. http://www.cfah.org/pdfs/Original research 188 Herrin J, et al.BMJ Qual Saf 2016; 25:182 –189.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/bmjqs-2015-004006.PMC4789699.pdf
"2“Health Policy Brief: Patient Engagement, ”Health Affairs, 14 Feb 2013. http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=86 3 W eingart SN, Zhu J, Chiapetta L, et al.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/bmjqs-2015-004006.PMC4789699.pdf
http://www.hcahpsonline.org/files/HCAHPS%20Fact%20Sheet%20May%202012.pdf (accessed Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/bmjqs-2015-004006.PMC4789699.pdf
http://www.medicare.gov/ hospitalcompare/search.html (accessed Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/bmjqs-2015-004006.PMC4789699.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2014-206914).,Non-OADS,/arxiv_data1/oa_pdf/b5/1d/annrheumdis-2014-206914.PMC4789700.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Blieden M, Paramore LC, Shah D, et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/1d/annrheumdis-2014-206914.PMC4789700.pdf
"The problem with Plan-Do-Study-Act cycles Julie E Reed,1Alan J Card2,3 1NIHR CLAHRC NWL, Imperial College London, London, UK 2Department of Management, University of Notre Dame, NotreDame, Indiana, USA 3Evidence-Based Health Solutions, LLC, Notre Dame, Indiana, USA Correspondence to Dr Julie E Reed, NIHR CLAHRC NWL, Imperial College London,Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK; julie.reed02@imperial.ac.uk Accepted 23 November 2015 Published Online First 23 December 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-005094 To cite: Reed JE, Card AJ.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/bmjqs-2015-005076.PMC4789701.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/REFERENCES 1 Langley GJ, Moen R, Nolan KM, et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/bmjqs-2015-005076.PMC4789701.pdf
"London, 2014. http://www.health.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/bmjqs-2015-005076.PMC4789701.pdf
"London, 2013. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/226703/Berwick_Report.pdf 21 Batalden P .",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/bmjqs-2015-005076.PMC4789701.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ejhpharm-2015-000736).,Non-OADS,/arxiv_data1/oa_pdf/60/d6/ejhpharm-2015-000736.PMC4789703.pdf
"FRAX is the name of a published tool, the FRAX(R) tool, available at https://www.shef.ac.uk/FRAX/tool.jsp 82 Blagburn J, et al.Eur J Hosp Pharm 2016; 23:80–85.",OADS,/arxiv_data1/oa_pdf/60/d6/ejhpharm-2015-000736.PMC4789703.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Table 2 Multivariate logistical regression analysis examining factors associated with readmission Indicators OR95% CI Lower Upper Intervention effect (ward) 0.539 0.299 0.969 Uses MDS 1.619 0.903 2.905Self-medication assessment required 0.494 0.271 0.898Discharge medication list sent in real time 2.423 1.359 4.322 Constant 0.166 MDS, monitored dosage system.",Non-OADS,/arxiv_data1/oa_pdf/60/d6/ejhpharm-2015-000736.PMC4789703.pdf
http://www.kingsfund.org.uk/sites/ ﬁles/kf/ Avoiding-Hospital-Admissions-Sarah-Purdy-December2010_0.pdf (accessed 4 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/60/d6/ejhpharm-2015-000736.PMC4789703.pdf
http://www.hscic.gov.uk/hrg (accessed Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/d6/ejhpharm-2015-000736.PMC4789703.pdf
https://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/ 364476/The_quality_of_clinical_coding_in_the_NHS.pdf (accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/60/d6/ejhpharm-2015-000736.PMC4789703.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Orchard J.,Non-OADS,/arxiv_data1/oa_pdf/5f/8e/bjsports-2015-095788.PMC4789704.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ archdischild-2015-309676).,Non-OADS,/arxiv_data1/oa_pdf/64/a0/archdischild-2015-309676.PMC4789705.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Sands R, Shanmugavadivel D, Stephenson T, et al.",Non-OADS,/arxiv_data1/oa_pdf/64/a0/archdischild-2015-309676.PMC4789705.pdf
"The Cochrane Collaboration, 2011. http://http://www.cochrane –handbook.org 12 Higgins JP, Thompson SG, Deeks JJ, et al.",OADS,/arxiv_data1/oa_pdf/64/a0/archdischild-2015-309676.PMC4789705.pdf
"Pediatric Oncall [serial online]; 2006 (cited 1 January 2006):3. http://www.pediatriconcall.com/fordoctor/Conferenceabstracts/racecadotrial.asp 25 Cézard JP, Duhamel JF, Meyer M, et al.E fﬁcacy and tolerability of racecadotril in acute diarrhea in children.",Non-OADS,/arxiv_data1/oa_pdf/64/a0/archdischild-2015-309676.PMC4789705.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ bjsports-2015-094758).,Non-OADS,/arxiv_data1/oa_pdf/f3/59/bjsports-2015-094758.PMC4789708.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Fry RW, Morton AR, Keast D. Overtraining in athletes.",Non-OADS,/arxiv_data1/oa_pdf/f3/59/bjsports-2015-094758.PMC4789708.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Gerdes J, Lemke H, Baisch H, et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/c6/jclinpath-2015-203174.PMC4789709.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Hannestad YS, Rortveit G, Sandvik H, et al.",OADS,/arxiv_data1/oa_pdf/7d/51/acupmed-2015-010828.PMC4789711.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jclinpath-2015-202976).,Non-OADS,/arxiv_data1/oa_pdf/ef/80/jclinpath-2015-202976.PMC4789713.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Cryan JF, Dinan TG.",Non-OADS,/arxiv_data1/oa_pdf/ef/80/jclinpath-2015-202976.PMC4789713.pdf
"Low energy intake during the ﬁrst 4 weeks of life increases the risk for severe retinopathy of prematurity in extremely preterm infants Elisabeth Stoltz Sjöström,1Pia Lundgren,2Inger Öhlund,1Gerd Holmström,3 Ann Hellström,2Magnus Domellöf1 1Department of Clinical Sciences, Paediatrics, UmeåUniversity, Umeå, Sweden 2Institute of Neuroscience and Physiology, SahlgrenskaAcademy at University ofGothenburg, Gothenburg, Sweden 3Department of Neuroscience, Ophthalmology, UppsalaUniversity, Uppsala, Sweden Correspondence to Dr Magnus Domellöf,Department of ClinicalSciences, Paediatrics, Umeå University, Umeå 901 85, Sweden; magnus.domellof@pediatri.umu.se Received 21 May 2014 Revised 20 November 2014 Accepted 10 January 2015Published Online First12 February 2015 ▸http://dx.doi.org/10.1136/ fetalneonatal-2015-308221 To cite: Stoltz Sjöström E, Lundgren P, Öhlund I, et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/2f/fetalneonatal-2014-306816.PMC4789715.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Kong L, Fry M, Al-Samarraie M, et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/2f/fetalneonatal-2014-306816.PMC4789715.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/archdischild-2015-308458).,Non-OADS,/arxiv_data1/oa_pdf/b8/3d/fetalneonatal-2015-308458.PMC4789716.pdf
"Correspondence to Neda Razaz, Women ’s Hospital of British Columbia, RoomC403—4500 Oak Street, Vancouver, British Columbia, Canada V6H 3N1; Neda.Razaz@gmail.com Received 21 February 2015 Revised 2 June 2015 Accepted 11 June 2015 Published Online First17 July 2015 ▸http://dx.doi.org/10.1136/ fetalneonatal-2015-308483 To cite: Razaz N, Boyce WT, Brownell M, et al.Arch Dis Child Fetal Neonatal Ed 2016; 101: F114–F120.ABSTRACT Objective To assess the relationship between the 5 min Apgar score and developmental vulnerability at 5 years ofage.Design Population-based retrospective cohort study.",Non-OADS,/arxiv_data1/oa_pdf/b8/3d/fetalneonatal-2015-308458.PMC4789716.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/Table 4 Adjusted ORs and 95% CIs showing the association between 5 min Apgar score and vulnerability within each of the five Early Development Instrument (EDI ) domains Physical health and well-being domain* Social domain* Emotional domain* Language domain* Communication domain* Factors OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value Apgar 0–3 2.70 (1.19 to 6.13) 0.01 0.84 (0.25 to 2.81) 0.77 1.18 (0.40 to 3.34) 0.70 2.71 (1.22 to 6.01) 0.01 1.73 (0.70 to 4.28) 0.20 4 1.74 (0.64 to 4.73) 0.28 2.10 (0.82 to 5.43) 0.12 1.36 (0.45 to 4.06) 0.59 1.77 (0.69 to 4.56) 0.24 1.20 (0.41 to 3.58) 0.745 2.43 (1.41 to 4.20) <0.01 1.77 (0.97 to 3.20) 0.06 1.60 (0.85 to 2.98) 0.14 0.95 (0.49 to 1.84) 0.87 0.66 (0.30 to 1.47) 0.316 1.55 (1.02 to 2.36) 0.04 1.48 (0.97 to 2.27) 0.07 1.17 (0.73 to 1.87) 0.52 1.19 (0.78 to 1.83) 0.41 0.96 (0.59 to 1.54) 0.86 7 1.45 (1.10 to 1.91) 0.01 1.36 (1.03 to 1.81) 0.03 1.60 (1.21 to 2.10) <0.001 1.01 (0.76 to 1.34) 0.97 1.12 (0.84 to 1.49) 0.45 8 1.24 (1.03 to 1.49) 0.02 1.14 (0.95 to 1.37) 0.16 1.24 (1.03 to 1.50) 0.02 0.98 (0.82 to 1.17) 0.84 0.98 (0.81 to 1.17) 0.79 9 1.23 (1.05 to 1.44) 0.01 1.14 (0.97 to 1.33) 0.11 1.20 (1.03 to 1.41) 0.02 0.98 (0.85 to 1.13) 0.78 1.02 (0.87. to 1.18) 0.83 10 1.00 ( –) – 1.00 ( –) – 1.00 ( –) – 1.00 ( –) – 1.00 ( –) – Bold represents p value <0.05.,Non-OADS,/arxiv_data1/oa_pdf/b8/3d/fetalneonatal-2015-308458.PMC4789716.pdf
"Manitoba Centre for Health Policy, 2010. http://mchp-appserv.cpe.umanitoba.ca/reference/Health_Ineq_ ﬁnal_WEB.pdf 15 Mustard C, Derksen S, Berthelot J, et al.",Non-OADS,/arxiv_data1/oa_pdf/b8/3d/fetalneonatal-2015-308458.PMC4789716.pdf
"2012. http://www.offordcentre.com/readiness/ ﬁles/updated_ normative_II.pdf 20 Santos R, Brownell MD, Ekuma O, et al.",OADS,/arxiv_data1/oa_pdf/b8/3d/fetalneonatal-2015-308458.PMC4789716.pdf
"Manitoba: Healthy Child Manitoba, 2011. http://www.gov.mb.ca/healthychild/edi/edireport_MB_201011.pdf, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b8/3d/fetalneonatal-2015-308458.PMC4789716.pdf
"To viewplease visit the journal online (http://dx.doi.org/10.1136/ emermed-2014-204581) 1Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK 2Emergency Department, Royal Victoria In ﬁrmary, Newcastle upon Tyne, UK Correspondence to Dr K Parkinson, Institute of Health and Society, NewcastleUniversity, Baddiley-ClarkBuilding, Richardson Road, Newcastle upon Tyne NE2 4AX, UK;kathryn.parkinson@ncl.ac.uk Received 12 December 2014 Revised 1 September 2015 Accepted 7 October 2015 ▸http://dx.doi.org/10.1136/ emermed-2015-205295 To cite: Parkinson K, Newbury-Birch D, Phillipson A, et al.Emerg Med J 2016; 33:187 –193.ABSTRACT Background Alcohol related hospital attendances are a potentially avoidable burden on emergencydepartments (EDs).",Non-OADS,/arxiv_data1/oa_pdf/23/68/emermed-2014-204581.PMC4789717.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Lim SS, Vos T, Flaxman AD, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/68/emermed-2014-204581.PMC4789717.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ bjophthalmol-2014-306482).,OADS,/arxiv_data1/oa_pdf/72/ff/bjophthalmol-2014-306482.PMC4789718.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Congdon N, O ’Colmain B, Klaver CC, et al.",Non-OADS,/arxiv_data1/oa_pdf/72/ff/bjophthalmol-2014-306482.PMC4789718.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Knop E, Knop N, Millar T, et al .",Non-OADS,/arxiv_data1/oa_pdf/ca/6b/bjophthalmol-2015-307415.PMC4789719.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Yin L, Wu X, Gong Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/af/fb/bjophthalmol-2015-306607.PMC4789720.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjophthalmol-2015-306732).,OADS,/arxiv_data1/oa_pdf/14/fc/bjophthalmol-2015-306732.PMC4789721.pdf
"8 W e calculated 82 patients per group (E1, C) (software PSV .3.0.43; http://biostat.mc.vanderbilt.edu/PowerSampleSize) forthe continuity corrected χ 2test to have 80% power at two-sided type I error rate of 5% assuming event proportion of 35% (E1)and 15% (C).",Non-OADS,/arxiv_data1/oa_pdf/14/fc/bjophthalmol-2015-306732.PMC4789721.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ogasawara H, Feke GT, Yoshida A, et al .",Non-OADS,/arxiv_data1/oa_pdf/14/fc/bjophthalmol-2015-306732.PMC4789721.pdf
http://orcid.org/0000-0003-4670-6802.,Non-OADS,/arxiv_data1/oa_pdf/31/6b/MSM-28-46.PMC4789722.pdf
ORCID ID: http://orcid.org/0000-0002-0178-7066 E-mail: ramadandacaj@gmail.com doi: 10.5455/aim.2016.24.,Non-OADS,/arxiv_data1/oa_pdf/c2/22/AIM-24-12.PMC4789733.pdf
Available online  at: http://www.irimo.ir/english/publication/index.asp .,Non-OADS,/arxiv_data1/oa_pdf/ce/06/MSM-28-17.PMC4789740.pdf
Available from: http://www.hhs.gov/ocr/privacy/hipaa/understanding/srsummary.html.,OADS,/arxiv_data1/oa_pdf/69/e2/AIM-24-47.PMC4789743.pdf
"Presidency of the I.R.I, Statistic senter of Iran., Available on: http://www.amar.org.ir/Portals/0/sarshomari90/n_ sarshomari90_2.pdf., 2011.",Non-OADS,/arxiv_data1/oa_pdf/f0/63/MSM-28-41.PMC4789745.pdf
ORCID ID: http://orcid.org/0000-0002-9080-5456.,OADS,/arxiv_data1/oa_pdf/6a/b5/AIM-24-78.PMC4789746.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Mustian KM, Sprod LK, Palesh OG, et al.",Non-OADS,/arxiv_data1/oa_pdf/61/32/bmjspcare-2014-000692.PMC4789756.pdf
Protocols for MLPA and Sanger sequen-cing for the DMD gene can be found on the Eurogentest website (http://www.eurogentest.org).,Non-OADS,/arxiv_data1/oa_pdf/77/6a/jmedgenet-2015-103387.PMC4789806.pdf
"A recent surveywas conducted among 41 individuals (primarily (paediatric)neurologists and clinical geneticists from Europe, T urkey andIndia) working with patients with DMD and attending aTREAT-NMD DMD masterclass (funded by an educationalgrant from PTC therapeutics) (survey results are being prepared for publication on http://www.treat-nmd.eu).",Non-OADS,/arxiv_data1/oa_pdf/77/6a/jmedgenet-2015-103387.PMC4789806.pdf
"When reporting mutations, it is important to use standard nomenclature as described on the website of the Human GenomeVariation Society (http://www.hgvs.org/ mutnomen/).",Non-OADS,/arxiv_data1/oa_pdf/77/6a/jmedgenet-2015-103387.PMC4789806.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Emery AE.,Non-OADS,/arxiv_data1/oa_pdf/77/6a/jmedgenet-2015-103387.PMC4789806.pdf
"Pediatr Pulmonol 2015. http://dx.doi.org/10.1002/ ppul.23215 8 Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L,Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB.",OADS,/arxiv_data1/oa_pdf/77/6a/jmedgenet-2015-103387.PMC4789806.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Eriksen M, Mackay J, Ross H. The tobacco atlas .",Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.facebook.com/pages/Dokha/10312749639377 (accessed 29 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.facebook.com/EnjoyDokha (accessed 29 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.facebook.com/iconicdokha (accessed 29 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.facebook.com/medwakh.dokha (accessed 29 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
"http://www.facebook.com/midwakh (accessed 29 Dec 2013).13 Al-Houqani M, Ali R, Hajat C. Tobacco smoking using midwakh is an emerging health problem —evidence from a large cross-sectional survey in the United Arab Emirates.",Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://apps.nccd.cdc.gov/GTSSData/Ancillary/DataReports.aspx?CAID=1 (accessed 29 Dec 2013).,OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://nccd.cdc.gov/GTSSData/Ancillary/DataReports.aspx?CAID=1 (accessed 29 Dec 2013).,OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.sarudama.com/ miscellaneous/arabic_midwakh_pipes_and_dokha.shtml (accessed 29 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
2012. http://gulfnews.com/news/gulf/ uae/education/dubai-s-teenagers-take-to-dokha-1.1039067 (accessed 29 Dec2013).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.dokhausa.com (accessed 29 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.lung.org/stop-smoking/tobacco-control-advocacy/reports-resources/cessation-economic-bene ﬁts/reports/ hookah-policy-brief.pdf (accessed 10 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
"Ann Arbour: Institute for Social Research, The University of Michigan, 2014. http://www.monitoringthefuture.org/pubs/m onographs/mtf- overview2013.pdf 31 Dokha.Com: We Adore Our Customers!",Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.dokha.com/customerfeedback (accessed 10 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
http://www.medwakh.com/ (accessed 10 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
2014. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394667.htm (accessed 10 Jul 2014).34 2010 Yearbook of Immigration Statistics.,OADS,/arxiv_data1/oa_pdf/ef/31/tobaccocontrol-2013-051530.PMC4789808.pdf
See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Watterson A. J Epidemiol Community Health 2016; 70:219–220.,Non-OADS,/arxiv_data1/oa_pdf/e0/f8/jech-2014-205359.PMC4789810.pdf
"UNEP Global Environmental Alert Service, 2012. http://www.unep.org/pdf/UNEP-GEAS_NOV_2012.pdf(accessed 8 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/e0/f8/jech-2014-205359.PMC4789810.pdf
http://dea.org.au/images/general/DEA_-_The_Health_Factor_05-13.pdf (accessed 8 Dec 2014).7 American Public Health Association.,OADS,/arxiv_data1/oa_pdf/e0/f8/jech-2014-205359.PMC4789810.pdf
2012. http://www.apha.org/advocacy/policy/policysearch/default.htm?id=1439 (accessed 8 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/e0/f8/jech-2014-205359.PMC4789810.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Varshney M, Mahapatra A, Krishnan V, et al .",Non-OADS,/arxiv_data1/oa_pdf/84/4d/jech-2015-205546.PMC4789812.pdf
"15In this cohort, WMH volume (WMHv) was measured using a previously validated, semiauto- mated volumetric method (facilitated by MRIcro , University of Nottingham School of Psychology, Nottingham, UK; http://www.mricro.com).",OADS,/arxiv_data1/oa_pdf/29/c2/jnnp-2014-309685.PMC4789815.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1O ’Sullivan M. Leukoaraiosis.,Non-OADS,/arxiv_data1/oa_pdf/29/c2/jnnp-2014-309685.PMC4789815.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/jech- 2015-205652).,OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
"The lower immunisation rate in recent migrants compared to settled migrants concords with Islam and Azad ’s 46study and gives credence to the theory of migrant adaptation as settledmigrants have adapted to the culture, norms and living condi-tions and so utilisation of health services may be better than the Table 3 Quality assessment of included studies using the Newcastle-Ottawa Scale adapted for cross-sectional studies SelectionComparabilityOutcome First author, yearClear definition ofmigrationstatusSample size calculationreportedParticipants representative ofRUM groupNon-respondents documentedComparable participants; controlfor potentialconfoundersObjective only and/orsubjectiveassessmentAppropriate statistical test Total Anand, 2014 X X X X 4 Antai, 2010 X X X X X X x 7Chhabra, 2007 X X X X X x 6Guo, 2000 X X X X 4Han, 2014 X X X X X X x 7Hu, 2013 X X X X X X X x 8Huang, 2011 X X X 3Keshri, 2013 X X X X X X x 7Kusuma, 2010 X X X X X X X x 8Sun, 2005 X X X X X X X X X x 10Tamoghna, 2011 X X X 3 Based on an adapted form of the Newcastle-Ottawa scale for cohort studies adapted by Herzog et al for cross-sectional studies http://www.biomedcentral.com/1471 –2458/13/154.",Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
"Table 4 Summary table for individual vaccine coverage in RUM versus national coverage estimates Immunisation coverage (in per cent) Study author, year, countryDTP3 OPV3 MEASLES HBV BCG RUM NC RUM NC RUM NC RUM NC RUM NC Antai 2010, Nigeria 12 54 27 54 21 56 –– 30 62 Kusuma 2010, India 73 72 72 70 76 74 62 37 91 87Anand 2014, India 33 72 35 70 30 74 32 67 78 87Sun 2005, China 88 87 91 87 88 86 84 84 –– Hu 2013, China 53 99 53 99 46 99 55 99 33 99Han 2014, China 74 99 75 99 72 99 72 99 76 99 DTP3, diphtheria-tetanus-pertussis; OPV3, oral polio vaccine; HBV, hepatitis B vaccine; RUM, rural –urban migrants; NC, national coverage from WHO-UNICEF estimates for corresponding year http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html Awoh AB, Plugge E. J Epidemiol Community Health 2016; 70:305 –311.",Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ 310 Awoh AB, Plugge E. J Epidemiol Community Health 2016; 70:305 –311.",Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
2014. http://www.who.int/hac/techguidance/health_of_migrants/en/ (accessed3 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
Pediatric Oncall 2014;11. http://www.pediatriconcall.com/Journal/Article/FullText.,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.who.int/bulletin/volumes/88/4/10 –010410/en/ (accessed 5 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734462/ (accessed 3 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
2014. http://www.who.int/topics/ immunization/en/ (accessed 3 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
2014. http://www.who.int/ mediacentre/factsheets/fs378/en/ (accessed 30 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.who.int/bulletin/volumes/87/7/08 –053819/en/ (accessed 12 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
2014. http://data.worldbank.org/about/ country-and-lending-groups (accessed 23 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
"Abuja, Nigeria: 2009. http://dhsprogram.com/ pubs/pdf/FR222/FR222.pdf (accessed 12 Jul 2014).",Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://iussp.org/sites/default/ ﬁles/ event_call_for_papers/Full%20paper.pdf (accessed 17 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.sjph.,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11372398 (accessed 20 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.jbjc.org/EN/abstract/abstract7290.shtml (accessed 17 May 2014).,OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://medind.nic.in/icb/t07/i2/icbt07i2p131.pdf (accessed 17 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
http://www.ncbi.nlm.nih.gov/pubmed/19941996 (accessed 18 May 2014) 41 Hoshaw-Woodard S. Description and comparison of the methods of cluster sampling and lot quality assurance sampling to assess immunization coverage .,OADS,/arxiv_data1/oa_pdf/0d/a2/jech-2015-205652.PMC4789817.pdf
"To viewplease visit the journal online(http://dx.doi.org/10.1136/ tobaccocontrol-2014-051630) 1MRC/CSO Social & Public Health Sciences Unit, Universityof Glasgow, Glasgow, UK 2Institute for Social & Economic Research, University of Essex, Colchester, UK Correspondence to Michael J Green, MRC/CSOSocial & Public Health Sciences Unit, University of Glasgow, 200 Ren ﬁeld Street, Glasgow G2 3BQ, UK; michael.green@glasgow.ac.uk Received 19 February 2014 Accepted 7 October 2014Published Online First7 November 2014 To cite: Green MJ, Leyland AH, Sweeting H, et al.Tob Control 2016; 25:203 –210.ABSTRACT Objective Smoking usually develops in adolescence and is patterned by socioeconomic position (SEP).",Non-OADS,/arxiv_data1/oa_pdf/70/12/tobaccocontrol-2014-051630.PMC4789819.pdf
Data sharing statement The data used in this article are publicly available at: http://discover.ukdataservice.ac.uk/series/?sn=200005.,OADS,/arxiv_data1/oa_pdf/70/12/tobaccocontrol-2014-051630.PMC4789819.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Jarvis MJ, Wardle J.",Non-OADS,/arxiv_data1/oa_pdf/70/12/tobaccocontrol-2014-051630.PMC4789819.pdf
http://www.ash.org.uk/ ﬁles/documents/ASH_741.pdf (accessed 14 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/70/12/tobaccocontrol-2014-051630.PMC4789819.pdf
"Action on Smoking and Health, 2010. http://www.ash.org.uk/tax/ analysis (accessed 14 Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/70/12/tobaccocontrol-2014-051630.PMC4789819.pdf
See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Wise K. Occup Environ Med 2016; 73:215.,Non-OADS,/arxiv_data1/oa_pdf/8b/f5/oemed-2015-103133.PMC4789820.pdf
"Received 22 June 2015 Accepted 3 July 2015 Published Online First 2 February 2016 ▸http://dx.doi.org/10.1136/oemed-2015-103255 Occup Environ Med 2016; 73:215. doi:10.1136/oemed-2015-103133 REFERENCE 1 Casas L, Espinosa A, Borràs-Santos A, et al .",OADS,/arxiv_data1/oa_pdf/8b/f5/oemed-2015-103133.PMC4789820.pdf
"Competing interests JH and EW are employed part-time, respectively, as Lead Academic and Country Director of the Liberia Country programme of theInternational Growth Centre (IGC) (http://www.theigc.org/), which funded the research.",Non-OADS,/arxiv_data1/oa_pdf/af/23/jech-2015-205959.PMC4789821.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Toweh A, Farge E. Liberia con ﬁrms new Ebola case as outbreak spreads.",Non-OADS,/arxiv_data1/oa_pdf/af/23/jech-2015-205959.PMC4789821.pdf
http://www.reuters.com/article/2015/07/14/us-health-ebola-idUSKCN0PO1EN20150714 (accessed 14 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/af/23/jech-2015-205959.PMC4789821.pdf
"Washington DC: World Bank Group, 2015. http://documents.worldbank.org/curated/en/2015/01/23831803/economic-impact-Ebola-sub-saharan-africa-updated-estimates-2015 (accessed 19 Mar 2015).3 Glennerster R, Suri T. The implications of the Ebola outbreak on markets, traders, and food security in Sierra Leone.",Non-OADS,/arxiv_data1/oa_pdf/af/23/jech-2015-205959.PMC4789821.pdf
http://www.theigc.org/wp-content/uploads/2015/ 01/Economic-Impact-of-Ebola-Bulletin-Two2.pdf (accessed 19 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/af/23/jech-2015-205959.PMC4789821.pdf
"To view please visit the journal online (http://dx.doi.org/10.1136/jech-2015-206040) 1NIHR School for Public Health Research (SPHR) 2School of Social and Community Medicine,University of Bristol, Bristol, UK 3ScHARR, School of Health and Related Research, University ofShefﬁeld, Shef ﬁeld, UK 4Department of Health Services Research and Policy, London School of Hygiene and TropicalMedicine, London, UK Correspondence to Dr F de Vocht, School of Social and Community Medicine,University of Bristol, CanyngeHall, 39 Whatley Road, Bristol, BS8 2PS, UK; frank.devocht@bristol.ac.uk Measurable effects of local alcohol licensing policies onpopulation health in England.",Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Health Committee.,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
"Written evidence from the Department of Health (GAS 01) .U K Parliament, 2012. http://www.publications.parliament.uk/pa/cm201213/cmselect/ cmhealth/132/132we02.htm#footnote_1 (accessed 26 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
2014. http://www.hscic.gov.uk/ catalogue/PUB14184/alc-eng-2014-rep.pdf (accessed 26 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
2012. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/224075/alcohol-strategy.,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
"http://www.webcitation.org/6b4N3ljs1 6 Wagenaar AC, Tobler AL, Komro KA.",Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
2011. http://www.legislation.gov.uk/ukpga/2011/13/pdfs/ukpga_20110013_en.pdf(accessed 26 Aug 2015) http://www.webcitation.org/6b4NBIWEp 8 Her Majesty ’s Stationery Of ﬁce.Licensing Act .,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
"London, 2012. https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ ﬁle/98101/guidance-section-182-licensing.pdf (accessed 26 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
http://www.webcitation.org/6b4NOLKEU 10 Livingston M. A longitudinal analysis of alcohol outlet density and assault.,OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
"London, 2007. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/ ﬁle/77949/RevisedGuidanceJune2007.pdf (accessed 26 Aug 2015) http://www.webcitation.org/6b4NUUUqA 16 Babor T, Caetano R, Casswell S, et al.Policy options considered.",Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
2014. https://www.gov.uk/government/collections/alcohol-and-late- night-refreshment-licensing-england-and-wales-statistics (accessed 26 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
http://www.webcitation.org/6b4NapCzZ 22 UK Government.,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/7448/1622442.pdf (accessed 26 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
http://www.webcitation.org/6b4NgJKYT 23 PHE.,OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
http://www.webcitation.org/6b4Nlogai 24 PHE.,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
http://www.webcitation.org/6b4NpQDva 25 WHO.,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
2014. http://www.lape.org.uk/data.html 27 Department for Communities and Local Government.,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
2011. https://www.gov.uk/government/statistics/english-indices-of- deprivation-2010 (accessed 26 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
http://www.webcitation.org/6b4Nw9IHX 28 Faraway J.,Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
"Local Government Association, 2013. http://www.local.gov.uk/publications/-/journal_content/56/10180/3841108/ PUBLICATION (accessed 26 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
http://www.webcitation.org/6b4O0vevv 34 Gustafson P. Measurement error and misclassi ﬁcation in statistics and epidemiology .,OADS,/arxiv_data1/oa_pdf/70/f8/jech-2015-206040.PMC4789824.pdf
To view thisﬁle please visit the journal online (http://dx.doi.org/10.1136/gutjnl-2015-310893).,Non-OADS,/arxiv_data1/oa_pdf/0b/d9/gutjnl-2015-310893.PMC4789826.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Harewood GC, Wiersema MJ, Melton LJ III.",Non-OADS,/arxiv_data1/oa_pdf/0b/d9/gutjnl-2015-310893.PMC4789826.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2014-308735).,Non-OADS,/arxiv_data1/oa_pdf/7e/12/gutjnl-2014-308735.PMC4789828.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Virgin HW, Levine B. Autophagy genes in immunity.",Non-OADS,/arxiv_data1/oa_pdf/7e/12/gutjnl-2014-308735.PMC4789828.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2014-308815).,OADS,/arxiv_data1/oa_pdf/fb/25/gutjnl-2014-308815.PMC4789829.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Liacouras CA, Furuta GT, Hirano I, et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/25/gutjnl-2014-308815.PMC4789829.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2014-308316).,OADS,/arxiv_data1/oa_pdf/f9/9b/gutjnl-2014-308316.PMC4789830.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Lavanchy D. Evolving epidemiology of hepatitis C virus.,Non-OADS,/arxiv_data1/oa_pdf/f9/9b/gutjnl-2014-308316.PMC4789830.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/61/ceg-9-049.PMC4789833.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical and Experimental Gastroenterology 2016:9 49–58Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  49REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S8353 3A systematic review of disease-related  stigmatization in patients living with inflammatory  bowel disease Tiffany H Taft Laurie Keefer Division of Gastroenterology and  Hepatology, Northwestern University  Feinberg School of Medicine, Chicago,   iL, USA Correspondence: Laurie Keefer   ichan School of Medicine at Mount Sinai,  Susan and Leonard Feinstein iBD Center,  17 E 102nd Street, 5th floor, New Y ork,  NY 10029, USA   T el +1 212 824 7770   Fax +1 312 695 3999   Email laurie.keefer@mssm.ed uAbstract:  Chronic illness stigma is a global public health issue.",Non-OADS,/arxiv_data1/oa_pdf/95/61/ceg-9-049.PMC4789833.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/95/61/ceg-9-049.PMC4789833.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/61/ceg-9-049.PMC4789833.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/a2/ott-9-1159.PMC4789834.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1159–1166OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1159Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10042 7screening mirnas for early diagnosis of  colorectal cancer by small rna deep sequencing  and evaluation in a chinese patient population Xiaofeng Wang1,2,* li chen3,* heiying Jin1,4 shuiming Wang1 Yajie Zhang1 Xiaoqing Tang3 guiliang Tang3 1national center of colorectal  surgery, The Third affiliated hospital  of nanjing University of chinese  Medicine, 2graduate school of nanjing  University of Traditional chinese  Medicine, nanjing, People’s republic  of china; 3Department of Biological  sciences, Michigan Technological  University, houghton, M i, Usa;   4Department of general surgery,   Peking University international  hospital, Beijing, People’s republic  of china *These authors contributed equally to  this workPurpose:  This study aims to screen microRNAs (miRNAs), for an early diagnosis of colorec - tal cancer, by deep sequencing and evaluation of total miRNAs using clinical samples from a  Chinese patient population.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/ott-9-1159.PMC4789834.pdf
"Although application of comprehensive treatments, correspondence: heiying Jin Department of general surgery, Peking  University international hospital, 1  life science Park road, Beijing 102206,  People’s republic of china Tel +86 133 8279 3886 email jinheiying@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Screening of miRNAs for early diagnosis of colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S100427",Non-OADS,/arxiv_data1/oa_pdf/58/a2/ott-9-1159.PMC4789834.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/58/a2/ott-9-1159.PMC4789834.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/a2/ott-9-1159.PMC4789834.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/ea/dddt-10-1077.PMC4789835.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1077–1083submit your manuscript | www.dovepress.co m Dove press  1077 http: //dx.doi.org/10.2147/DDDT .S9376 8Protective effects of honokiol on ischemia/ reperfusion injury of rat ovary: an experimental  study senem Yaman T unc1 elif agacayak1 neval Yaman goruk2 Mehmet sait icen1 abdulkadir T urgut1 Ulas alabalik3 cihan T ogrul4 cenap ekinci5 aysun ekinci6 Talip gul1 1Department of Obstetrics and  gynecology, school of Medicine, Dicle  University, 2Department of Obstetrics  and gynecology, Diyarbakir Memorial  hospital, 3Department of Pathology,   school of Medicine, Dicle University,   Diyarbakir, 4Department of Obstetrics  and gynecology, school of Medicine,   hitit University, corum, 5Department  of histology and embryology,   6Department of Medical Biochemistry,   school of Medicine, Dicle University,   Diyarbakir, T urkeyAim:  The purpose of this study was to investigate the protective effect of honokiol on  experimental ischemia/reperfusion injury of rat ovary.",Non-OADS,/arxiv_data1/oa_pdf/aa/ea/dddt-10-1077.PMC4789835.pdf
"This way, potential necrosis can be avoided.3,4 However, the  recovery of ovarian circulation after detorsion might cause a pathologic process  called ischemia/reperfusion (I/R) injury characterized by oxidative stress, leading to  deteriorated tissue damage.5 The causes of I/R injury of the ovary include elevated correspondence: senem Yaman Tunc Department of Obstetrics and  gynecology, school of Medicine, Dicle  University, silvan street, Post Box 21280,  Diyarbakir, Turkey Tel +90 412 248 8001 ext 4904 Fax +90 412 248 8523 email drsenemtunc@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y aman Tunc et al Running head recto: Effects of honokiol on ovarian I/R injury DOI: http://dx.doi.org/10.2147/DDDT.S93768",Non-OADS,/arxiv_data1/oa_pdf/aa/ea/dddt-10-1077.PMC4789835.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/aa/ea/dddt-10-1077.PMC4789835.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/ea/dddt-10-1077.PMC4789835.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9c/f7/opth-10-411.PMC4789836.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 411–418Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  411Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S9885 3Role of aflibercept for macular edema following  branch retinal vein occlusion: comparison of  clinical trials Patrick Oellers1,2 Dilraj S Grewal1,2 Sharon Fekrat1,2 1Duke eye Center, Duke University  Medical Center, 2Surgical Service,   Durham veterans Affairs Medical  Center, Durham, NC, USAAbstract:  For years, the standard of care for branch-retinal-vein-occlusion-associated macular  edema was initial observation followed by grid-pattern laser photocoagulation for persistent edema.",Non-OADS,/arxiv_data1/oa_pdf/9c/f7/opth-10-411.PMC4789836.pdf
"This review outlines recent trials evaluating treatment Correspondence: Sharon Fekrat Duke eye Center, Duke University  Medical Center 3802, 2351 erwin Road,  Durham, NC 27710, USA Tel +1 919 684 1857 Fax +1 919 681 6474 email fekra001@mc.duke.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Oellers et al Running head recto: Aflibercept for BRVO DOI: http://dx.doi.org/10.2147/OPTH.S98853",Non-OADS,/arxiv_data1/oa_pdf/9c/f7/opth-10-411.PMC4789836.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9c/f7/opth-10-411.PMC4789836.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/f7/opth-10-411.PMC4789836.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/34/tcrm-12-373.PMC4789838.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 373–377Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  373ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9926 2Comparison of propofol–hydromorphone and  propofol–dexmedetomidine in patients with  intubation after maxillofacial plastic surgery Wei Peng1,2 Tiejun Zhang2 Yanlin Wang1 1Department of anesthesiology,   Zhongnan hospital, 2Department of  anesthesiology, school and hospital  of stomatology, Wuhan University,   Wuhan, hubei, People’s Republic of  ChinaObjective:  To compare the sedation and analgesic effects between propofol–hydromorphone  and propofol–dexmedetomidine in patients with postoperative intubation after maxillofacial  plastic surgery.",Non-OADS,/arxiv_data1/oa_pdf/c2/34/tcrm-12-373.PMC4789838.pdf
"Although anesthetists have made many efforts  including administration of lidocaine gel, dexmedetomidine, and midazolam to maintain  safe and comfortable tracheal tube, these approaches failed to fix the controversy.3,4Correspondence: Yanlin Wang Department of anesthesiology, Zhongnan  hospital, Wuhan University, Donghu  street 169, Wuhan 430071, hubei,  People’s Republic of China Tel +86 27 876 862 15 Fax +86 27 876 862 15 email yanlin_wang98@sina.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Peng et al Running head recto: Propofol–hydromorphone vs propofol–dexmedetomidine DOI: http://dx.doi.org/10.2147/TCRM.S99262",Non-OADS,/arxiv_data1/oa_pdf/c2/34/tcrm-12-373.PMC4789838.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/c2/34/tcrm-12-373.PMC4789838.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/34/tcrm-12-373.PMC4789838.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/3b/dddt-10-1047.PMC4789839.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1047–1058Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1047Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8779 2Efficacy and safety of modified-release prednisone  in patients with rheumatoid arthritis Marco Krasselt Christoph Baerwald Rheumatology Unit, Clinic for  Gastroenterology and Rheumatology,   Department of internal Medicine,   Neurology and Dermatology,   University of Leipzig, Leipzig,   GermanyAbstract:  The introduction of modified-release (MR) prednisone adds a drug with encouraging  potential to the armamentarium of the rheumatologist.",Non-OADS,/arxiv_data1/oa_pdf/27/3b/dddt-10-1047.PMC4789839.pdf
"de Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Krasselt and Baerwald Running head recto: Efficacy and safety of MR prednisone DOI: http://dx.doi.org/10.2147/DDDT.S87792",Non-OADS,/arxiv_data1/oa_pdf/27/3b/dddt-10-1047.PMC4789839.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/27/3b/dddt-10-1047.PMC4789839.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/3b/dddt-10-1047.PMC4789839.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/ac/dddt-10-1059.PMC4789840.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1059–1076Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1059Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9956 8rgD(F/s/V)-Dex: towards the development  of novel, effective, and safe glucocorticoids Xueyun Jiang1 Ming Zhao1,2 Yuji Wang1 haimei Zhu1 shurui Zhao1 Jianhui Wu1 Yuanbo song3 shiqi Peng1 1Beijing area Major laboratory of  Peptide and small Molecular Drugs,   engineering research center of  endogenous Prophylactic of Ministry  of education of china, Beijing  laboratory of Biomedical Materials,   college of Pharmaceutical sciences,   capital Medical University, Beijing,   People’s republic of china; 2Faculty of  Biomedical science and environmental  Biology, Kaohsiung Medical University,   Kaohsiung, Taiwan; 3guangxi Pusen  Biotechnology co. ltd., nanning,   guangxi, People’s republic of chinaAbstract:  Dexamethasone (Dex) is an effective glucocorticoid in treating inflammation and  preventing rejection reaction.",Non-OADS,/arxiv_data1/oa_pdf/17/ac/dddt-10-1059.PMC4789840.pdf
"In cardiac surgery,  intraoperative high-dose of Dex is associated with rethoracotomy risk.17 A single dose  of Dex was associated with myocardial hypertrophy of laryngeal edema in a preterm  infant.18 For patients in valvular cardiac surgery, high-dose Dex has no protective  effect on the occurrence of postpericardiotomy syndrome,19 while low-dose Dex may  worsen the survival of surgery patients with rectal cancer.20 The psychiatric and cogni - tive symptoms resembling major depression could be observed in patients’ elevated  levels of Dex.21 Preterm labor risk could result from Dex use.22 The treatment with  Dex (postnatally) is associated with adverse motor outcome, such as abnormal fine correspondence: Ming Zhao; shiqi Peng Beijing area Major laboratory of Peptide  and small Molecular Drugs, engineering  research center of endogenous  Prophylactic of Ministry of education of  china, Beijing laboratory of Biomedical  Materials, college of Pharmaceutical  sciences, capital Medical University,  Beijing 100069, People’s republic  of china email mingzhao@bjmu.edu.c n;   sqpeng@bjmu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Jiang et al Running head recto: Development of novel, effective, and safe glucocorticoid: RGD(F/S/V)-Dex DOI: http://dx.doi.org/10.2147/DDDT.S99568",Non-OADS,/arxiv_data1/oa_pdf/17/ac/dddt-10-1059.PMC4789840.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/17/ac/dddt-10-1059.PMC4789840.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/ac/dddt-10-1059.PMC4789840.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics The Application of Clinical Genetics 2016:9 33–38Dove press submit your manuscript | www.dovepress.co m Dove press  OriG inAl reseArChopen access to scientific and medical research Open Access Full T ext Article 33 http: //dx.doi.org/10.2147/TACG.S7824 1Analysis of the CFTR gene in Venezuelan cystic  fibrosis patients, identification of six novel cystic  fibrosis-causing genetic variants Karen sánchez1 Elizabeth de Mendonca1 Xiorama Matute2 ismenia Chaustre2 Marlene Villalón3 howard Takiff4 1Unit of Genetic and Forensic Studies,   Venezuelan institute for scientific  Research (IVIC), 2Hospital JM de los  Ríos, 3Hospital José Ignacio Baldo,   Algodonal, National Reference Unit,   4Laboratory of Molecular Genetics,   Venezuelan institute for scientific  Research (IVIC), Caracas, Venezuela.",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
Available from: http://www.genet.sickkids.on.ca/app.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
Available from:http://www.google.com/patents/WO2010088630A2.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
Available from: http://www.cftr2.org/ browse.php .,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
"Available from: http://www.hgvs.org/ mutnomen/recs-DNA.htm l. Accessed October 7, 2014.",OADS,/arxiv_data1/oa_pdf/5e/b0/tacg-9-033.PMC4789841.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/86/ott-9-1167.PMC4789842.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1167–1173OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1167Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10226 5Efficacy and safety of vascular endothelial growth  factor receptor tyrosine kinase inhibitors in the  treatment of advanced thyroid cancer: a meta- analysis of randomized controlled trials Wufuer Yimaer* aizizi abudouyimu* Ye Tian sailike Magaoweiya Duman Bagedati hao Wen Department of Vascular Thyroid  surgery, gastrointestinal Vascular  center, The First affiliated hospital  of Xinjiang Medical University,   Urumqi, Xinjiang Province, People’s  republic of china *These authors contributed equally to  this workBackground:  We performed a systematic review and meta-analysis to determine the efficacy  and safety of the US Food and Drug Administration approved vascular endothelial growth  factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in the treatment of advanced thyroid  cancer.",Non-OADS,/arxiv_data1/oa_pdf/6e/86/ott-9-1167.PMC4789842.pdf
"Keywords:  angiogenesis inhibitors, toxicity, clinical trials, thyroid cancer, meta-analysis Introduction Thyroid cancer is the most common neoplasm of the endocrine system with incidence  rates steadily increasing over the past 10 years.1 In 2014, ~62,980 new cases of thyroid  cancer were diagnosed and ~1,890 cancer deaths occurred from the disease in USA.2  Although the prognosis is excellent for the majority of patients treated by surgery,  thyroid-stimulating hormone-suppressive therapy, and radioiodine ablation, with an  overall survival rate of 97.7% at 5 years,3 local recurrence occurs in up to 20% of  patients and distant metastases in ~10% at 10 years.4 Until now, the medical approach correspondence: hao Wen gastrointestinal Vascular center,  The First Affiliated Hospital of Xinjiang  Medical University, no 137, south  liyushan road, Urumqi, Xinjiang province  830054, People’s republic of china Tel +86 991 436 2974 Fax +86 991 436 4780 email haowen20151212@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yimaer et al Running head recto: Efficacy and safety of VEGFR-TKIs in ATC DOI: http://dx.doi.org/10.2147/OTT.S102265",Non-OADS,/arxiv_data1/oa_pdf/6e/86/ott-9-1167.PMC4789842.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6e/86/ott-9-1167.PMC4789842.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/86/ott-9-1167.PMC4789842.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/9a/ott-9-1275.PMC4789843.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1275–1280OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1275Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9442 5association of OPn rs11730582 polymorphism  with cancer risk: a meta-analysis lanlan he1,* Y ong Wang2,* 1emergency Department,   Zhenjiang  First People’s  hospital,   Zhenjiang, People’s republic of  china; 2Department of interventional  radiology and Vascular surgery,   Zhongda hospital, southeast  University, nanjing, Jiangsu, People’s  republic of china *Both authors contributed equally  to this workPurpose:  Several molecular epidemiological studies have investigated the association between  OPN rs11730582 C .T polymorphism and cancer risk, but the results are inconsistent.",Non-OADS,/arxiv_data1/oa_pdf/98/9a/ott-9-1275.PMC4789843.pdf
"However, previous literature about the correspondence: lanlan he emergency Department, Zhenjiang First  People’s hospital, Zhenjiang 212000,  People’s republic of china email lanlanhe12@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: He and Wang Running head recto: OPN rs11730582 polymorphism and cancer risk DOI: http://dx.doi.org/10.2147/OTT.S94425",Non-OADS,/arxiv_data1/oa_pdf/98/9a/ott-9-1275.PMC4789843.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/98/9a/ott-9-1275.PMC4789843.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/9a/ott-9-1275.PMC4789843.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/48/dddt-10-1029.PMC4789844.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1029–1034Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1029Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9471 0stability studies of lincomycin hydrochloride in  aqueous solution and intravenous infusion fluids Petra czarniak Michael Boddy Bruce sunderland Jeff D hughes school of Pharmacy, curtin  University, Perth, W a, australiaPurpose:  The purpose of this study was to evaluate the chemical stability of Lincocin®  (lincomycin hydrochloride) in commonly used intravenous fluids at room temperature (25 °C),  at accelerated-degradation temperatures and in selected buffer solutions.",Non-OADS,/arxiv_data1/oa_pdf/eb/48/dddt-10-1029.PMC4789844.pdf
"It has a spectrum of activity  against Gram-positive bacteria and most anaerobes, but not Gram-negative aerobes.1  Its action may be bactericidal or bacteriostatic, dependent on the concentration of the  drug attained at the site of infection and the susceptibility of the infecting organism.2  It is indicated for the treatment of serious infections due to susceptible strains of  Gram-positive aerobes, such as staphylococci, streptococci, and pneumococci, and is  generally reserved for patients who are allergic to penicillin.3 In Australia, lincomycin is only available as a solution for injection (600 mg in  2 mL), and is the only parenteral lincosamide where the cost is subsidized by the  Pharmaceutical Benefits Scheme.4 Intravenous (IV) doses are administered on the  basis of 1 g Lincocin® diluted in not less than 100 mL of an appropriate solution  and infused over a period of not less than 1 hour to avoid severe cardiopulmonary  reactions.3 Infusion solutions reported to be physically compatible with Lincocin® correspondence: Petra czarniak school of Pharmacy, curtin University,  Kent street, Bentley, Perth, Wa 6102,  australia Tel +61 8 9266 7419 Fax +61 8 9266 2769 email p.czarniak@curtin.edu.a u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Czarniak et al Running head recto: Lincomycin stability DOI: http://dx.doi.org/10.2147/DDDT.S94710",Non-OADS,/arxiv_data1/oa_pdf/eb/48/dddt-10-1029.PMC4789844.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/eb/48/dddt-10-1029.PMC4789844.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/48/dddt-10-1029.PMC4789844.pdf
Available from: https://www.mimsonline.com.au.dbgw.lis.curtin.edu.,Non-OADS,/arxiv_data1/oa_pdf/eb/48/dddt-10-1029.PMC4789844.pdf
Available from: http://www.pbs.,Non-OADS,/arxiv_data1/oa_pdf/eb/48/dddt-10-1029.PMC4789844.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/cc/ott-9-1231.PMC4789845.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1231–1239OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1231Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9922 8Mir-381 functions as a tumor suppressor in  colorectal cancer by targeting T wist1 Xinxin he Yangnian Wei Y ong Wang ling liu Wen Wang nianfeng li Department of hepatobiliary and  Pancreatic surgery, Xiangya  hospital,   central south University, hunan,   People’s republic of chinaAbstract:  MiR-381 has been reported to be dysregulated in several human cancers.",Non-OADS,/arxiv_data1/oa_pdf/98/cc/ott-9-1231.PMC4789845.pdf
"Recently, increasing reports have revealed the close relationship between dys - regulated microRNAs (miRNAs) and the development of CRC, which highlights the role  of miRNAs as potential biomarkers and therapeutic targets in patients with CRC.5–7 miRNAs are a class of short and noncoding RNAs that negatively regulate the  expression of protein-coding genes by directly binding their 3 ′ untranslated region  (3′-UTR), leading to the posttranscriptional translation inhibition or mRNA  degradation.8,9 In CRC, many miRNAs have been found to be involved in the regula - tion of multiple cellular functions, such as cell proliferation, invasion, and migration.10  For example, miR-143 and miR-145 function as tumor suppressors by inhibiting cell  proliferation, invasion, and metastasis,11,12 while miR-21 acts as an important promoter  of oncogenesis.13,14 CRC pathogenesis is particularly accompanied by the epithelial– mesenchymal transition (EMT) that is considered the primary step in distant metastasis  of many types of cancer, the major concern in clinical cancer therapy.15,16 Recent  findings showed that miRNA is important in regulating the EMT process in CRC.17–19  Therefore, identification of EMT-associated miRNAs as biomarkers or therapeutic  targets is of great importance.correspondence: nianfeng li Department of hepatobiliary and  Pancreatic surgery, Xiangya hosptial,  central south University, nO 87  Xiangya road, changsha, hunan 410008,  People’s republic of china Tel +86 731 8975 3060 Fax +86 731 8975 3060 email linianfeng66@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: He et al Running head recto: MiR-381 inhibits colorectal cancer by targeting Twist1 DOI: http://dx.doi.org/10.2147/OTT.S99228",Non-OADS,/arxiv_data1/oa_pdf/98/cc/ott-9-1231.PMC4789845.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/98/cc/ott-9-1231.PMC4789845.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/cc/ott-9-1231.PMC4789845.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/75/dddt-10-1035.PMC4789846.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy Drug Design, Development and Therapy 2016:10 1035–1045Dove press submit your manuscript | www.dovepress.co m Dove press  Original researchopen access to scientific and medical research Open access Full T ext article 1035 http: //dx.doi.org/10.2147/DDDT .S10170 1Chloroquine enhances the efficacy of cisplatin by  suppressing autophagy in human adrenocortical  carcinoma treatment liang Qin1,* Tianyuan Xu1,* leilei Xia1 Xianjin Wang1 Xiang Zhang1 Xiaohua Zhang1 Zhaowei Zhu1 shan Zhong1 chuandong Wang2 Zhoujun shen1 1Department of Urology, ruijin  hospital, shanghai Jiao T ong University  school of Medicine, 2Key Laboratory  of stem cell Biology, shanghai  institutes for Biological sciences,   chinese academy of sciences,   shanghai Jiao Tong University school  of Medicine, shanghai, People’s  Republic of China *These authors contributed equally  to this workBackground:  It has been demonstrated that chloroquine (CQ) enhances the efficacy of  chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/0d/75/dddt-10-1035.PMC4789846.pdf
"However, the 5-year survival of  these patients is usually ,15%.4 Cytotoxic therapy (cisplatin, DDP) is an indispens - able part of systemic chemotherapy for ACC.5 As the most widely tested cytotoxic correspondence: Zhoujun shen Department of Urology, ruijin hospital,  shanghai Jiao Tong University school of  Medicine, 197, 2nd ruijin road, shanghai  200025, People’s Republic of China Tel/fax +86 21 6431 5370 email s henzj06@sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Qin et al Running head recto: Chloroquine in treating human adrenocortical carcinoma DOI: http://dx.doi.org/10.2147/DDDT.S101701",Non-OADS,/arxiv_data1/oa_pdf/0d/75/dddt-10-1035.PMC4789846.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0d/75/dddt-10-1035.PMC4789846.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/75/dddt-10-1035.PMC4789846.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/06/b9/ott-9-1181.PMC4789847.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1181–1188OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1181Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9824 2Profile of farletuzumab and its potential in the  treatment of solid tumors Seiya Sato Hiroaki itamochi Department of Obstetrics and  Gynecology, iwate Medical University  School of Medicine, Morioka, JapanAbstract:  Folate receptor (FR) α expression in normal tissues is restricted to a subpopulation  of epithelial cells.",Non-OADS,/arxiv_data1/oa_pdf/06/b9/ott-9-1181.PMC4789847.pdf
"Farletuzumab is considered to induce immune-dependent  cell death, although no underlying mechanism has yet been clarified.11 Farletuzumab  has shown efficacy in both preclinical and clinical studies as a single agent and  in combination chemotherapy with minimal drug-specific toxicity.12 However, no  improvement in progression-free survival (PFS) was observed in Phase III clinical Correspondence: Hiroaki itamochi Department of Obstetrics and  Gynecology, iwate Medical University  School of Medicine, 19-1 Uchimaru,  Morioka 020-8505, Iwate, Japan Tel +81 19 651 5111 Fax +81 19 622 1900 email itamochi@iwate-med.ac.j p Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Sato and Itamochi Running head recto: Farletuzumab in the treatment of solid tumors DOI: http://dx.doi.org/10.2147/OTT.S98242",Non-OADS,/arxiv_data1/oa_pdf/06/b9/ott-9-1181.PMC4789847.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/06/b9/ott-9-1181.PMC4789847.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/b9/ott-9-1181.PMC4789847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e1/05/ott-9-1175.PMC4789849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1175–1179OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1175Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10242 4The evaluation of the association between  the metabolic syndrome and tumor grade  and stage of bladder cancer in a chinese  population nan sha1,2,* hao Xu1,2,* Tao chen1,2,* Da-wei Tian1,2 Wan-qin Xie3 lin-guo Xie1,2 Yu Zhang1,2 chen Xing1,2 Xiao-teng liu1,2 Zhong-hua shen1,2 Zhou-liang Wu1,2 hai-long hu1,2 chang-li Wu1,2 1Department of Urology, The second  hospital of Tianjin Medical University,   2Tianjin Key laboratory of Urology,   Tianjin institute of Urology, Tianjin,   3Key laboratory of genetics and Birth  health of hunan province, Family  Planning research institute of hunan  Province, changsha, hunan, People’s  republic of china *These authors contributed equally  to this workObjective:  The objective of this article was to summarize the relationship between some  components of metabolic syndrome (MetS) and the histopathologic findings in bladder cancer  in a Chinese population.",Non-OADS,/arxiv_data1/oa_pdf/e1/05/ott-9-1175.PMC4789849.pdf
"In developed  countries, ~360,000 men and women are diagnosed with bladder cancer; the highest  incidence rates are found in the countries of Europe and North America.3 However,  it is of note that the incidence of bladder cancer has been steadily increasing in the  People’s Republic of China over recent years.4correspondence: hai-long hu;   chang-li Wu Department of Urology, The second  hospital of Tianjin Medical University,  Tianjin institute of Urology, 23 Pingjiang  road, hexi District, Tianjin 300211,  People’s republic of china email huhailonglove@163.co m;   wujygc2003@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Sha et al Running head recto: Association between MetS and bladder cancer in a Chinese population DOI: http://dx.doi.org/10.2147/OTT.S102424",Non-OADS,/arxiv_data1/oa_pdf/e1/05/ott-9-1175.PMC4789849.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e1/05/ott-9-1175.PMC4789849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/ott-9-1175.PMC4789849.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/09/dddt-10-1085.PMC4789850.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1085–1099Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1085Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8080 4Spotlight on botulinum toxin and its potential  in the treatment of stroke-related spasticity Michelle Kaku David M Simpson Department of Neurology, icahn  School of Medicine at Mount Sinai,   New Y ork, NY, USAAbstract:  Poststroke spasticity affects up to one-half of stroke patients and has debilitating  effects, contributing to diminished activities of daily living, quality of life, pain, and functional  impairments.",Non-OADS,/arxiv_data1/oa_pdf/b8/09/dddt-10-1085.PMC4789850.pdf
"However, this therapy is Correspondence: Michelle Kaku Department of Neurology, icahn School  of Medicine at Mount Sinai, 1 Gustave L  Levy Place, New York, NY 10029, USA Tel +1 917 836 7223 email michellekaku@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Kaku and Simpson Running head recto: BoNT and its potential in the treatment of stroke-related spasticity DOI: http://dx.doi.org/10.2147/DDDT.S80804",Non-OADS,/arxiv_data1/oa_pdf/b8/09/dddt-10-1085.PMC4789850.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b8/09/dddt-10-1085.PMC4789850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/09/dddt-10-1085.PMC4789850.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/0c/ott-9-1189.PMC4789851.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1189–1204OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1189Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9890 6The role of semaphorin 4D as a potential  biomarker for antiangiogenic therapy in colorectal  cancer Xiaojie Ding1,2,* lijuan Qiu1,2,* lijuan Zhang3 Juemin Xi1,2 Duo li1,2 Xinwei huang1,2 Yujiao Zhao1,2 Xiaodang Wang1,2 Qiangming sun1,2 1institute of Medical Biology, chinese  academy of Medical sciences and Peking  Union Medical college, 2Molecular  epidemiology Joint laboratory, Yunnan  Key laboratory of Vaccine research &  Development on severe infectious  Diseases, 3Department of Pathology,  The Third Affiliated Hospital of Kunming  Medical University (Yunnan Provincial  Tumor hospital), Kunming, People’s  republic of china *These authors contributed equally  to this workBackground:  Semaphorin 4D (Sema4D) belongs to the class IV semaphorins, and accumulating  evidence has indicated that its elevated level may be one strategy by which tumors evade current anti - angiogenic therapies.",Non-OADS,/arxiv_data1/oa_pdf/d8/0c/ott-9-1189.PMC4789851.pdf
"correspondence: Qiangming sun institute of Medical Biology, chinese  academy of Medical sciences and Peking  Union Medical college (caMs & PUMc),  935 Jiao ling road, Kunming,  Yunnan Province 650118, People’s  republic of china Tel +86 136 4887 7862 Fax +86 871 6833 4483 email msun08@yahoo.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ding et al Running head recto: Semaphorin 4D as a biomarker for antiangiogenic therapy in CRC DOI: http://dx.doi.org/10.2147/OTT.S98906",Non-OADS,/arxiv_data1/oa_pdf/d8/0c/ott-9-1189.PMC4789851.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d8/0c/ott-9-1189.PMC4789851.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/0c/ott-9-1189.PMC4789851.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/d8/ott-9-1241.PMC4789883.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1241–1249OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1241Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9422 8The relationship between apolipoprotein e gene  ε2/ε3/ε4 polymorphism and breast cancer risk:  a systematic review and meta-analysis Yun-long liu1 hao-Min Zhang1 hong-Ming Pan2 Yu-hang Bao2 Jing Xue2 Tian-chang Wang1 Xiao-cheng Dong1 Xiao-ling li3 hong-guang Bao1 1Department of chest surgery,   The second affiliated hospital  of Qiqihar Medical University,   2Basic Medical science college,   Qiqihar Medical University, Qiqihar,   heilongjiang, People’s republic of  china; 3Department of anatomy,   Basic Medical science college,   Qiqihar Medical University, Qiqihar,   heilongjiang, People’s republic of  chinaObjective:  We conducted a systematic review and meta-analysis aiming to assess the relationship  between apolipoprotein E ( APOE ) gene ε2/ε3/ε4 polymorphism and breast cancer risk.",Non-OADS,/arxiv_data1/oa_pdf/aa/d8/ott-9-1241.PMC4789883.pdf
"Beyond this well-known function, evidence is amassing to  reveal a different role for APOE in carcinogenesis and tumor development.5 The gene correspondence: hong-guang Bao Department of chest surgery, The  Second Affiliated Hospital of Qiqihar  Medical University, Zhonghua West road  37, Jianhua District, Qiqihar city 161006,  heilongjiang Province, People’s republic  of china Tel +86 452 2736 380 email bhg28k@163.co m  Xiao-ling li Department of anatomy, Basic Medical  science college, Qiqihar Medical  University, Bukui north street 333,  Jianhua District, Qiqihar city 161006,  heilongjiang Province, People’s republic  of china Tel +86 452 2663 182 email lixiaoling_lsm@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: APOE and breast cancer: a meta-analysis DOI: http://dx.doi.org/10.2147/OTT.S94228",Non-OADS,/arxiv_data1/oa_pdf/aa/d8/ott-9-1241.PMC4789883.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/aa/d8/ott-9-1241.PMC4789883.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/d8/ott-9-1241.PMC4789883.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/d6/ott-9-1269.PMC4789894.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1269–1273OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1269Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9968 4Clinical benefits of combined chemotherapy with  s-1, oxaliplatin, and docetaxel in advanced gastric  cancer patients with palliative surgery Yan liu1 Ye Feng2 Y ongjian gao2 ruizhi hou2 1Department of Ultrasonography,   2Department of Gastrointestinal  Disease, China–Japan Union Hospital,   Jilin University, Changchun, People’s  Republic of ChinaBackground and aim:  Advanced gastric cancer accounts for a substantial portion of  cancer-related mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a6/d6/ott-9-1269.PMC4789894.pdf
"Keywords:  gastric cancer, palliative resection, S-1, oxaliplatin, docetaxel, combination  chemotherapy Introduction Gastric cancer is the third leading cause of cancer deaths worldwide.1,2 The disease is  characterized by its heterogeneous histology and genetic background.3 Surgical resec - tion is potentially curative in patients with early gastric cancer, but for patients with  advanced cancer, the clinical outcomes are among the poorest of all solid-organ tumors  because of the high rate of distinct metastasis and recurrence.4,5 A better understand - ing of cancer biology has allowed the development of molecular-targeted therapies,  for example, bevacizumab, sunitinib, and sorafenib, that inhibit angiogenesis.6 The  usefulness of these novel agents remains to be further investigated, and chemotherapy correspondence: ruizhi hou Department of Gastrointestinal  Disease, China–Japan Union Hospital,  Jilin University, 126 Xiantai Street,  Changchun 130033, People’s  Republic of China Tel +86 139 4406 4810 email houruizhi15802@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel DOI: http://dx.doi.org/10.2147/OTT.S99684",Non-OADS,/arxiv_data1/oa_pdf/a6/d6/ott-9-1269.PMC4789894.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a6/d6/ott-9-1269.PMC4789894.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/d6/ott-9-1269.PMC4789894.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/dddt-10-933.PMC4790082.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 933–948Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  933Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9746 3celastrol inhibits prostaglandin e2-induced  proliferation and osteogenic differentiation of  fibroblasts isolated from ankylosing spondylitis  hip tissues in vitro Yu-cong Zou1,* Xian-Wen Yang2,* shi-guo Yuan1 Pei Zhang1 Yi-Kai li1 1school of Traditional chinese  Medicine, southern Medical  University, 2The Third affiliated  hospital, guangzhou University of  Traditional chinese Medicine, guang  Zhou, People’s republic of china *These authors contributed equally  to this workBackground:  Heterotopic ossification on the enthesis, which develops after subsequent  inflammation, is one of the most distinctive features in ankylosing spondylitis (AS).",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/dddt-10-933.PMC4790082.pdf
"As an important mediator of inflammation, prostaglandin E2 (PGE-2) modulates  the anabolic/catabolic process, which occurs in the bone forming and absorption,3  and is the most abundant among prostaglandins in osteoblasts.4 PGE-2 promotes bone  remodeling through inducing osteoblast cell differentiation5,6 and is widely involved  in the heterotopic ossification.7,8 Moreover, PGE-2 plays a more essential role in the  development of heterotopic ossification than other prostaglandins in the rabbit model.9 correspondence: Yi-Kai li school of Traditional chinese Medicine,  southern Medical University, guang Zhou  avenue north 1838 Baiyun District, guang  Zhou, 510515, People’s republic of china Tel +86 20 6164 8254 Fax +86 20 6164 8255 email gzliyikai@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zou et al Running head recto: Celastrol inhibits PGE-2-induced proliferation and osteogenesis DOI: http://dx.doi.org/10.2147/DDDT.S97463",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/dddt-10-933.PMC4790082.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/dddt-10-933.PMC4790082.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/dddt-10-933.PMC4790082.pdf
Inactivation of Ezh2  accentuated expression of genes highly expressed  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/9a/nihms-761377.PMC4790111.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2016.01.064 .",OADS,/arxiv_data1/oa_pdf/a2/9a/nihms-761377.PMC4790111.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 1 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowEditorial Central or axial atlantoaxial instability: Expanding  understanding of craniovertebral junction Atul Goel Department of Neurosurgery, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital and Lilavati Hospital a nd  Research Center, Bandra, Mumbai, Maharashtra, India Corresponding author: Prof. Atul Goel, Department of Neurosurgery, King Edward VII Memorial Hospital and Seth G.S.",Non-OADS,/arxiv_data1/oa_pdf/da/33/JCVJS-7-1.PMC4790141.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit : http://www.jcvjs.com/editorialboard.asp13 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Evaluation of the efficiency of cervical orthoses  on cervical fracture: A review of literature Mohammad Taghi Karimi, Mostafa Kamali, Francis Fatoye1 Department of Orthotics and Prosthetics, Rehabilitation Faculty, Isfahan University of Medical Sciences, Isfahan, Iran, 1Department of Health  Professions, Manchester Metropolitan University, United Kingdom Corresponding author: Dr. Mohammad Taghi Karimi, Musculoskeletal Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/93/68/JCVJS-7-13.PMC4790142.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 20 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Is atlantoaxial instability the cause of “high” cervical  ossified posterior longitudinal ligament?,Non-OADS,/arxiv_data1/oa_pdf/06/2e/JCVJS-7-20.PMC4790143.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 26 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Diffusion tensor imaging of cervical spinal cord: A  quantitative diagnostic tool in cervical spondylotic myelopathy Zafer Orkun Toktas, Bahattin Tanr ıkulu1, Orkun Koban2, Turker Kilic, Deniz Konya Department of Neurosurgery, School of Medicine, Bahcesehir University, 1Department of Neurosurgery, Marmara University Research and Training  Hospital, 2Department of Neurosurgery, Marmara University Institute of Neurological Sciences, Istanbul, Turkey Corresponding author: Dr. Zafer Orkun Toktas, Altaycesme Mah.",Non-OADS,/arxiv_data1/oa_pdf/52/72/JCVJS-7-26.PMC4790144.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 31 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Upright magnetic resonance imaging of the lumbar  spine: Back pain and radiculopathy Ha Son Nguyen1, Ninh Doan1, Saman Shabani1, Jamie Baisden1, Christopher Wol ﬂ a1,  Glenn Paskoff2, Barry Shender2, Brian Stemper1,3 1Department of Neurosurgery, Medical College of Wisconsin, 3Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin, 2Naval Air Warfare  Center, Aircraft Division, Patuxent River, Maryland, USA Corresponding author: Dr. Brian Stemper, Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin, 5000 W National Avenue, M ilwaukee - 53295, Wisconsin, USA.",Non-OADS,/arxiv_data1/oa_pdf/07/ba/JCVJS-7-31.PMC4790145.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 38 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Factors affecting results of fluoroscopy-guided facet  joint injection: Probable differences in the outcome of treatment between pure facet joint hypertrophy and concomitant diseases Akif Albayrak, Baris Ozkul, Mehmet Bulent Balioglu, Yunus Atici, Muhammet Zeki Gultekin1,  Merih Dilan Albayrak2 Department of Orthopaedics and Traumatology, MS Baltalimani Bone Disease and Research Hospital Istanbul, 1Department of Orthopaedics  and Traumatology, Sanliurfa State Hospital, Sanliurfa, 2Department of Anesthesiology, Yedikule Chest Disease and Research Hospital, Istanbul,  Turkey Corresponding author: Dr. Akif Albayrak, Ka ğıthane Merkez Mahallesinde, Ece Sok Gönülevleri Sit C Blok Daire 5, Istanbul, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/9d/96/JCVJS-7-38.PMC4790146.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 43 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Posterolateral instrumented fusion with and without  transforaminal lumbar interbody fusion for the treatment of adult isthmic spondylolisthesis: A randomized clinical trial with 2-year follow-up Mohammad Reza Etemadifar, Abdollah Hadi, Mehran Feizi Masouleh1  Departments of Orthopedic Spinal Surgery, 1Orthopedics, Isfahan University of Medical Science, Isfahan, Iran Corresponding author: Dr. Mehran Feizi Masouleh, Department of Orthopedics, Isfahan University of Medical Science, Isfahan, Ira n. E-mail: mfiezm@yahoo.com Journal of Craniovertebral Junction and Spine 2016, 7:9 Abstract Background:  Spondylolisthesis is a common cause of surgery in patients with lower back pain.",Non-OADS,/arxiv_data1/oa_pdf/15/71/JCVJS-7-43.PMC4790148.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 50 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Unilateral lag-screw technique for an isolated anterior  1/4 atlas fracture Semih Keskil, Murat Göksel, Ula ş Yüksel Department of Neurosurgery, Medical School, K ırıkkale University, K ırıkkale, Turkey  Corresponding author: Semih Keskil, 736.",Non-OADS,/arxiv_data1/oa_pdf/32/d3/JCVJS-7-50.PMC4790149.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 55 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowOriginal Article Minimally invasive space shuttle laminotomy  for degenerative lumbar spinal canal stenosis Shunji Asamoto, Jun Muto1, Hiroyuki Jimbo2 Department of Neurosurgery, Mita Hospital, International University of Health and Welfare, Otawara, 1Department of Neurosurgery, Keio University,  School of Medicine, 2Department of Neurosurgery, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan Corresponding author: Prof. Shunji Asamoto, Department of Neurosurgery, Mita Hospital, International University of Health and W elfare, 1-4-3 Mita,  Minato-Ku - 108-8329, Tokyo, Japan.",Non-OADS,/arxiv_data1/oa_pdf/a4/63/JCVJS-7-55.PMC4790150.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 59 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report Recurrent craniospinal epidermoid: A case report Abhidha Shah, Manoj Patil, Atul Goel Department of Neurosurgery, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, I ndia Corresponding author: Dr. Abhidha Shah, Department of Neurosurgery, Seth Gordhandas Sunderdas Medical College and King Edward M emorial Hospital, Parel,  Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/23/f7/JCVJS-7-59.PMC4790151.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 62 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report An unusual cause of unilateral facial injuries caused  by horseshoe headrest during prone positional craniovertebral junction surgery Chetna Shamshery, Rudrashish Haldar, Arun Srivastava1, Ashutosh Kaushal, Shashi Srivastava,  Prabhat K. Singh Departments of Anaesthesiology and 1Neurosurgery, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India Corresponding author: Dr. Rudrashish Haldar, Department of Anaesthesiology, Sanjay Gandhi Post Graduate Institute of Medical Sc iences, Rae Bareilly Road,  Lucknow - 226 014, Uttar Pradesh, India.",Non-OADS,/arxiv_data1/oa_pdf/c7/c8/JCVJS-7-62.PMC4790152.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 65 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowCase Report Extradural spinal meningioma: Revisiting a rare entity Guruprasad Bettaswamy, Paurush Ambesh, Kuntal Kanti Das, Rabi Sahu, Arun Srivastava,  Anant Mehrotra, Awadhesh Jaiswal, Sushila Jaiswal1, Sanjay Behari Departments of Neurosurgery and 1Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India Corresponding author: Dr. Kuntal Kanti Das, Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Science s, Raebareilly Road,  Lucknow - 226 014, Uttar Pradesh, India.",Non-OADS,/arxiv_data1/oa_pdf/af/11/JCVJS-7-65.PMC4790153.pdf
"For Instructions for Author,  Please visit: http://www.jcvjs.com/contributors.asp",Non-OADS,/arxiv_data1/oa_pdf/af/11/JCVJS-7-65.PMC4790153.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 7 © 2016 Journal of Craniovertebral Junction and Spine | Published by Wolters Kluwer - MedknowReview Article Ligamentum flavum hematomas: Why does it  mostly occur in old Asian males?,Non-OADS,/arxiv_data1/oa_pdf/04/1c/JCVJS-7-7.PMC4790154.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Levothyroxine effects and limbic glucose metabolism M Bauer et al 236 Molecular Psychiatry (2016), 229 –236 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/66/d1/mp2014186a.PMC4790155.pdf
Glutamic acid decarboxylase (GAD) antibodiesFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services11,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services12,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services13,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services14,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services15,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services16,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services17,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services18,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services19,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services20,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services21,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Clinical Spectrum of Stiff Person Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services22,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services23,Non-OADS,/arxiv_data1/oa_pdf/7c/14/tre-06-340-7522-1.PMC4790195.pdf
"Finally, there is a roundness to the waveform in the PD spiral that is notFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/07/37/tre-06-370-7522-1.PMC4790196.pdf
"The ET spiral is worse in the upper right and lower left quadrants.Morgan S, Louis ED PD Masquerading as ET Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/07/37/tre-06-370-7522-1.PMC4790196.pdf
7One factor common to these pathophy-Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Non-motor Symptoms of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Non-motor Symptoms of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Non-motor Symptoms of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Mov Disorder 2002;17:633–637, doi: http://dx.doi.org/10.1002/mds.10222.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"J Neural Transm (Vienna) 2012;119:1383–1387; discussion 73, doi: http://dx.doi.org/ 10.1007/s00702-012-0878-8.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Mov Disorder 2014;29:1329–1330, doi: http://dx.doi.org/10.1002/mds.25965.6.Louis ED, Vonsattel JP.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Mov Disorder 2008;23:174–1782, doi: http://dx.doi.org/10.1002/mds.21731.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Curr Opin Neurol 2007;20:447–452, doi: http://dx.doi.org/10.1097/ WCO.0b013e3281e66942.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Neurology 2006;66:69–74, doi: http://dx.doi.org/10.1212/01.wnl.0000192393.05850.ec.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Neurology 2009;73: 621–625, doi: http://dx.doi.org/10.1212/WNL.0b013e3181b389f1.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Tremor Other Hyperkinet Mov (N Y) 2012;2, doi: http://dx.doi.org/10.7916/D89W0D7W.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Mov Disorder 2012;27:432–434, doi: http://dx.doi.org/10.1002/mds.24049.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Neurology 2001;57:785–790, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"J Int Neuropsychol Soc 2002;8: 125–129, doi: http://dx.doi.org/10.1017/S1355617702001121.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Acta Neurol Scand 2012;125:332–337, doi: http://dx.doi.org/10.1111/j.1600-0404.2011.01573.x.",OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Neurology 2003;61: 1804–1806, doi: http://dx.doi.org/10.1212/01.WNL.0000099075.19951.8C.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Mov Disorder 2013;28: 1700–1707, doi: http://dx.doi.org/10.1002/mds.25590.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Mov Disorder 2006;21:1114–1118, doi: http://dx.doi.org/10.1002/mds.20884.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Psychiatr Res 1991;38:143–162, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Fortschritte Neurol Psychiatr 2006;74:714–722, doi: http://dx.doi.org/10.1055/s-2006-932164.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Non-motor Symptoms of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Respiration 1999;66:440–447, doi: http://dx.doi.org/ 10.1159/000029408.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Neurology 2000;55:1621–1626, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Parkinsonism Relat Disord 2008;14:93–101, doi: http://dx.doi.org/ 10.1016/j.parkreldis.2007.06.008.",OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Ann Otol Rhinol Laryngol 2001;110:976–981, doi: http://dx.doi.org/10.1177/000348940111 001015.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Tremor Other Hyperkinet Mov (N Y) 2014;4, doi: http://dx.doi.org/10.7916/D8RF5S4J.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Tremor Other Hyperkinet Mov (N Y) 2014;4, doi: http://dx.doi.org/10.7916/D8D798MZ.32.Louis ED, Barnes L, Albert SM, et al.",OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Tremor Other Hyperkinet Mov (N Y) 2012;2, doi: http://dx.doi.org/10.7916/D8N58K4H.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Neurology 2006;67:33– 38, doi: http://dx.doi.org/10.1212/01.wnl.0000230572.07791.22.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Parkinsonism Relat Disord 2005;11:375–380, doi: http://dx.doi.org/ 10.1016/j.parkreldis.2005.04.007.",OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Mov Disorder 2008;23:1435–1440, doi: http://dx.doi.org/10.1002/mds.22124.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"37.Sahin HA, Terzi M, Uc ¸ak S, Yapici O, Basoglu T, Onar M. Frontal functions in young patients with essential tremor: a case comparison study.J Neuropsychiatr Clin Neurosci 2006;18:64–72, doi: http://dx.doi.org/10.1176/ jnp.18.1.64.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Parkinsonism Relat Disord 2012;18:279–284, doi: http://dx.doi.org/10.1016/j.parkreldis.2011.11.004.",OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"Neurology 2002;59:1631–1633, doi: http://dx.doi.org/10.1212/01.WNL.0000033798.85208.F2.Non-motor Symptoms of Essential Tremor Musacchio T, Purrer V, Papagianni A, et al.",Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/d3/16/tre-06-361-7522-1.PMC4790197.pdf
"The history of generalized seizures, ADHD, and learning disability may be good clues to the diagnosis in this setting.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/49/95/tre-06-371-7522-1.PMC4790204.pdf
Dyskinesias in GLUT-1 Deficiency Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/49/95/tre-06-371-7522-1.PMC4790204.pdf
"Furthermore, when combinedwith published cases in the established literature, there is a suggestion that high frequency with moderate to high v oltage drives this therapeutic gain.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/a9/c4/tre-06-369-7522-1.PMC4790205.pdf
DBS for Isolated Myoclonus in Myoclonus Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/tre-06-369-7522-1.PMC4790205.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/tre-06-369-7522-1.PMC4790205.pdf
DBS for Isolated Myoclonus in Myoclonus Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/tre-06-369-7522-1.PMC4790205.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/tre-06-369-7522-1.PMC4790205.pdf
DBS for Isolated Myoclonus in Myoclonus Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/tre-06-369-7522-1.PMC4790205.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/tre-06-369-7522-1.PMC4790205.pdf
Individual references were also identified from reference sections of identified articles.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
Endogenous GABA in the CNS isOndo W Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"+ + AMPA SV2A Acetazolamide +++ TPA023 +++ a2,3 No effect Lamotrigine +++ ++ HVA Phenytoin +++Carbamazepine +++ Oxcarbazepine +++ Lacosamide 1,2+++ Worsen Valproate ++ ++ ++ LVA UnknownFelbamate + ++ ++ + NMDA Tiagabine 2+++ (GAT) Vigabatrin +++GABA-TEssential Tremor Ondo W Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Agonist at the alpha-2 delta subunit of Ca 2+channels (gabapentin and pregabalin) may improve tremor.54–58These drugs bind to theTable 1.Continued Drugs Listing in Descending Efficacy forTremor (+++ to Worsen) 1Open GABAReceptorsIncrease GABASynthesisInhibit GABA MetabolismReuptakeInhibit NA ChannelInhibit Ca ChannelsInhibit GlutamateTransmissionCarbonic AnhydraseInhibitorOther Ethosuximide 1,2+++ LVA Perampanel +++ AMPA Stiripentol +++ a3 Rufinamide2+++ Retigabine2(ezogabine) + KCNQ2/3 Abbreviations: a2D, Alpha-2 Delta Subunit of Calcium Channel; AMPA, Alpha-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid; GABA, Gamma-Aminobutyric Acid; G ABA-T, GABA Transaminase (GABA metabolism) Vigabatrin; GAD, Glutamate Decarboxylase Activity Increased to Increase GABA; GAT, GABA Transporter-1 (GABA reup take) Tiagabine; HVA, High- Voltage Activated Calcium Channel Receptor (L, P, N types); KCNQ2/3, Voltage-Gated Potassium Channels, Activating M-current; LVA, Low-Voltage Ac tivated Calcium Channel Receptor (T- type); NMDA, N- Methyl- D-Aspartate; SV2A, Synaptic Vesicle Glycoprotein.1Efficacy based on authors’ expert opinion: +++, consistent efficacy in controlled trials; ++, inconsistent controlled data and/or consistent posi tive open label reports; +, any positive report of efficacy without preponderance of data suggesting a lack of effect.2‘Tremor listed as adverse events in .10% or reported to worsen tremor in small trials.Ondo W Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
AgentsEssential Tremor Ondo W Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"+ – + + +++ Nadolol 80–240/qd +++ – + + +++ Sotalol 80–320/bid + – + + +++Timolol 10–20/bid ++ ¡ +++ + Metoprolol 100–200/bid ++ – + ¡ ++ Atenolol 50–100/qd + – + ¡ + Pindolol 10–30/bid ++ + + + – Abbreviations: bid, Twice a Day; qd, Every Day.Propranolol #arotinolol; propranolol >metoprolol (doses where metoprolol loses B1 selectivity); propranolol .atenolol; propranolol .. pindolol.Ondo W Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Brain 2015;138:2934–2947, doi: http://dx.doi.org/10.1093/brain/awv225.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"J Neuropathol Exp Neurol 2010;69:262–271, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 2008;70:1452–1455, doi: http://dx.doi.org/10.1212/01.wnl.0000310425.76205.02.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2012;27:113–117, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurotherapeutics 2011;8:753–762, doi: http://dx.doi.org/10.1007/s13311-011-0045-1.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Parkinsonism Relat Disord 2015;21:848–851, doi: http://dx.doi.org/10.1016/j.parkreldis.2015.05.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2010;25:2274–2284, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 1984;34:221–222, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2003; 18:1280–1285, doi: http://dx.doi.org/10.1002/mds.10553.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"The effect of ethanol on alcohol-responsive essential tremor: A positron emission tomography study.Ann Neurol 1996;39:650–658, doi: http://dx.doi.org/10.1002/ana.410390515.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 1975;25:259, doi: http://dx.doi.org/10.1212/WNL.25.3.259.17.Leznik E, Llinas R. Role of gap junctions in synchronized neuronal oscillations in the inferior olive.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurochem Int 2004;45:971–978, doi: http://dx.doi.org/10.1016/j.neuint.2004.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Dig Dis Sci 2005;50: 103–110, doi: http://dx.doi.org/10.1007/s10620-005-1286-9.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Alcohol Clin Exp Res 2004;28:1284–1290, doi: http://dx.doi.org/10.1097/01.ALC.0000139705.17646.BA.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Can J Physiol Pharmacol 1982;60:610–614, doi: http://dx.doi.org/ 10.1139/y82-082.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"J Pharmacol Exp Ther 2008;327:910–917, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Psychopharmacology 2009;205:529–564, doi: http://dx.doi.org/10.1007/s00213-009-1562-z.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"1): S67–S73, doi: http://dx.doi.org/10.1016/j.psyneuen.2009.08.010.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"CNS Drugs 2012;26: 229–244, doi: http://dx.doi.org/10.2165/11599020-000000000-00000.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Tremor Other Hyperkinet Mov (NY ) 2014;4, doi: http://dx.doi.org/ 10.7916/D8SF2T9C.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"J Pharmacol Exp Ther 2012;341:809–819, doi: http://dx.doi.org/ 10.1124/jpet.111.189126.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Brain Res Rev 2011;65:113–123, doi: http://dx.doi.org/10.1016/j.brainresrev.2010.09.003.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Alcohol Clin Exp Res 2011;35:1948–1959, doi: http://dx.doi.org/10.1111/j.1530-0277.2011.01546.x.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Nat Neurosci 2007;10:40–48, doi: http://dx.doi.org/ 10.1038/nn1813.Essential Tremor Ondo W Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Eur J Neurol 2008;15:697–705, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Biochemistry 2003;42:11243–11252, doi: http://dx.doi.org/10.1021/bi034738f.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"J Psychopharmacol 2012;26:282–291, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Seizure 2013;22:589–600, doi: http://dx.doi.org/10.1016/ j.seizure.2013.04.015.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 1986;36:121–124, doi: http://dx.doi.org/10.1212/WNL.36.1.121.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2008;23:1955–1956, doi: http://dx.doi.org/10.1002/mds.22094.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Acta Neurol Scand 2011;124:72–82, doi: http://dx.doi.org/10.1111/ j.1600-0404.2011.01602.x.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Acta Neurol Scand 1983;68:248–252, doi: http://dx.doi.org/10.1111/j.1600-0404.1983.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"doi: http://dx.doi.org/10.1002/1531-8249(199908)46:2 , 249::AID-ANA15 .3.0.CO;2-C. 47.Frucht SJ, Bordelon Y, Houghton WH, Reardan D. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2005;20:1330–1337, doi: http://dx.doi.org/10.1002/mds.20605.48.Li Q, Kuhn CM, Wilson WA, Lewis DV.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neuroscience 2007;150:82–92, doi: http://dx.doi.org/10.1016/j.neuroscience.2007.08.023.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"J Neurosurg 2003;99:768–771, doi: http://dx.doi.org/10.3171/jns.2003.99.4.0768.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 1992;42: 1394–1394, doi: http://dx.doi.org/10.1212/WNL.42.7.1394.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurol Sci 2000;21:315–317, doi: http://dx.doi.org/ 10.1007/s100720070069.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 1993;43:1045–1047, doi: http://dx.doi.org/10.1212/WNL.43.5.1045.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 1996;47:1331–1332, doi: http://dx.doi.org/ 10.1212/WNL.47.5.1331.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2000;15:678–682, doi: http://dx.doi.org/10.1002/1531- 8257(200007)15:4 ,678::AID-MDS1012 .3.0.CO;2-0.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 1998;13:465–467, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2013;28:249–250, doi: http://dx.doi.org/10.1002/mds.25264.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"J Neurol Sci 2009;285:195–197, doi: http://dx.doi.org/10.1016/j.jns.2009.06.044.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Arch Neurol 1999;56:475–480, doi: http://dx.doi.org/10.1001/archneur.56.4.475.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Neurology 2005;64:1078–1080, doi: http://dx.doi.org/10.1212/ 01.WNL.0000154596.21335.2E.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Clin Neuropharmacol 2004;27:274–277, doi: http://dx.doi.org/10.1097/00002826-200411000-00004.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Clin Neuropharmacol 2010;33: 223–226, doi: http://dx.doi.org/10.1097/WNF.0b013e3181ebd109.Ondo W Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.Neuropharmacology 2010;59:380–387, doi: http://dx.doi.org/10.1016/ j.neuropharm.2010.05.012.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Pharmacol Biochem Behav 2011;97:656–659, doi: http://dx.doi.org/10.1016/j.pbb.2010.11.014.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Jpn J Pharmacol 1999; 81:244–246, doi: http://dx.doi.org/10.1254/jjp.81.244.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"J Psychopharmacol 2012;26:292–302, doi: http://dx.doi.org/ 10.1177/0269881111398685.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Parkinsonism Relat Disord 2003;9:341–347, doi: http://dx.doi.org/10.1016/S1353-8020(03)00029-4.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Korean J Radiol 2015;16:967–972, doi: http://dx.doi.org/10.3348/kjr.2015.16.5.967.71.Koller WC, Biary N. Metoprolol compared with propranolol in the treatment of essential tremor.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Arch Neurol 1984;41:171–172, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Clin Neuropharmacol 1987;10:449–452, doi: http://dx.doi.org/10.1097/ 00002826-198710000-00007.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2005;20:298–305, doi: http://dx.doi.org/10.1002/mds.20331.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"77.Paterson NE, Malekiani SA, Foreman MM, Olivier B, Hanania T. Pharmacological characterization of harmaline-induced tremor activity in mice.Eur J Pharmacol 2009;616:73–80, doi: http://dx.doi.org/10.1016/j.ejphar.2009.",OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Tremor Other Hyperkinet Mov (N Y) 2012;2, doi: http://dx.doi.org/10.7916/D8TD9W2P.",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"Mov Disord 2006;21: 1641–1649, doi: http://dx.doi.org/10.1002/mds.20940.Essential Tremor Ondo W Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/95/3f/tre-06-356-7522-1.PMC4790207.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 25, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jwh.2015.5671 222",Non-OADS,/arxiv_data1/oa_pdf/f4/3d/jwh.2015.5671.PMC4790210.pdf
"at: http://code.google.com/p/penmesh/ Accessed Septem- ber 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f4/3d/jwh.2015.5671.PMC4790210.pdf
"Available at: http://onlinelibrary.wiley.com/doi/ 10.1002/9780470744307.gat226/abstract Accessed Sep- tember 25, 2015.32.",Non-OADS,/arxiv_data1/oa_pdf/f4/3d/jwh.2015.5671.PMC4790210.pdf
"Available at: https://federalregister.gov/a/2014-03589 Accessed Sep- tember 25, 2015.",OADS,/arxiv_data1/oa_pdf/f4/3d/jwh.2015.5671.PMC4790210.pdf
"Available at: http://archive.ahrq.gov/news/newsroom/press-releases/2011/ ehcdefects.html Accessed September 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f4/3d/jwh.2015.5671.PMC4790210.pdf
"Available at: http://citoday.com/ pdfs/cit0313_F6_Tavris.pdf Accessed October 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f4/3d/jwh.2015.5671.PMC4790210.pdf
"Available at: https://federalregister.gov/a/ 2013-18813 Accessed September 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f4/3d/jwh.2015.5671.PMC4790210.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 18, Number 3, 2016 DOI: 10.1089/dia.2015.0342 136",Non-OADS,/arxiv_data1/oa_pdf/d0/c8/dia.2015.0342.PMC4790215.pdf
"Neuron, 2000, 28(2), 335-341. http://dx.doi.org/10.1016/S0896-6273(00)00112-4 [2] Nestler, E.J.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Neuron, 2002, 34(1), 13-25. http://dx.doi.org/10.1016/S0896-6273(02)00653-0 [3] Kessler, R.C.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Med., 2014, 44(8), 1779-1792. http://dx.doi.org/10.1017/S0033291713002419 [4] Delgado, P.L.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Pharmacol., 2006, 529(1-3), 114-121. http://dx.doi.org/10.1016/j.ejphar.2005.11.009 [7] Liu, L.; Li, B.; Zhou, Y.; Wang, L.; Tang, F.; Shao, D.; Jiang, X.; Zhao, H.; Cui, R.; Li, Y. Antidepressant-like effect of Fuzi total alkaloid on ovariectomized mice.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Sci., 2012, 120(4), 280-287. http://dx.doi.org/10.1254/jphs.12163FP [8] Owens, M.J. Selectivity of antidepressants: from the monoamine hypothesis of d e p r e s s i o n  t o  t h e  S S R I  r e v o l u t i o n  a n d  b e y o n d .",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychopharmacol., 2001, 16(1), 3-7. http://dx.doi.org/10.1002/hup.177 [10] De Kloet, E.R.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Rev., 1998, 19(3), 269-301. http://dx.doi.org/10.1210/er.19.3.269 [11] Hindmarch, I.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychiatry, 2002, 17 Suppl 3, 294-299. http://dx.doi.org/10.1016/S0924-9338(02)00653-3 [12] Krishnan, V.; Nestler, E.J.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Nature, 2008, 455(7215), 894-902. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Ageing Dev., 2005, 126(9), 913-922. http://dx.doi.org/10.1016/ j.mad.2005.03.012 [15] Heilbronn, L.K.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"JAMA, 2006, 295(13), 1539-1548. http://dx.doi.org/10.1001/ jama.295.13.1539 [16] Kishi, T.; Hirooka, Y.; Ogawa, K.; Konno, S.; Sunagawa, K. Calorie restriction inhibits sympathetic nerve activity via anti-oxidant effect in the rostral ventrolateral medulla of obesity-induced hypertensive rats.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Hypertens, 2011, 33(4), 240-245. http://dx.doi.org/10.3109/10641963.2011.583969 [17] Larson-Meyer, D.E.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Diabetes Care, 2006, 29(6), 1337-1344. http://dx.doi.org/10.2337/dc05-2565 [18] Martin, B.; Mattson, M.P.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Rev., 2006, 5(3), 332-353. http://dx.doi.org/10.1016/ j.arr.2006.04.002",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Metab., 2003, 47(5), 194-200. http://dx.doi.org/10.1159/000070485 [21] Carter, C.S.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Metab., 2007, 32(5), 954-966. http://dx.doi.org/10.1139/H07-085 [22] Sheehan, M. Sports therapy in mental illness.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Neurosci., 2008, 28(12), 3071-3075. http://dx.doi.org/10.1523/JNEUROSCI.5584-07.2008 [24] Husaini, B.A.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"J. Orthopsychiatry, 1997, 67(1), 48-58. http://dx.doi.org/10.1037/h0080210 [25] Moreno-Dominguez, S.; Rodriguez-Ruiz, S.; Fernandez-Santaella, M.C.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Rev., 2012, 20(6), 461-467. http://dx.doi.org/10.1002/erv.2187 [26] Hussin, N.M.; Shahar, S.; Teng, N.I.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Behav., 2008, 94(5), 643-648. http://dx.doi.org/10.1016/j.physbeh.2008.04.017 [28] Michalsen, A.; Weidenhammer, W.; Melchart, D.; Langhorst, J.; Saha, J.; Dobos, G. Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes--well-being and side effects with and without mineral supplements.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Forsch Komplementarmed Klass Naturheilkd, 2002, 9(4), 221-227. http://dx.doi.org/10.1159/ 000066032 [29] Michalsen, A.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Metab., 2009, 54(3), 184-188. http://dx.doi.org/10.1159/000217815 [31] Govic, A.; Levay, E.A.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Behav., 2009, 96(4-5), 581-585. http://dx.doi.org/10.1016/ j.physbeh.2008.12.012 [32] Manzanero, S.; Gelderblom, M.; Magnus, T.; Arumugam, T.V.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Stroke Med., 2011, 3, 8. http://dx.doi.org/10.1186/2040-7378-3-8 [33] Farooq, S.; Nazar, Z.; Akhtar, J.; Irfan, M.; Subhan, F.; Ahmed, Z.; Khan, E.H.; Naeem, F. Effect of fasting during Ramadan on serum lithium level and m e n t a l  s t a t e  i n  b i p o l a r  a f f e c t i v e  d i s o r d e r .",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychopharmacol., 2010, 25(6), 323-327. http://dx.doi.org/ 10.1097/YIC.0b013e32833d18b2 [34] Sanders, C.E.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Pediatr., 2009, 30(5), 376-384. http://dx.doi.org/10.1097/DBP.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Med., 2000, 62(5), 633-638. http://dx.doi.org/10.1097/00006842-200009000-00006 [37] Brosse, A.L.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Sports Med., 2002, 32(12), 741-760.  http://dx.doi.org/10.2165/00007256-200232120-00001 [38] Estabrooke, I.V.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Nature, 2005, 437(7058), 556-559. http://dx.doi.org/10.1038/nature04071 [41] Samson, W.K.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Neuro- pharmacology, 2011, 60(7-8), 1337-1346. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Neuroscience, 1999, 88(4), 1199-1212. http://dx.doi.org/10.1016/S0306-4522(98)00273-5 [46] Nibuya, M.; Nestler, E.J.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Brain Res., 2011, 216(1), 136-145. http://dx.doi.org/10.1016/j.bbr.2010.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Neurosci., 2001, 16(1), 1-12. http://dx.doi.org/10.1385/JMN:16:1:1 [49] Castren, E.; Voikar, V.; Rantamaki, T. Role of neurotrophic factors in depression.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Science, 2001, 294(5548), 1945-1948. http://dx.doi.org/10.1126/science.1065057 [52] Araya, A.V.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Endocrine, 2008, 33(3), 300-304. http://dx.doi.org/10.1007/s12020-008-9090-x [53] Fontan-Lozano, A.; Lopez-Lluch, G.; Delgado-Garcia, J.M.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Health Aging, 2008, 12(3), 183-185. http://dx.doi.org/10.1007/BF02982616 [55] Amorosi, M. Correlation between sport and depression.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Commun., 1995, 207(1), 312-317. http://dx.doi.org/10.1006/bbrc.1995.1189 [57] Brown, A.J.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Hypotheses, 2007, 68(2), 268-271. http://dx.doi.org/10.1016/ j.mehy.2006.07.043 [58] Maalouf, M.; Rho, J.M.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychiatry Res., 2013, 209(3), 253-258. http://dx.doi.org/ 10.1016/j.psychres.2012.12.018 [60] Jauregui-Lobera, I. Neuroimaging in eating disorders.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Treat., 2011, 7, 577-584. http://dx.doi.org/10.2147/ NDT.S25186 [61] Carrier, K.M.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychol., 1994, 128(5), 517-535. http://dx.doi.org/10.1080/00223980.1994.9914910 [62] Chacon, F.; Esquifino, A.I.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Int., 2005, 22(2), 253-265. http://dx.doi.org/10.1081/CBI-200053522 [63] Levay, E.A.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Res., 2010, 30(5), 366-373. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Metab., 2000, 44(3), 101-107. http://dx.doi.org/10.1159/000012830 [65] Altemus, M.; Glowa, J.R.; Galliven, E.; Leong, Y.M.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Behav., 1996, 53(1), 123-131. http://dx.doi.org/10.1016/0091-3057(95)02003-9 [66] Huether, G.; Z h o u ,  D .",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"J. Neural Transm., 1997, 104(10), 993-1004. http://dx.doi.org/10.1007/BF01273313 [67] Haleem, D.J.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Dev Brain Res., 1997, 104 (1-2), 131-136. http://dx.doi.org/10.1016/S0165-3806(97)00149-1 [70] Jahng, J.W.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Brain Res., 2000, 81(1-2), 51-61. http://dx.doi.org/10.1016/S0169-328X(00)00167-4 [72] Lira, A.; Zhou, M.; Castanon, N.; Ansorge, M.S.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychiatry, 2003, 54(10), 960-971. http://dx.doi.org/10.1016/ S0006-3223(03)00696-6 [73] Malison, R.T.; Price, L.H.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychiatry, 1998, 44(11), 1090-1098. http://dx.doi.org/10.1016/S0006-3223(98)00272-8 [74] Jahng, J.W.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Brain Res Dev Brain Res, 1998, 107(2), 241-246. http://dx.doi.org/10.1016/S0165-3806(98)00013-3 [75] Duclos, M.; Bouchet, M.; Vettier, A.; Richard, D. Genetic differences in hypothalamic-pituitary-adrenal axis activity and food restriction-induced hyperactivity in three inbred strains of rats.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Neuroendocrinol., 2005, 17(11), 740-752. http://dx.doi.org/10.1111/ j.1365-2826.2005.01367.x [76] Jahng, J.W.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Brain Res., 2005, 1048(1-2), 185-192. http://dx.doi.org/10.1016/j.brainres.2005.04.072 [77] Holmes, M.C.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Behav., 2007, 87(1), 104-114. http://dx.doi.org/10.1016/j.pbb.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Endocrinol., 2006, 31(2), 105-122. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Endocrinology, 2006, 147(1), 520-529. http://dx.doi.org/ 10.1210/en.2005-0956 [81] Kim, E.; Seo, S.; Chung, H.; Park, S. Role of Glucocorticoids in Fasting-induced Changes in Hypothalamic and Pituitary Components of the Growth Hormone (GH)-axis.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Pharmacol., 2008, 12(5), 217-223. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Endocrinol., 2004, 180(3), 369-378. http://dx.doi.org/10.1677/joe.0.1800369 [83] Friedman, J.M.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
http://dx.doi.org/10.3945/ajcn.,Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Invest., 2005, 28(1), 89-99. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Res., 1996, 28(12), 714-717. http://dx.doi.org/10.1055/s-2007-979885",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychiatry, 2005, 29(4), 565-570. http://dx.doi.org/10.1016/j.pnpbp.2005.01.009 [88] Milaneschi, Y.; Simonsick, E.M.; Vogelzangs, N.; Strotmeyer, E.S.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Psychiatry, 2012, 73(9), 1205-1211. http://dx.doi.org/10.4088/JCP.11m07552 [89] Lu, X.Y.",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Pharmacol., 2007, 7(6), 648-652. http://dx.doi.org/10.1016/j.coph.2007.10.010 [90] Yamada, N.; Katsuura, G.; Ochi, Y.; Ebihara, K.; Kusakabe, T.; Hosoda, K.; Nakao, K. Impaired CNS leptin action is implicated in depression associated with obesity.",OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"Endocrinology, 2011, 152(7), 2634-2643.http://dx.doi.org/10.1210/en.2011-0004  Received: November 06, 2014 Revised: January 13, 2015 Accepted: January 25, 2015",Non-OADS,/arxiv_data1/oa_pdf/3d/46/CN-13-536.PMC4790398.pdf
"North Am., 1996, 19(2), 179-200. http://dx.doi.org/10.1016/S0193-953X(05)70283-5 [3] Di Benedetto, B.; Rupprecht, R.; Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases.",Non-OADS,/arxiv_data1/oa_pdf/12/10/CN-13-505.PMC4790399.pdf
"Reports, 2014, 66(4), 534-44. doi:http://dx.doi.org/10.1016/j.pharep.2014.03.001.",OADS,/arxiv_data1/oa_pdf/12/10/CN-13-505.PMC4790399.pdf
"J. Psychiatry, 1985, 142(8), 905-910. http://dx.doi.org/10.1176/ajp.142.8.905 [3] Armitage, R. Sleep and circadian rhythms in mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Suppl., 2007, (433), 104-115. http://dx.doi.org/ 10.1111/j.1600-0447.2007.00968.x [4] Gresham, S.C.; Agnew, H.W.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Gen. Psychiatry, 1965, 13(6), 503-507. http://dx.doi.org/10.1001/ archpsyc.1965.01730060021003 [5] Gottesmann, C.; Gottesman, I.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurobiol., 2007, 81(4), 237-250. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Rev, 1997, 1(1), 45-56. http://dx.doi.org/10.1016/S1087-0792(97)90005-8 [8] Steiger, A.; Kimura, M. Wake and sleep EEG provide biomarkers in depression.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Res., 2010, 44(4), 242-252. http://dx.doi.org/10.1016/j.jpsychires.2009.08.013 [9] Sharpley, C.F.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 2013, 256, 368-376. http://dx.doi.org/10.1016/j.bbr.2013.08.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Des., 2012, 18(36), 5802-5817. http://dx.doi.org/10.2174/138161212803523608 [11] Wichniak, A.; Wierzbicka, A.; Jernajczyk, W. Sleep as a biomarker for depression.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 2013, 25(5), 632-645. http://dx.doi.org/10.3109/09540261.2013.812067 [12] Palagini, L.; Baglioni, C.; Ciapparelli, A.; Gemignani, A.; Riemann, D. REM sleep dysregulation in depression: state of the art.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Sleep Med Rev, 2013, 17(5), 377-390. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Health Nurs., 2010, 17(10), 857-861. http://dx.doi.org/10.1111/j.1365-2850.2010.01598.x [14] Lopes, M.C.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Sleep Med., 2007, 9(1), 33-41. http://dx.doi.org/10.1016/j.sleep.2007.01.011 [15] Hoffmann, R.; Hendrickse, W.; Rush, A.J.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry Res, 2000, 95(3), 215-225. http://dx.doi.org/10.1016/S0165-1781(00)00181-5 [16] Olbrich, S.; Arns, M. EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 2013, 25(5), 604-618. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 2002, 26(6), 1211-1215. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"P s y c h i a t r y, 1985, 20(4), 431-442. http://dx.doi.org/ 10.1016/0006-3223(85)90045-9 [19] Lauer, C.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 1991, 29(10), 979-993. http://dx.doi.org/10.1016/0006-3223(91)90355-P [20] Goetz, R.R.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Disord., 1991, 22(1), 91-100. http://dx.doi.org/10.1016/0165-0327(91)90089-B [21] Wichniak, A.; Riemann, D.; Kiemen, A.; Voderholzer, U.; Jernajczyk, W. Comparison between eye movement latency and REM sleep parameters in major depression.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurosci., 2000, 250(1), 48-52. http://dx.doi.org/10.1007/ s004060050009 [22] Jernajczyk, W. Latency of eye movement and other REM sleep parameters in bipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 1986, 21(5), 465-472. http://dx.doi.org/10.1016/0006-3223(86)90188-5 [23] Gillin, J.C.; Duncan, W.C.; Murphy, D.L.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry Res., 1981, 4(1), 73-78. http://dx.doi.org/10.1016/0165-1781(81)90010-X [24] Foster, F.G.; Kupfer, D.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Gen. Psychiatry, 1976, 33(9), 1119-1123. http://dx.doi.org/10.1001/archpsyc.1976.01770090109011 [25] Kupfer, D.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Dis., 1966, 142(2), 117-126. http://dx.doi.org/10.1097/00005053-196602000-00002 [27] Green, W.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Dis., 1966, 143(2), 123-134. http://dx.doi.org/10.1097/00005053-196608000-00002 [28] Kupfer, D.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Lancet, 1972, 2(7779), 684-686. http://dx.doi.org/10.1016/S0140-6736(72) 92090-9 [29] Adrien, J.; Dugovic, C.; Martin, P. Sleep-wakefulness patterns in the helpless rat.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Behav., 1991, 49(2), 257-262. http://dx.doi.org/10.1016/0031-9384(91)90041-L [30] Gronli, J.; Murison, R.; Bjorvatn, B.; Sorensen, E.; Portas, C.M.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 2004, 150(1-2), 139-147. http://dx.doi.org/ 10.1016/S0166-4328(03)00252-3 [31] Wang, Y.Q.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurochem., 2012, 120(2), 314-324. http://dx.doi.org/10.1111/j.1471-4159.2011.07558.x [32] Dugovic, C.; Maccari, S.; Weibel, L.; Turek, F.W.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neuroreport, 2000, 11(3), 627-631. http://dx.doi.org/ 10.1097/00001756-200002280-00038 [34] Aserinsky, E.; Kleitman, N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Science, 1953, 118, 273-274. http://dx.doi.org/10.1126/science.118.3062.273 [35] Dement, W. The occurrence of low voltage, fast, electro- encephalogram patterns during behavioral sleep in the cat.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurophysiol., 1958, 10, 291-296. http://dx.doi.org/10.1016/0013-4694(58)90037-3 [36] Jouvet, M.; Michel, F. Electromyographic correlations of sleep in the chronic decorticate & mesencephalic cat.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Physiol., 2007, 584(3), 735-741. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 1992, 569(2), 210-220. http://dx.doi.org/ 10.1016/0006-8993(92)90632-J [40] Steriade, M.; Pare, D.; Datta, S.; Oakson, G.; Dossi, R.C.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Physiol., 2004, 554(1), 202-215. http://dx.doi.org/10.1113/jphysiol.2003.052134 [42] Hobson, J.A.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurol., 2006, 495(5), 573-586. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Experientia, 1978, 34, 61-62. http://dx.doi.org/10.1007/BF01921902 [49] De Andres, I.; Gomez-Montoya, J.; Gutierrez-Rivas, E.; Reinoso-Suarez, F. Differential action upon sleep states of ventrolateral and central areas of pontine tegmental field.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neuroscience, 1998, 83, 1137-1144. http://dx.doi.org/10.1016/ S0306-4522(97)00494-6 [51] Reinoso-Suárez, F.; De Andrés, I.; Rodrigo-Angulo, M.L.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurosci., 1994, 6(12), 1829-1836. http://dx.doi.org/10.1111/j.1460-9568.1994.tb00575.x [52] De La Roza, C.; Martinez-Mena, J.; Sanchez-Valle, M.E.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res, 2004, 1020(1-2), 118-129. http://dx.doi.org/10.1016/j.brainres.2004.06.019 [53] Xi, M.C.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 2003, 976(2), 253-258. http://dx.doi.org/10.1016/S0006-8993(03)02566-6 [54] Xi, M.C.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurosci., 2004, 24, 10670-10678. http://dx.doi.org/10.1523/JNEUROSCI.1987-04.2004 [55] McCarley, R.W.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Science, 1971, 174, 1250-1252. http://dx.doi.org/10.1126/science.174.4015.1250 [56] Chu, N.S.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Science, 1973, 179, 908-910. http://dx.doi.org/10.1126/ science.179.4076.908 [57] Hobson, J.A.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Science, 1975, 189, 55-58. http://dx.doi.org/10.1126/ science.1094539 [58] Jacobs, B.L.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurobiol., 1986, 27, 183-194. http://dx.doi.org/10.1016/0301-0082(86)90008-0 [59] McGinty, D.J.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 1976, 101, 569-575. http://dx.doi.org/10.1016/0006-8993(76)90480-7 [60] Sherin, J.E.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 1989, 76, 519-529. http://dx.doi.org/10.1007/BF00248908 [63] Sakai, K. Executive mechanisms of paradoxical sleep.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Res., 2002, 70(4), 611-621. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neuroreport, 1996, 7(15-17), 2449-2453. http://dx.doi.org/10.1097/00001756-199611040-00009 [66] Mallick, B.N.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Nature, 2006, 441(7093), 589-594. http://dx.doi.org/10.1038/nature04767 [68] Naughton, M.; Mulrooney, J.B.; Leonard, B.E.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacol., 2000, 15(6), 397-415. http://dx.doi.org/10.1002/1099-1077 (200008)15:6<397::AID-HUP212>3.0.CO;2-L [69] Wilson, S.; Argyropoulos, S. Antidepressants and sleep - A  qualitative review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Drugs, 2005, 65(7), 927-947. http://dx.doi.org/10.2165/00003495-200565070-00003 [70] Jones, B.E.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 1977, 124(3), 473-496. http://dx.doi.org/10.1016/0006-8993(77)90948-9 [71] Mouret, J.; Coindet, J. Polygraphic evidence against a critical role of the raphe nuclei in sleep in the rat.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res, 1980, 186(2), 273-287. http://dx.doi.org/10.1016/0006-8993(80)90975-0 [72] Shouse, M.N.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 1992, 571(1), 50-63. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 2002, 51(6), 457-462. http://dx.doi.org/10.1016/S0006-3223(01)01287-2 [74] Prathiba, J.; Kumar, K.B.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 2000, 867(1-2), 243-245. http://dx.doi.org/10.1016/S0006-8993(00)02248-4 [75] Benca, R.M.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Gen. Psychiatry, 1992, 49(8), 651-668; discussion 669-670. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"J. Psychiatry, 1989, 146(6), 697-707. http://dx.doi.org/10.1176/ ajp.146.6.697 [77] Newman, A.B.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"J Am Geriatr Soc, 2000, 48(2), 115-123. http://dx.doi.org/10.1111/j.1532-5415.2000.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Rev., 2000, 4(3), 253-262. http://dx.doi.org/10.1053/smrv.1999.0075 [79] Adrien, J. Neurobiological bases for the relation between sleep and depression.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Rev., 2002, 6(5), 341-351. http://dx.doi.org/ 10.1016/S1087-0792(01)90200-X",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry Res., 2013, 214(3), 422-428. http://dx.doi.org/10.1016/ j.pscychresns.2013.09.007 [81] Sheline, Y.I.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"U. S. A., 1996, 93(9), 3908-3913. http://dx.doi.org/ 10.1073/pnas.93.9.3908 [82] Hegde, P.; Jayakrishnan, H.R.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Res., 2011, 1382, 155-164. http://dx.doi.org/10.1016/j.brainres.2011.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurosci., 2013, 7. http://dx.doi.org/10.3389/fnbeh.2013.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Science, 1989, 244(4901), 224-226. http://dx.doi.org/ 10.1126/science.2704997 [87] Xu, L.; Holscher, C.; Anwyl, R.; Rowan, M.J. Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticit y by stress.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"U. S. A., 1998, 95(6), 3204-3208. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neuropharmacology,  2014, 86C, 125-132. http://dx.doi.org/10.1016/j.neuropharm.2014.07.005 [89] Wang, R.Y.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Science, 1977, 197(4298), 89-91. http://dx.doi.org/10.1126/science.194312 [90] Aizawa, H.; Yanagihara, S.; Kobayashi, M.; Niisato, K.; Takekawa, T.; Harukuni, R.; McHugh, T.J.; Fukai, T.; Isomura, Y.; Okamoto, H. The synchronous activity of lateral habenular neurons is essential for regulating hippocampal theta oscillation.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurosci., 2013, 33(20), 8909-8921. http://dx.doi.org/10.1523/ JNEUROSCI.4369-12.2013 [91] Aizawa, H.; Cui, W.; Tanaka, K.; Okamoto, H. Hyperactivation of the habenula as a link between depression and sleep disturbance.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neurosci., 2013, 7, 826. http://dx.doi.org/10.3389/ fnhum.2013.00826 [92] Staner, L.; Kerkhofs, M.; Detroux, D.; Leyman, S.; Linkowski, P.; Mendlewicz, J.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacology, 1978, 59, 267-272. http://dx.doi.org/10.1007/BF00426633 [94] Mayers, A.G.; B a l d w i n ,  D .",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacol., 2005, 20(8), 533-559. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Behav., 2002, 73, 557-563. http://dx.doi.org/10.1016/S0091-3057(02)00812-2 [96] Steiger, A.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacol., 1988, 8(5), 349-354. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Scand., 1990, 81(1), 24-31. http://dx.doi.org/10.1111/j.1600-0447.1990.tb06444.x [98] Le Bon, O.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Care, 2009, 45(3), 191-197. http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Gen. Psychiatry, 2001, 58(3), 268-276. http://dx.doi.org/10.1001/ archpsyc.58.3.268 [101] Jindal, R.D.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 2005, 66(4), 450-454. http://dx.doi.org/10.4088/JCP.v66n0407 [103] Steiger, A.; von Bardeleben, U.; Guldner, J.; Lauer, C.; Rothe, B.; Holsboer, F. The sleep EEG and nocturnal hormonal secretion studies on changes during the course of depression and on effects of CNS-active drugs.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 1993, 17(1), 125-137. http://dx.doi.org/10.1016/0278-5846(93) 90037-S [104] Shipley, J.E.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacology (Berl), 1985, 85(1), 14-22. http://dx.doi.org/10.1007/BF00427316 [105] Sanchez, C.; Brennum, L.T.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Behav., 2007, 86(3), 468-476. http://dx.doi.org/10.1016/ j.pbb.2007.01.006 [106] von Bardeleben, U.; Steiger, A.; Gerken, A.; Holsboer, F. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Ther., 1984, 36(2), 251-259. http://dx.doi.org/10.1038/clpt.1984.171 [108] Rush, A.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Eur Neuropsychopharmacol, 2007, 17(8), 527-531. http://dx.doi.org/10.1016/j.euroneuro.2007.01.006 [111] Thase, M.E.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Med., 1988, 50(6), 627-633. http://dx.doi.org/10.1097/00006842-198811000-00009 [113] Sonntag, A.; Rothe, B.; Guldner, J.; Yassouridis, A.; Holsboer, F.; Steiger, A. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Depression, 1996, 4(1), 1-13. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"4    553 Psychiatry, 1995, 152(2), 274-276. http://dx.doi.org/10.1176/ ajp.152.2.274 [115] Kuenzel, H.E.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Pharmacopsychiatry, 2004, 37(5), 193-195. http://dx.doi.org/10.1055/s-2004-827242 [116] Aslan, S.; Isik, E.; Cosar, B.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neuropsychopharmacology, 2006, 31(4), 832-844. http://dx.doi.org/10.1038/sj.npp.1300923 [118] Landolt, H.P.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"http://dx.doi.org/10.1016/S0893-133X(01)00321-9 [119] Murck, H.; Frieboes, R.M.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacology, 2001, 155(2), 187-192. http://dx.doi.org/10.1007/s002130100703 [120] Ruigt, G.S.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Pharmacol., 1990, 38(6), 551-554. http://dx.doi.org/10.1007/ BF00278580 [121] Smith, M.I.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Behav., 2002, 71(4), 599-605. http://dx.doi.org/10.1016/S0091-3057(01) 00702-X [122] Argyropoulos, S.V.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Sleep Res., 2009, 18(3), 342-348. http://dx.doi.org/10.1111/j.1365-2869.2008.00724.x [123] Sato, H.; Ito, C.; Tashiro, M.; Hiraoka, K.; Shibuya, K.; Funaki, Y.; Iwata, R.; Matsuoka, H.; Yanai, K. Histamine H(1) receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacology (Berl), 2013, 230(2), 227-234. http://dx.doi.org/10.1007/s00213-013-3146-1 [124] Haddjeri, N.; Blier, P.; de Montigny, C. Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacol., 1995, 10 Suppl 4, 11-17. http://dx.doi.org/10.1097/00004850-199512004-00003 [125] Houghton, W.C.; Scammell, T.E.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Rev., 2004, 8(5), 355-366. http://dx.doi.org/ 10.1016/j.smrv.2004.01.004 [126] He, M.L.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"(Engl), 2011, 124(12), 1779-1783. http://dx.doi.org/10.1016/s0924-9338(11)72847-4 [127] Krstic, J.; Buzadzic, I.; Milanovic, S.D.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"J. ECT, 2014, 30(4), 325-331. http://dx.doi.org/10.1097/ YCT.0000000000000099 [128] Casarotto, S.; Canali, P.; Rosanova, M.; Pigorini, A.; Fecchio, M.; Mariotti, M.; Lucca, A.; Colombo, C.; Benedetti, F.; Massimini, M. Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalography.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Topogr., 2013, 26(2), 326-337. http://dx.doi.org/10.1007/s10548-012-0256-8 [129] Pellicciari, M.C.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Brain Stimul., 2013, 6(3), 390-396. http://dx.doi.org/10.1016/j.brs.2012.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Affect Disord., 1990, 18(1), 67-73. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Affect Disord., 1994, 31(3), 151-164. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacol., 1993, 7(3-4), 181-189. http://dx.doi.org/10.1097/00004850-199300730-00009 [136] Kerkhofs, M.; Rielaert, C.; de Maertelaer, V.; Linkowski, P.; Czarka, M.; Mendlewicz, J. Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacol., 1990, 5(4), 253-260. http://dx.doi.org/ 10.1097/00004850-199010000-00002 [137] Wilson, S.J.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychopharmacol., 2000, 14(4), 378-386. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Neuropsychobiology, 1988, 19(1), 25-34. http://dx.doi.org/10.1159/000118429 [139] Van Bemmel, A.L.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Sleep Res., 1993, 2(3), 156-162. http://dx.doi.org/10.1111/j.1365-2869.1993.tb00080.x [140] Winokur, A.; Sateia, M.J.; Hayes, J.B.; Bayles-Dazet, W.; MacDonald, M.M.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psychiatry, 2000, 48(1), 75-78. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Psycho- pharmacol., 2004, 19(5), 299-303. http://dx.doi.org/10.1002/hup.600 [142] Mouret, J.; Lemoine, P.; Minuit, M.P.",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"http://dx.doi.org/10.1007/BF00172629   Received: July 11, 2014 Revised: January 11, 2015 Accepted: January 25, 2015",Non-OADS,/arxiv_data1/oa_pdf/c8/4e/CN-13-543.PMC4790401.pdf
"Biochem., 2013, 31, 761-777. http://dx.doi.org/10.1159/000350094 [2] Penninx, B.W.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Cancer Inst., 1998, 90, 1888-1893. http://dx.doi.org/10.1093/jnci/90.24.1888 [3] Bouvier, N. Trenque, T., Millart, H. Development of antidepressant drugs.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuron, 2002, 28, 13-25. http://dx.doi.org/10.1016/ S0896-6273(02)00653-0 [5] Qing-Qiu, M.; Zhen, H.; Siu-Po; Yan-Fang, X.; Chun-Tao, C. Role of 5-HT1A and 5-HT1B receptors in the antidepressant-like effect of piperine in the forced swim test.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Lett., 2011, 504, 181-184. http://dx.doi.org/10.1016/j.neulet.2011.09.038 [6] Plácido, L.; García-Portilla, M. P. Llaneza-Suáreza, D., Armott, B.; Pérez-López, F. R. Depressive disorders and the menopause transition.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Maturitas, 2012, 71, 120-130. http://dx.doi.org/10.1016/ j.maturitas.2011.11.017 [7] Susan, Nolen-Hoeksema.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Sci., 2001, 10, 173-186. http://dx.doi.org/10.1111/ 1467-8721.00142 [8] Kessler, R. C.; McGonagle, K. A.; Swartz, M.; Blazer, D. G.; Nelson, C. B.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Disord., 1993, 29, 85-96. http://dx.doi.org/10.1016/0165-0327(93) 90026-G [9] WU.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroscience, 2013, 239, 67-83. http://dx.doi.org/10.1016/j.neuroscience.2012.10.024 [10] Heldring, N.; Pike, A.; Andersson, S.; Matthews, J.; Cheng, G.; Hartman, J.; Tujague, M.; Strom, A.; Treuter, E.; Warner, M.; Gustafsson, J.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Rev., 2007, 87, 905-931. http://dx.doi.org/ 10.1152/physrev.00026.2006 [11] Idil, C.; Ronald, S. D. Influence of Estradiol, Stress, and 5-HT2A Agonist Treatment on Brain-Derived Neurotrophic Factor Expression in Female Rats.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2003, 54, 59-69. http://dx.doi.org/10.1016/S0006-3223(03)00236-1 [12] Behl, C. Oestrogen as a neuroprotective hormone.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychopharmacol., 2001, 16, 29-36. http://dx.doi.org/10.1002/hup.180 [14] Dezheng, Z.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Biochem., 2007, 102, 1245-1255. http://dx.doi.org/10.1002/ jcb.21355 [15] Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Nature, 1999, 402, 656-660. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Science, 1996, 273, 974-977. http://dx.doi.org/10.1126/science.273.5277.974 [17] Nakazato, M.; Murakami,N.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Nature, 2001, 409, 194-198. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Ther., 2012, 35, 316-326. http://dx.doi.org/ 10.1016/j.pharmthera.2012.06.004 [19] Axel, S.; Martin, D.; Petra, S.; Michael, K. Ghrelin in mental health, sleep, memory.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
", 2011, 340, 88-96. http://dx.doi.org/10.1016/j.mce.2011.02.013 [20] Cuellar, J. N.; Isokawa, M. Ghrelin-induced activation of cAMP signal transduction and its negative regulation by endocannabinoids in the hippocampus.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuropharmacology, 2011, 60, 842-851. http://dx.doi.org/10.1016/j.neuropharm.2010.12.024 [21] Zigman, J. M.; Jones, J. E.; Lee, C. E.; Saper, C. B.; Elmquist, J. K. Expression of ghrelin receptor mRNA in the rat and the mouse brain.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurol., 2006, 494, 528-548. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurosci., 2008, 11, 752-3. http://dx.doi.org/10.1038/nn.2139 [24] Carlini, V. P.; Varas, M. M.; Cragnolini, A.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Commun., 2004, 313, 635-641. http://dx.doi.org/10.1016/j.bbrc.2003.11.150 [25] Tschop, M.; Smiley, D.L.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Nature, 2000, 4 0 7, 908-913. http://dx.doi.org/10.1038/ 35038090 [26] Nakazato, M.; Murakami, N.; Date, Y.; Kojima, M.; Matsuo, H.; Kangawa, K.; Matsukura, S. A role for ghrelin in the central regulation of feeding.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Nature, 2001, 409, 194-198. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatric Res., 2009, 43, 671-679. http://dx.doi.org/10.1016/j.jpsychires.2008.09.007 [29] Usdan, L. S.; Khaodhiar, L.; Apovian, C. M. The endocrinopathies of anorexia nervosa.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Pract., 2008, 14, 1055-1063. http://dx.doi.org/10.4158/EP.14.8.1055 [30] Rask-Andersen M.; Olszewski, P. K.; Levine, A.S.; Schiöth, H. B. Molecular mechanisms underlying a n o r e x i a  n e r v o s a :  F o c u s  o n  human gene association studies and systems controlling food intake.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Rev., 2010, 62, 147-164. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Med., 2003, 33, 1387-1394. http://dx.doi.org/10.1017/ S0033291703008316",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychoneuroendocrinology, 2013, 38, 1545-1552. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Gen. Psychiatry, 2006, 63, 824-830. http://dx.doi.org/10.1001/ archpsyc.63.7.824 [35] Saliha, O.; Aslı, B.; Ummuhan, A.; Mustafa, B. Serum Ghrelin and Leptin Levels in Patients with Depression and the Effects of Treatment.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatric Res., 2011, 45, 421-426. http://dx.doi.org/10.1016/j.jpsychires.2010.09.002 [37] Michael, L.; Ichiro, S.; Sherri, Osborne-Lawrence; Rovinsky, S.A., Anderson, J.G., Jung, S., Birnbaum, S., Yanagisawa, M., Elmquist, J.K., Nestler, E.J., Zigman, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurosci., 2008, 11(7), 752-753. http://dx.doi.org/10.1038/nn.2139 [38] Valeria, P. C.; Daniele, G. M.; Florencia, B.; Ghersi, M.; Ponzio, M.F.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Peptides, 2012, 35, 160-165. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2001, 49, 753-762. http://dx.doi.org/ 10.1016/S0006-3223(00)01114-8 [40] Hymie, A.; Zul, M.; Shawn, H. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurobiol., 2008, 85, 1-74. http://dx.doi.org/10.1016/j.pneurobio.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Peptides, 2011, 32, 1606-1616. http://dx.doi.org/10.1016/j.peptides.2011.07.001 [43] Michelsen, K.A.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Rev., 2007, 55, 329-42. http://dx.doi.org/10.1016/j.brainresrev.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Bras Cienc., 2005, 77, 103-11. http://dx.doi.org/10.1590/S0001-37652005000100008 [45] Caroline, H.; Mayte, Alvarez-Crespo.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuropharmacology, 2014, 79, 498-505. http://dx.doi.org/10.1016/j.neuropharm.2013.12.012 [46] Karolina P. Skibicka; Suzanne L. Dickson.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Peptides, 2011, 32, 2265-2273. http://dx.doi.org/10.1016/j.peptides.2011.05.016 [47] Alvarez-Crespo, M.; Skibicka, K. P.; Farkas, I.; Molnar, C. S.; Egecioglu, E.; Hrabovszky, E.; Liposits, Z.; Dickson, S. L. The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"PloS One, 2012, 7, 420-21. http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinol., 2006, 20, 1772-1785. http://dx.doi.org/10.1210/ me.2005-0084 [49] Conkright, M. D.; Canettieri, G.; Screaton, R.; Guzman, E.; Miraglia, L.; Hogenesch, J.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Cell, 2003, 12, 413-423. http://dx.doi.org/10.1016/j.molcel.2003.08.013 [50] Shaywitz, A. J.; Greenberg, M. E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Biochem., 1999, 68, 821-861. http://dx.doi.org/ 10.1146/annurev.biochem.68.1.821 [51] Ferrini, F.; Salio, C.; Lossi, L.; Merighi, A. Ghrelin in central neurons.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuropharmacol, 2009, 7, 37-49. http://dx.doi.org/ 10.2174/157015909787602779 [52] Ulrike, B.; Christine, N.; Irmgard, C.; Doris, K.; Christoph, H.; Willhart, K. A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: Reversal of chronic psychosocial stress-induced increasein CRE/CREB-directed gene transcription in transgenic reporter gene mice.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Pharmacol., 2010, 633, 33-38. http://dx.doi.org/10.1016/ j.ejphar.2010.01.016 [53] Cuellar, J. N.; Masako, I. Ghrelin-induced activation of cAMP signal transduction and its negative regulation by endocannabinoids in the hippocampus.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuropharmacology, 2011, 60, 842-851. http://dx.doi.org/10.1016/j.neuropharm.2010.12.024 [54] Eriksson, PS.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Med., 1998, 4, 1313-1317. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Hippocampus, 2006, 16, 239-249. http://dx.doi.org/10.1002/ hipo.20156 [56] Jacobs, B. L. Adult brain neurogenesis and depression.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Immun., 2002, 16, 602-609. http://dx.doi.org/10.1016/ S0889-1591(02)00015-6 [57] Gould, E.; Tanapat, P.; Hastings, N.B.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Sci., 1999, 3, 186-192. http://dx.doi.org/10.1016/S1364-6613(99)01310-8 [58] Maura, B.; René, H.; Underwood, M, D.; Rosoklija, G. B.; Andrew, J.; Dwork, J.; John, M.; Victoria, A. Hippocampal Angiogenesis and Progenitor Cell Proliferation Are Increased with Antidepressant U s e  i n  M a j o r  D e p r e s s i o n .",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Science, 2003, 301, 805- 809. http://dx.doi.org/10.1126/science.1083328 [60] Sahay, A.; Hen, R. Adult hippocampal neurogenesis in depression.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurosci., 2007, 10, 1110 -1115. http://dx.doi.org/10.1038/ nn1969 [61] Hanson, N.D.; Owens, M.J; Boss-Williams, K.A; Weiss, J.M; Nemeroff, C.B.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychoneuroendocrinology, 2011, 36, 1520 -1529. http://dx.doi.org/10.1016/j.psyneuen.2011.04.006 [62] Snyder, J.S.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Nature, 2011, 476, 458-461. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 2001, 122, 1-9. http://dx.doi.org/10.1016/ S0166-4328(01)00170-X [65] Czeh, B.; Michaelis, T.; Watanabe, T.; Frahm, J.; De Biurrun, G.; Van Kampen, M.; Bartololomucci, A.; Fuchs, E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 2005, 1040, 55-63. http://dx.doi.org/10.1016/j.brainres.2005.01.065 [67] Kathryn, A.  C.; Cheryl, S. W. Cell cycle regulation, neurogenesis, and depression.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuropharmacology, 2010, 58, 683-693. http://dx.doi.org/10.1016/j.neuropharm.2009.12.004 [69] Hyunju, C.; Endan, Li.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinol., 2013, 218, 49-59. http://dx.doi.org/10.1530/JOE-13-0045 [70] Zhao, C.; Deng, W.; Gage, F.H.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Cell, 2008, 132, 645-660. http://dx.doi.org/10.1016/j.cell.2008.01.033 [71] Li, E.; Chung, H.; Kim, Y.; Kim, D.H.; Ryu, J.H.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrine J.,  2013, 60(6), 781-9. http://dx.doi.org/10.1507/endocrj.EJ13-0008 [72] Jiyeon, L.; Eunjin, L.; Yumi, K.; Endan, L.; Seungjoon, P. Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinol., 2010, 205, 263-270. http://dx.doi.org/ 10.1677/JOE-10-0040 [73] Simpson, J.; Kelly, J.P. An investigation of whether there are sex differences in certain behavioural and neurochemical parameters in the rat.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 2012, 229, 289-300. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Health, 2014, 17, 87-95. http://dx.doi.org/10.1007/s00737-013-0403-6 [75] Payne, J.L.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2009, 17(2), 72-86. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2013, 40, 199-206. http://dx.doi.org/10.1016/j.pnpbp.2012.10.002 [77] Studd, J.; Nappi, R. E. Reproductive depression.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinol., 2012, 28, 42-45. http://dx.doi.org/10.3109/09513590.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Climacteric, 2012, 15, 3-9. http://dx.doi.org/10.3109/13697137.2011.620188 [79] Dennerstein, L.; Guthrie, J.R.; Clark, M.; Lehert, P.; Henderson, V.W.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Menopause, 2004, 11, 563-8. http://dx.doi.org/10.1097/01.GME.0000113844.74462.F6 [80] Frey, B.N.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Menopause Int., 2008, 14, 123-8. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Climacteric, 2011, 14, 637-642. http://dx.doi.org/10.3109/13697137.2011.609285 [82] Lagunas, N.; Calmarza-Font, I.; Diz-Chaves, Y.; Luis, M. Garcia-Segura.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Behav., 2010, 58, 786-791 http://dx.doi.org/10.1016/ j.yhbeh.2010.07.014 [83] Schmidt, P. J.; Rubinow, D. R. Menopause-related affective disorders: a justification for further study.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"J. Psychiatry, 1991, 148, 844-852. http://dx.doi.org/10.1176/ajp.148.7.844 [84] Pokorski, M.; Siwiec, P. Memory, depression, and progressing old age in women.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Gen. Psychiatry, 2004, 61, 62-70. http://dx.doi.org/10.1001/archpsyc.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Maturitas, 2008, 6 1, 54-66. http://dx.doi.org/10.1016/j.maturitas.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Sci., 2009, 1179, 70-85. http://dx.doi.org/10.1111/j.1749-6632.2009.04982.x [89] Weber, M. T.; Maki P.M.; McDermott, M. P. Cognition and mood in perimenopause: A systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Biol., 2014, 142, 90-98. http://dx.doi.org/ 10.1016/j.jsbmb.2013.06.001 [90] Borrow, A. P.; Cameron, N.M. Estrogenic mediation of serotonergic and neurotrophic systems: Implications for female mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2014, 54, 13-25. http://dx.doi.org/10.1016/j.pnpbp.2014.05.009 [91] Mark, D.; Mark, G. Ovariectomy-induced disruption of long-term synaptic depression in the hippocampal CA1 region in vivo i s  attenuated with chronic estrogen replacement.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Learning Memory, 2005, 83, 13-21. http://dx.doi.org/10.1016/j.nlm.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 2012, 227, 100-108. http://dx.doi.org/10.1016/j.bbr.2011.10.047 [93] Erin, E. S.; Pauline, M. M.; Jeffrey, R. B.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Menopause, 2010, 17, 874-886. http://dx.doi.org/10.1097/gme.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurobiol., 2001, 64(3), 251-67. http://dx.doi.org/10.1016/S0301-0082(00)00059-9 [95] Weiser, M.J.; Foradori, C.D.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Rev., 2008, 57, 309-320. http://dx.doi.org/10.1016/j.brainresrev.2007.05.013 [96] Roisin, W.; Susan, R. D.; Emorfia, G.; Zoe, G.; Stuart, L.; Henry, B.; Jayashri, K. Hormonal therapies for new onset and relapsed depression during perimenopause.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"http://dx.doi.org/10.1016/j.maturitas.2012.06.011 [97] Thompson, D.S.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Breast  J., 1999, 5, 375-82. http://dx.doi.org/10.1046/j.1524-4741.1999.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 1997, 82, 704. http://dx.doi.org/ 10.1210/jc.82.2.703 [99] Erika, Estrada-Camarena.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"http://dx.doi.org/10.1016/ 0031-9384(89)90238-2 [101] Frye, C. A.; Walf, A.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurosci., 2004, 118, 306-313. http://dx.doi.org/10.1037/0735-7044.118.2.306 [102] Frye, C. A.; Wawrzycki, J.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Behav., 2003, 44, 319-326. http://dx.doi.org/10.1016/ S0018-506X(03)00159-4 [103] Estrada-Camarena, E.; Fernández-Guasti, A.; López-Rubalcava, C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2006, 59, 40-47. http://dx.doi.org/ 10.1016/j.biopsych.2005.06.012 [105] Okada, M; Hayashi, N; Kometani, M; Nakao, K; Inukai, T. Influences of ovary ectomy and continuous replacement of 17beta-estradiol on the tail skin temperature and behavior in the forced",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Pharmacol., 1997, 73, 93-96. http://dx.doi.org/10.1254/jjp.73.93 [106] Natalia, L.; Isabel, Calmarza-Font.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Behav., 2010, 58, 786-791. http://dx.doi.org/10.1016/ j.yhbeh.2010.07.014 [107] Schmidt, P.J.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"J. Obstetrics Gynecol., 2000, 183, 414-20. http://dx.doi.org/10.1067/ mob.2000.106004 [108] Julie, K. S.; Gerard, S.; Gilles, T.; Paul, K. M. Sex Differences in Diencephalon Serotonin Transporter Availability in Major Depression.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2006, 59, 40-47. http://dx.doi.org/ 10.1016/j.biopsych.2005.06.012 [109] Robert, K.; Aitchison, K. J.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2010, 22(5), 485-500. http://dx.doi.org/10.3109/09540261.2010.496448 [110] Smith, LJ.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuropsychopharmacology, 2004, 29, 2035-2045. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 1983, 51, 73-76. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Cell Neurosci., 1993, 4, 83-92. http://dx.doi.org/10.1006/mcne.1993.1010 [114] Cyr, M.; Bosse, R.; Di Paolo, T. Gonadal hormones modulate 5-hydroxytryptamine2A receptors: Emphasis on the rat frontal cortex.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroscience, 1998, 83, 829-836. http://dx.doi.org/10.1016/S0306-4522(97)00445-4 [115] Sumner, B. E. H.; Grant, K. E.; Rosie, R.; Hegele-Hartung, C.; Fritzemeier, K. H.; Fink, G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites andmRNA levels in the brain of ovariectomized rats withor without acute estradiol replacement.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 1999, 73(1-2), 119-128. http://dx.doi.org/10.1016/S0169-328X(99)00243-0 [116] Fink, G.; Sumner, B. E. Oestrogen andmental state.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurol., 1998, 391(3), 322-34. http://dx.doi.org/10.1002/ (SICI)1096-9861(19980216)391:3<322::AID-CNE3>3.0.CO;2-3 [118] Stoffel, E. C.; Craft, R, M. Ovarian hormone withdrawal-induced depression in female rats.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Behav., 2004, 83, 505-513. http://dx.doi.org/10.1016/j.physbeh.2004.08.033 [119] McEwen, B.S.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Rev., 1999, 20, 279-307. http://dx.doi.org/10.1210/ er.20.3.279 [120] Pau, K.Y.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroendocrinol., 2000, 1 2, 899-909. http://dx.doi.org/10.1046/ j.1365-2826.2000.00549.x [121] Vetrivelan, R.; Mallick, HN.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroscience, 2006, 139, 1141-1151. http://dx.doi.org/10.1016/j.neuroscience.2006.01.046 [122] Becker, J.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Synapse, 1990, 5, 157-164. http://dx.doi.org/10.1002/syn.890050211 [123] Di Paolo, T.; Diagle, M.; Picard, V.; Barden, N. Effect of acute and chronic 17 beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 1983, 113, 1935-1941. http://dx.doi.org/10.1210/endo-113-6-1935 [125] Morissette, M.; Levesque, D.; Belanger, A.; Di Paolo, T. A physiological dose of estradiol with progesterone affects striatum biogenic amines.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Pharmacol., 1990, 68, 1520-1526. http://dx.doi.org/10.1139/y90-231 [126] Munaro, N. I.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroendocrinology, 1978, 26, 270-276. http://dx.doi.org/10.1159/000122782 [127] Cone, R. I.; Davis, G. A.; Goy, R. W. Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomised rat.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Bull., 1981, 7, 639-644. http://dx.doi.org/10.1016/0361-9230(81)90111-8 [128] Pecins-Thompson, M.; Brown, N. A.; Kohama, S. G.; Bethea, C. L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 1988, 122, 2619 -2625. http://dx.doi.org/10.1210/endo-122-6-2619 [130] McQueen, J.K.; Wilson, H.; Dow, R.C.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Life Sci., 1983, 32, 2015-2021. http://dx.doi.org/10.1016/0024-3205(83)90053-X [133] Osterlund, M. K.; Halldin, C.; Hurd, Y. L. Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Synapse, 2000, 35(1), 39-44. http://dx.doi.org/10.1002/(SICI)1098-2396(200001)35:1<39::AID-SYN5>3.0.CO;2-T [134] Osterlund, M. K.; Hurd, Y. L. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expres- s i o n  i n  the limbic system of female rats.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 1998, 55(1), 169-172. http://dx.doi.org/10.1016/S0169-328X(98)00018-7 [135] Pecins-Thompson, M.; Bethea, C. L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroscience, 1999, 89(1), 267-277. http://dx.doi.org/10.1016/S0306-4522(98)00326-1 [136] Fink, G.; Sumner, B.; Rosie, R.; Wilson, H.; McQueen, J. Androgen actions on central serotonin neurotransmission: Relevance for mood, mental state and memory.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 1999, 105(1), 53-68. http://dx.doi.org/10.1016/S0166-4328(99)00082-0 [137] Sumner, B. E. H.; Fink, G. Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Biol., 1995, 54(1-2), 15-20. http://dx.doi.org/10.1016/0960-0760(95)00075-B [138] Sumner, B. E. H.; Grant, K.E.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 1999, 73(1-2), 119-128. http://dx.doi.org/10.1016/S0169-328X(99)00243-0 [139] Komulainen, P.; Pedersen, M.; Tuomo, H.; Bruunsgaard, H. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Memory, 2008, 90, 596-603. http://dx.doi.org/10.1016/j.nlm.2008.07.014 [140] Castre˄ n E.; Rantamaki, T. The Role of BDNF and Its Receptors i n Depression and Antidepressant Drug Action: Reactivation of Developmental Plasticity.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatry, 2003, 54, 59-69. http://dx.doi.org/10.1016/S0006-3223(03)00236-1 [143] Scharfman, H. E.; Maclusky, N. J.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Trends Neurosci., 2005, 28, 79-85. http://dx.doi.org/10.1016/ j.tins.2004.12.005 [144] Zhou, J.; Zhang, H.; Cohen, R. S.; Pandey, S, C. Effects of estrogen treatment on expression of BDNF and CREB expression and phosphorylation in rat amygdaloid and hippocampal structures.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroendocrinology, 2005, 81(5), 294-310. http://dx.doi.org/10.1159/000088448 [145] Spencer, J. L.; Waters, E. M.; Romeo, R. D.; Wood, G. E.; Teresa M. A.; McEwen, B.S.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroscience, 2013, 239, 67-83. http://dx.doi.org/10.1016/j.neuroscience.2012.10.024 [147] Farida, S.; Danielle, K. Lewis.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuro- endocrinol., 2006, 27, 404-414. http://dx.doi.org/10.1016/j.yfrne.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Hippocampus, 2006, 16, 225-232. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Rev., 2008, 57, 332-341. http://dx.doi.org/10.1016/j.brainresrev.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 2012, 2 2 7, 400-409. http://dx.doi.org/10.1016/j.bbr.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neurosci., 2003, 18, 2903-9. http://dx.doi.org/ 10.1111/j.1460-9568.2003.02965.x [152] Pawluski, J. L.; Brummelte, S.; Barha, C. K.; Tamara, M. Crozier; Galea, L. A. M..",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychoneuroendocrinology, 2007, 32, 480-492. http://dx.doi.org/10.1016/j.psyneuen.2007.02.012 [154] Christie, D.; Yan, L. F.; Zuoxin, W. Estrogen and adult neurogenesis in the amygdala and hypothalamus.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Rev., 2008, 57, 342-351. http://dx.doi.org/10.1016/j.brainresrev.2007.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 1986, 391, 151-159. http://dx.doi.org/10.1016/0165-3806(86) 90017-9 [156] Chowen, J.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroendocrinology, 1992, 56, 895-901. http://dx.doi.org/10.1159/000126321 [157] Michael, K.; Mary, G.; Petra, S.; Lisa, G.; Martin, D.; Sara, K.; Manfred, U.; Alexander, Y.; Axel, S. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychoneuroendocrinology, 2010, 35, 297-304. http://dx.doi.org/ 10.1016/j.psyneuen.2009.07.007 [158] Barkan, A. L.; Dimaraki, E. V.; Jessup, S. K.; Symons, K. V.; Ermolenko, M.; Jaffe, C. A. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 2003, 88, 2180-2184. http://dx.doi.org/10.1210/jc.2002-021169 [159] Akamizu, T.; Murayama, T.; Teramukai, S.; Miura, K.; Bando, I.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinol., 2006, 188, 333-344. http://dx.doi.org/10.1677/joe.1.06442 [160] Kellokoski, E.; P o y k k o, S. M.; K a r j a l a i n e n, A. H.; kkola, O; Heikkinen, J.;  Kesäniemi, Y.A.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 2005, 90, 2954-63. http://dx.doi.org/10.1210/jc.2004-2016 [161] Di Carlo, C.; T o m m a s e l l i, G. A.; G a r g a n o, V.;  Sammartino, A., Bifulco, G., Tauchmanova, L., Colao, A., Nappi, C. E f f e c t s  o f  estrogenprogestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Menopause, 2007, 14, 3 8-44. http://dx.doi.org/10.1097/ 01.gme.0000227855.04732.7b [162] Lambrinoudaki, I. V.; Christodoulakos, G.E.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Maturitas, 2008, 59, 62-71. http://dx.doi.org/10.1016/j.maturitas.2007.10.003 [163] Grinspoon, S.; Miller, K. K.; Herzog, D. B.; Grieco, K. A.; Klibanski, A.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 2004, 89, 3988-3993. http://dx.doi.org/ 10.1210/jc.2004-0287 [164] Kellokoski, E.; Poykko, S. M.; Karjalainen, A. H.; Ukkola, O.; Heikkinen, J.; Kesaniemi, Y.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 2005, 90, 2954-2963. http://dx.doi.org/10.1210/jc.2004-2016 [165] Johannes, D.; Veldhuis.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 2008, 93(10), 4020-4026. http://dx.doi.org/10.1210/jc.2008-0522 [167] Ichiro, S.; Toru, T.; Mami, Y.; Takashi, T.; Zhao Z.; Takafumi, S. Gastric estrogen directly induces ghrelin expression and production in the rat stomach.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Reprod., 2009, 81, 1154-1163. http://dx.doi.org/10.1095/biolreprod.109.079038 [171] Michopoulos, V.; M. Embree, K. R.;  Reding, K., Sanchez, M.M., Toufexis, D., Votaw, J.R., Voll, R.J., Goodman, M.M., Rivier, J., Wilson, M.E., Berga, S.L.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroscience, 2013, 250, 300-308. http://dx.doi.org/ 10.1016/j.neuroscience.2013.07.002 [172] Wenlong, Z.; Zhihai, L.; Juan, S.; Shulin, C. Expression of ghrelin in the porcine hypothalamo-pituitary-ovary axis during the estrous cycle.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Sci., 2008, 109, 356-367. http://dx.doi.org/ 10.1016/j.anireprosci.2007.12.020 [173] Burger, L. L.; Dalkin, A. C.; Aylor, K. W.; Workman, L. J.; Haisenleder, D. J.; Marshall, J. C. Regulation of gonadotropin subunit transcription after ovary ectomy in the rat: measurement of subunit primary transcripts reveals differential roles of GnRH and inhibin.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 2001, 142, 3435-42. http://dx.doi.org/ 10.1210/endo.142.8.8315 [174] Olson, D. R.; Blake, C. A. Basal luteinizing hormone and folliclestimulating hormone release rates as a function of time after castration in female and male rats.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Neuroendocrinology, 1991, 53, 124-33. http://dx.doi.org/10.1159/000125709 [175] Maki, M.; Ichiro, S.; Reiko, W.; Mami, Y.; Kinji, I.; Takafumi, S. Estrogen modulates ghrelin expression in the female rat stomach.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"4    535 Peptides, 2004, 25, 289-297. http://dx.doi.org/10.1016/j.peptides.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Fert., 1985, 73, 585-592. http://dx.doi.org/10.1530/jrf.0.0730585 [177] Rafael, Ferna´ndez-Ferna´ndez.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Reproduction, 2007, 133, 1223-1232. http://dx.doi.org/10.1530/ REP-06-0227 [178] Iqbal, J.; Kurose, Y.; Canny, B.; Clarke, I. J.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 2006, 147, 510-9. http://dx.doi.org/10.1210/ en.2005-1048 [179] Kaynard, A. H.; Pau, K. Y.; Hess, D. L.; Spies, H. G. Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus macaques.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 1990, 127, 2437-2444. http://dx.doi.org/10.1210/endo-127-5-2437 [180] Vulliemoz, N. R; Xiao, E.; Xia-Zhang, L.; Wardlaw, S. L; Ferin, M. Central infusion of AGRP suppresses pulsatile release in ovariectomized rhesus monkeys.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 2005, 146(2), 784-9. http://dx.doi.org/10.1210/en.2004-1093 [181] Vulliemoz, N. R; Xiao, E.; Xia-Zhang, L.; Germond, M.; Rivier, J.; Ferin, M. Decrease in L u t e i n i z i n g  H o r m o n e  P u l s e  F r e q u e n c y  during a Five-Hour Peripheral Ghrelin Infusion in the Ovari ectomized Rhesus Monkey.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 2004, 89(11), 5718-5723. http://dx.doi.org/10.1210/jc.2004-1244 [182] Michael, K.; Doreen, S.; Manfred, U.; Axel, S. Ghrelin suppresses nocturnal secretion of luteinizing hormone (LH) and thyroid stimulating hormone (TSH) in patients with major depression.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatric Res., 2013, 47, 1236-1239. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Metab., 2008, 93(9), 3633-3639. http://dx.doi.org/ 10.1210/jc.2008-0049 [184] Kaynard, A. H.; Pau, K. Y.; Hess, D. L.; Spies, H. G. Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus macaques.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 1990, 127, 2437-2444 http://dx.doi.org/10.1210/endo-127-5-2437 [185] Vulliemoz, N. R.; Xiao, E.; Xia-Zhang, L.; Wardlaw, S. L.; Ferin, M. Central infusion of AGRP suppresses pulsatile release in ovariectomized rhesus monkeys.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Diabetes, 2001, 50, 2438-2443. http://dx.doi.org/10.2337/diabetes.50.11.2438 [187] Chen, H. Y.; Trumbauer, M. E.; Chen, A. S.; Weingarth, D.T., Adams, J.R., Frazie,r E.G., Shen, Z., Marsh, D.J., Feighner,S.D., Guan, X.M., Ye, Z., Nargund, R.P., Smith, RG, Van der Ploeg L.H., Howard, A.D., MacNeil, D.J., Qian, S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 2004, 145, 2607-2612. http://dx.doi.org/ 10.1210/en.2003-1596 [188] Vullie´moz, N. R.; Xiao, E.; Xia-Zhang, L.; Rivier, J.; Ferin, M. Astressin, B, a nonselective CRH receptor antagonist, prevents the inhibitory effect of ghrelin on LH pulse frequency in the ovariectomized rhesus monkey.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Endocrinology, 2008, 149, 869-874 http://dx.doi.org/10.1210/en.2007-1350 [189] Rivier, J. E.; Kirby, D. A.; Lahrichi, S. L.; Corrigan, A.; Vale, W. W.; Rivier, C. L. Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Chem., 1999, 42, 3175-3182. http://dx.doi.org/10.1021/ jm9902133 [190] Kandi, P.; Hayslett, R. L. Nicotine and 17 -estradiol produce an antidepressant-like effect in female ovariectomized rats Brain.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Bull., 2011, 84, 224-228. http://dx.doi.org/10.1016/j.brainresbull.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatr., 2001, 9, 393-399. http://dx.doi.org/10.1097/00019442-200111000-00007 [193] Schneider, L.; Small, G.; Hamilton, S.; Bystrisky, A.; Nemeroff; C. Meyers, B. Estrogen replacement and response to fluoxetine in surgically menopausal women.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatr., 1997, 5, 97-106. http://dx.doi.org/10.1097/00019442-199721520-00002 [194] Hong, Z.; Qian, H.; Hao, X.; Lei, N.; Jiang-Ning, Z. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: Involvement of 5-HT1A receptors.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Brain Res., 2009, 196, 200-206. http://dx.doi.org/10.1016/j.bbr.",OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"J. Psychiatry, 2000, 157, 1445-1452. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychopharmacology (Berl), 2004, 173, 139-45. http://dx.doi.org/10.1007/s00213-003-1707-4 [197] Sell, S. L.; Craft, R. M.; Seitz, P. K.; Stutz, S. J.; Cunningham, K. A.; Thomas, M. L. Estradiol-sertraline synergy in ovariectomized rats.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychoneuroendocrinology, 2008, 33, 1051-60. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/CN-13-524.PMC4790402.pdf
"Psychiatr., 2012, 169, 693-703. http://dx.doi.org/10.1176/appi.ajp.2012.11071105	  [3] Harmer, C.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2009, 195, 102-8. http://dx.doi.org/10.1176/appi.ajp.2012.11071105	  [4] Roiser, J.P.; Elliott, R.; Sahakian, B.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuropsychopharmacol., 2012, 37, 117-36. http://dx.doi.org/10.1038/npp.2011.183	  [5] Diener, C.; Kuehner, C.; Brusniak, W.; Ubl, B.; Wessa, M.; Flor, H. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuroimage, 2012, 61, 677-85. http://dx.doi.org/10.1016/j.neuroimage.2012.04.005	  [6] Anderson, I.M.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuroreport, 2007, 18, 1351-5. http://dx.doi.org/10.1097/ WNR.0b013e3282742115	  [7] Arce, E.; Simmons, A.N.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychopharmacology, 2008, 196, 661-72. http://dx.doi.org/10.1007/s00213-007-1004-8	  [8] Del-Ben, C.M.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuropsychopharmacol., 2005, 30, 1724-34. http://dx.doi.org/10.1038/sj.npp.1300728	  [9] Harmer, C.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2009, 194, 535-40. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuroimage, 2005, 27, 991-1001. http://dx.doi.org/10.1016/ j.neuroimage.2005.05.039	  [12] Windischberger, C.; Lanzenberger, R.; Holik, A.; Spindelegger, C.; Stein, P.; Moser, U.; Gerstl, F.; Fink, M.; Moser, E.; Kasper, S. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuroimage, 2010, 49, 1161-70. http://dx.doi.org/10.1016/j.neuroimage.2009.10.013	  [13] Norbury, R.; Taylor, M.J.; Selvaraj, S.; Murphy, S.E.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychopharmacology, 2009, 206, 197-204. http://dx.doi.org/10.1007/s00213-009-1597-1	  [14] Kraus, C.; Ganger, S.; Losak, J.; Hahn, A.; Savli, M.; Kranz, G.S.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuroimage, 2014, 84, 236-44. http://dx.doi.org/10.1016/ j.neuroimage.2013.08.036	  [15] van Wingen, G.A.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2007, 190, 531-2. http://dx.doi.org/10.1192/bjp.bp.106.031393	  [18] Miskowiak, K.; Papadatou-Pastou, M.; Cowen, P.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiatr., 2008, 13, 1011-20. http://dx.doi.org/10.1038/sj.mp.4002091",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychopharmacol., 2012, 20, 364-72. http://dx.doi.org/10.1037/a0027969	  [21] McCabe, C.; Mishor, Z.; Cowen, P.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"N., 2007, 19, 274-82. http://dx.doi.org/10.1176/jnp.2007.19.3.274	  [23] Anand, A.; Li, Y.; Wang, Y.; Wu, J.; Gao, S.; Bukhari, L.; Mathews, V.P.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuropsychopharmacol., 2005, 30, 1334-44. http://dx.doi.org/ 10.1038/sj.npp.1300725	  [24] Arnone, D.; McKie, S.; Elliott, R.; Thomas, E.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiatr., 2012, 169, 841-50. http://dx.doi.org/10.1176/ appi.ajp.2012.11121774	  [25] Benedetti, F.; Radaelli, D.; Bernasconi, A.; Dallaspezia, S.; Colombo, C.; Smeraldi, E. Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuropsychopharmacol., 2008, 33, 1909-18. http://dx.doi.org/10.1038/sj.npp.1301593	  [27] Davidson, R.J.; Irwin, W.; Anderle, M.J.; Kalin, N.H.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiatr., 2003, 160, 64-75. http://dx.doi.org/ 10.1176/appi.ajp.160.1.64	  [28] Fales, C.L.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Disord., 2009, 112, 206-11. http://dx.doi.org/10.1016/j.jad.2008.04.027	  [29] Fu, C.H.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiatr., 2007, 164, 599-607. http://dx.doi.org/ 10.1176/appi.ajp.164.4.599	  [30] Fu, C.H.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2004, 61, 877-89. http://dx.doi.org/10.1001/archpsyc.61.9.877	  [31] Godlewska, B.R.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
Short-term SSRI treatment normalises amygdala hype http://dx.doi.org/10.1017/S0033291712000591ractivity in depressed patients.,Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiatr., 2013, 170, 197-206. http://dx.doi.org/10.1176/appi.ajp.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychopharmacol., 2009, 23, 775-88. http://dx.doi.org/10.1177/ 0269881108093589	  [34] Lemogne, C.; Mayberg, H.; Bergouignan, L.; Volle, E.; Delaveau, P.; Lehericy, S.; Allilaire, J.F.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Disord., 2010, 124, 196-201. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuropsychoph., 2011, 14, 521-34. http://dx.doi.org/10.1017/ S1461145710001513	  [36] Lopez-Sola, M.; Pujol, J.; Hernandez-Ribas, R.; Harrison, B.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuropsychopharmacol., 2010, 35, 2305-17. http://dx.doi.org/10.1038/npp.2010.108	  [37] Miller, J.M.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Res., 2013, 214, 296-305. http://dx.doi.org/10.1016/j.pscychresns.2013.08.001	  [38] Rizvi, S.J.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Disord., 2013, 1 5 1, 573-81. http://dx.doi.org/10.1016/j.jad.2013.06.050	  [39] Robertson, B.; Wang, L.; Diaz, M.T.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2007, 6 8, 261-7. http://dx.doi.org/10.4088/JCP.v68n0212	  [40] Rosenblau, G.; Sterzer, P.; Stoy, M.; Park, S.; Friedel, E.; Heinz, A.; Pilhatsch, M.; Bauer, M.; Strohle, A. Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychopharmacol., 2012, 26, 1424-33. http://dx.doi.org/10.1177/0269881112450779	  [41] Ruhe, H.G.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2012, 73, 451-9. http://dx.doi.org/10.4088/JCP.10m06584	  [42] Samson, A.C.; Meisenzahl, E.; Scheuerecker, J.; Rose, E.; Schoepf, V.; Wiesmann, M.; Frodl, T. Brain activation predicts treatment improvement in patients with major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Res., 2011, 45, 1214-22. http://dx.doi.org/10.1016/ j.jpsychires.2011.03.009	  [43] Schaefer, H.S.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2006, 60, 974-86. http://dx.doi.org/ 10.1016/j.biopsych.2006.03.024	  [44] Sheline, Y.I.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiat., 2001, 50, 651-8. http://dx.doi.org/10.1016/S0006-3223(01)01263-X	  [45] Stoy, M.; Schlagenhauf, F.; Sterzer, P.; Bermpohl, F.; Hagele, C.; Suchotzki, K.; Schmack, K.; Wrase, J.; Ricken, R.; Knutson, B.; Adli, M.; Bauer, M.; Heinz, A.; Strohle, A. Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychopharmacol., 2012, 26, 677-88. http://dx.doi.org/10.1177/ 0269881111416686	  [46] Tao, R.; Calley, C.S.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychiatr., 2012, 169, 381-8. http://dx.doi.org/ 10.1176/appi.ajp.2011.11040615	  [47] Victor, T.A.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuropsychoph., 2013, 16, 2195-208. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neurosci., 2010, 35, 247-57. http://dx.doi.org/10.1503/jpn.090081	  [49] Walsh, N.D.; Williams, S.C.; Brammer, M.J.; Bullmore, E.T.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Med., 2014, 44, 1417-26. http://dx.doi.org/10.1017/S0033291713002031	  [51] Wang, Y.; Xu, C.; Cao, X.; Gao, Q.; Li, J.; Liu, Z.; Sun, N.; Ren, Y.; Zhang, K. Effects of an antidepressant on neural correlates of emotional processing in patients with major depression.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Lett., 2012, 527, 55-9. http://dx.doi.org/10.1016/j.neulet.2012.08.034	  [52] Jiang, W.; Yin, Z.; Pang, Y.; Wu, F.; Kong, L.; Xu, K. Brain functional changes in facial expression recognition in patients with major depressive disorder before and after antidepressant treatment: A functional magnetic resonance imaging study.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Rev., 2013, 37, 2529-53. http://dx.doi.org/10.1016/j.neubiorev.2013.07.018	  [54] Leppanen, J.M.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Behav., 2006, 34, 207-46. http://dx.doi.org/10.1016/S0065-2407(06)80008-X	  [55] Poulsen, C.; Luu, P.; Crane, S.M.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Psychol., 2009, 118, 494-506. http://dx.doi.org/10.1037/ a0015920	  [56] Herrington, J.D.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Neuroimage, 2011, 56, 2348-55. http://dx.doi.org/10.1016/j.neuroimage.2011.03.072	  [57] Morris, J.S.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Brain, 1998, 121 (Pt 1), 47-57. http://dx.doi.org/10.1093/brain/121.1.47	  [58] Fu, C.H.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"Dis., 2013, 52, 75-83. http://dx.doi.org/10.1016/j.nbd.2012.05.008	  [59] Furey, M.L.",OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"JAMA Psychiatry, 2013, 70, 280-90. http://dx.doi.org/10.1001/2013.",Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/e6/d4/CN-13-466.PMC4790403.pdf
"JAMA, 2003, 289(23), 3095-3105. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuron, 2002, 34(1), 13-25. http://dx.doi.org/10.1016/S0896-6273(02)00653-0 [4] Ressler, K.J.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2007, 10(9), 1116-1124. http://dx.doi.org/10.1038/nn1944 [5] Byers, A.L.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Diabetologia, 2006, 49(5), 837-845. http://dx.doi.org/10.1007/s00125-006-0159-x [7] Evans, D.L.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychiatry, 2005, 58(3), 175-189. http://dx.doi.org/10.1016/ j.biopsych.2005.05.001 [8] Epel, E.S.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Res., 2010, 42(7), 467-482. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Gastroenterology, 2002, 122(4), 1140-1156. http://dx.doi.org/10.1053/gast.2002.32392 [11] Krishnan, V.; Nestler, E.J.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Nature, 2008, 455(7215), 894-902. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2006, 7(2), 137-151. http://dx.doi.org/10.1038/nrn1846 [13] (a) Uchida, S.; Hara, K.; Kobayashi, A.; Otsuki, K.; Yamagata, H.; Hobara, T.; Suzuki, T.; Miyata, N.; Watanabe, Y. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2014, 16(3), 281-295. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Disord., 2004, 82(2), 175-190. http://dx.doi.org/10.1016/j.jad.2004.04.002 [15] (a) Wong, M.L.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2001, 2(5), 343-351; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Behav., 2011, 60(1), 105-111. http://dx.doi.org/10.1038/35072566 [16] Hyman, S.E.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Cell, 2007, 131(2), 232-234. http://dx.doi.org/10.1016/j.cell.2007.10.008 [17] Hall, J.M.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropsychopharmacology, 2000, 23(5), 477-501. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Trends Neurosci., 2008, 31(9), 464-468. http://dx.doi.org/10.1016/j.tins.2008.06.006 [20] (a) Abe, H.; Hidaka, N.; Kawagoe, C.; Odagiri, K.; Watanabe, Y.; Ikeda, T.; Ishizuka, Y.; Hashiguchi, H.; Takeda, R.; Nishimori, T.; Ishida, Y. Prenatal psychological stress causes higher emotionality, depression-like behavior, and elevated activity in the hypothalamo-pituitary-adrenal axis.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Res., 2007, 59(2), 145-151; http://dx.doi.org/10.1016/j.neures.2007.06.1465 ( b )  P e n a ,  C .",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Biol., 2014, 426(20), 3389-3412; http://dx.doi.org/10.1016/j.jmb.2014.03.016 ( c )  D h a b h a r ,  F .",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Behav., 2013, 112, 104-110; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Rev., 2005, 29(4-5), 829-841. http://dx.doi.org/10.1016/j.neubiorev.2005.03.021 [23] (a) Krishnan, V.; Han, M.H.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Cell, 2007, 131(2), 391-404; http://dx.doi.org/10.1016/j.cell.2007.09.018 ( b )  W a n g ,  J .",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Nature, 2013, 493(7433), 532-536. http://dx.doi.org/10.1038/nature11713 [25] (a) Vetulani, J.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Rep., 2013, 65(6), 1451-1461; http://dx.doi.org/10.1016/S1734-1140(13) 71505-6 (b) Sung, Y.H.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Lett., 2010, 470(1), 86-90; http://dx.doi.org/10.1016/j.neulet.2009.12.063 (c) von Poser Toigo, E.; Diehl, L.A.; Ferreira, A.G.; Mackedanz, V.; Krolow, R.; Benitz, A.N.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Res., 2012, 37(1), 126-133. http://dx.doi.org/10.1007/s11064-011-0590-3",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Behav., 2014, 124, 451-457; http://dx.doi.org/10.1016/j.pbb.2014.07.015 (b) Song, C.; Leonard, B.E.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Rev., 2005, 29(4-5), 627-647. http://dx.doi.org/10.1016/j.neubiorev.2005.03.010 [27] Deacon, R.M.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Brain Res., 2002, 132(2), 203-213. http://dx.doi.org/10.1016/S0166-4328(01)00401-6 [28] (a) Faria, R.; Santana, M.M.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuroscience, 2014, 273, 1-11; http://dx.doi.org/10.1016/j.neuroscience.2014.04.042 (b) Banerjee, R.; Hazra, S.; Ghosh, A.K.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychiatry Investig., 2014, 11(3), 297-306. http://dx.doi.org/10.4306/pi.2014.11.3.297 [29] Gu, H.F.; Tang, C.K.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Atherosclerosis, 2012, 223(1), 69-77. http://dx.doi.org/10.1016/j.atherosclerosis.2012.01.021 [30] Hasan, K.M.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Age (Dordr), 2012, 34(6), 1421-1433. http://dx.doi.org/10.1007/ s11357-011-9319-0 [31] Keck, M.E.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Rev., 2005, 29(4-5), 867-889. http://dx.doi.org/10.1016/j.neubiorev.2005.03.003 [32] Opel, N.; Redlich, R.; Zwanzger, P.; Grotegerd, D.; Arolt, V.; Heindel, W.; Konrad, C.; Kugel, H.; Dannlowski, U. Hippocampal atrophy in major depression: a function of childhood maltreatment rather than diagnosis?",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropsychopharmacology, 2014, 39(12), 2723-2731. http://dx.doi.org/10.1038/npp.2014.145 [33] Domin, H.; Szewczyk, B.; Wozniak, M.; Wawrzak-Wlecial, A.; Smialowska, M. Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Brain Res., 2014, 273, 23-33. http://dx.doi.org/ 10.1016/j.bbr.2014.07.019 [34] Banasr, M.; Duman, R.S.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurochem., 2001, 77(3), 916-928. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Med., 2013, 19(6), 773-777. http://dx.doi.org/10.1038/nm.3162 [37] Schmidt, H.D.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Pharmacol., 2007, 18(5-6), 391-418. http://dx.doi.org/10.1097/FBP.0b013 e3282ee2aa8 [38] (a) Spalding, K.L.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Cell, 2013, 153(6), 1219-1227; http://dx.doi.org/10.1016/j.cell.2013.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Rev., 2009, 33(3), 232-252; http://dx.doi.org/10.1016/j.neubiorev.2008.08.007 ( c )  E i s c h ,  A .",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Science, 2012, 338(6103), 72-75. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Brain Res., 2014, 273, 133-138. http://dx.doi.org/10.1016/j.bbr.2014.07.040 [40] Liu, B.B.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Med., 2001, 7(5), 541-547. http://dx.doi.org/10.1038/87865 [43] (a) Schatzberg, A.F.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Pharmacol., 2008, 583(2-3), 358-364; http://dx.doi.org/10.1016/j.ejphar.2008.01.001 (b) Yamada, K.; Kobayashi, M.; Mori, A.; Jenner, P.; Kanda, T. Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Behav., 2013, 114-115, 23-30. http://dx.doi.org/10.1016/j.pbb.2013.10.022 [44] Bissette, G.; Klimek, V.; Pan, J.; Stockmeier, C.; Ordway, G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropsychopharmacology, 2003, 28(7), 1328-1335. http://dx.doi.org/10.1038/sj.npp.1300191 [45] Kurada, L.; Yang, C.; Lei, S. Corticotropin-releasing factor facilitates epileptiform activity in the entorhinal cortex: roles of CRF2 receptors and PKA pathway.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"http://dx.doi.org/10.1371/journal.pone.0088109 [46] Kormos, V.; Gaszner, B.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropeptides, 2013, 47(6), 401-419. http://dx.doi.org/10.1016/j.tips.2003.09.011 [47] Holmes, A.; Heilig, M.; Rupniak, N.M.; Steckler, T.; Griebel, G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Sci., 2003, 24(11), 580-588. http://dx.doi.org/10.1016/j.tips.2003.09.011 [48] Hodgson, R.A.; Mullins, D.; Lu, S.X.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Pharmacol., 2014, 730, 157-163. http://dx.doi.org/10.1016/j.ejphar.2014.02.027 [49] Grassi, D.; Lagunas, N.; Calmarza-Font, I.; Diz-Chaves, Y.; Garcia-Segura, L.M.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Brain Res., 2014, 1588, 55-62. http://dx.doi.org/10.1016/j.brainres.2014.09.006 [50] (a) Simon, N.G.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"CNS Drug Discov., 2008, 3(2), 77-93; http://dx.doi.org/10.2174/157488908784534586 ( b )  R o t z i n g e r , S.; Lovejoy, D.A.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Peptides, 2010, 31(4), 736-756. http://dx.doi.org/10.1016/j.peptides.2009.12.015 [51] Keck, M.E.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropsychopharmacology, 2003, 28(2), 235-243. http://dx.doi.org/10.1038/sj.npp.1300040 [52] Wersinger, S.R.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychiatry, 2002, 7(9), 975-984. http://dx.doi.org/10.1038/sj.mp.4001195 [53] (a) Traynelis, S.F.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Rev., 2010, 62(3), 405-496; http://dx.doi.org/10.1124/pr.109.002451 ( b )  D o r e ,  A .",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Nature, 2014, 511(7511), 557-562. http://dx.doi.org/10.1038/nature13396 [54] Hashimoto, K. The role of glutamate on the action of antidepressants.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychiatry, 2011, 35(7), 1558-1568. http://dx.doi.org/10.1016/j.pnpbp.2010.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Trends Neurosci., 2012, 35(1), 47-56. http://dx.doi.org/10.1016/j.tins.2011.11.004 [56] Feyissa, A.M.; Chandran, A.; Stockmeier, C.A.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychiatry, 2009, 33(1), 70-75. http://dx.doi.org/10.1016/j.pnpbp.2008.10.005 [57] Dang, Y.H.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Des., 2014, 20(32), 5151-5159. http://dx.doi.org/10.2174/1381612819666140110120435 [58] Jimenez-Sanchez, L.; Campa, L .",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropsychopharmacology, 2014, 39(11), 2673-2680. http://dx.doi.org/10.1038/npp.2014.123 [59] Gosek, P.; Chojnacka, M.; Bienkowski, P.; Swiecicki, L. Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Nature, 2014, 511(7508), 191-197. http://dx.doi.org/10.1038/nature13548 [62] Gould, T.D.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropharmacology, 2008, 54(3), 577-587. http://dx.doi.org/ 10.1016/j.neuropharm.2007.11.002 [63] Koike, H.; Fukumoto, K.; Iijima, M.; Chaki, S. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Brain Res., 2013, 238, 48-52. http://dx.doi.org/ 10.1016/j.bbr.2012.10.023 [64] Mohler, H. The GABA system in anxiety and depression and its therapeutic potential.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropharmacology, 2012, 62(1), 42-53. http://dx.doi.org/10.1016/j.neuropharm.2011.08.040 [65] Yang, A.M.; Ji, Y.K.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Peptides, 2011, 32(9), 1948-1952. http://dx.doi.org/10.1016/ j.peptides.2011.08.012 [66] Miller, P.S.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Nature, 2014, 512(7514), 270-275. http://dx.doi.org/ 10.1038/nature13293 [67] Feder, A.; Nestler, E.J.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2009, 10(6), 446-457. http://dx.doi.org/10.1038/nrn2649 [68] Zhu, C.B.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropsychopharmacology, 2006, 31(10), 2121-2131. http://dx.doi.org/10.1038/sj.npp.1301029 [69] Hassaine, G.; Deluz, C.; Grasso, L.; Wyss, R.; Tol, M.B.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Nature, 2014, 512(7514), 276-281. http://dx.doi.org/10.1038/nature13552 [70] Duman, R.S.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychiatry, 2006, 11(1), 86-98. http://dx.doi.org/10.1038/sj.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Brain Res., 2012, 235(2), 287-292. http://dx.doi.org/10.1016/j.bbr.2012.08.016 [73] Brennan, A.R.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Learn Mem., 2008, 15(3), 93-96. http://dx.doi.org/10.1101/lm.767408 [74] Stone, E.A.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Stress, 2009, 12(4), 350-361. http://dx.doi.org/10.1080/10253890802506383 [76] Miller, C.A.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuron, 2011, 69(2), 188-190. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuropsychopharmacol., 2006, 9(5), 607-612. http://dx.doi.org/10.1017/S1461145705006085 [78] Zhang, X.; Zhang, Z.; Sha, W.; Xie, C.; Xi, G.; Zhou, H.; Zhang, Y. Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychiatry Res., 2009, 170(2-3), 273-275. http://dx.doi.org/10.1016/j.psychres.2009.01.011 [79] Segerstrom, S.C.; Miller, G.E.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Psychol Bull, 2004, 130(4), 601-630. http://dx.doi.org/10.1037/ 0033-2909.130.4.601 [80] Liu, Y.; Ho, R.C.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Affect Disord., 2012, 139(3), 230-239. http://dx.doi.org/10.1016/j.jad.2011.08.003 [81] Reichenberg, A.; Yirmiya, R.; Schuld, A.; Kraus, T.; Haack, M.; Morag, A.; Pollmacher, T. Cytokine-associated emotional and cognitive disturbances in humans.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Gen. Psychiatry, 2001, 58(5), 445-452. http://dx.doi.org/10.1001/archpsyc.58.5.445 [82] Karrenbauer, B.D.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neuroimmunol., 2011, 237(1-2), 23-32. http://dx.doi.org/10.1016/ j.jneuroim.2011.05.011 [83] Wong, M.-L.; Licinio, J.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Trends Neurosci., 2000, 23(12), 618-625. http://dx.doi.org/10.1016/S0166-2236(00)01661-1 [85] Ericsson, A.; Liu, C.; Hart, R.P.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Dis., 2006, 23(3), 587-594. http://dx.doi.org/ 10.1016/j.nbd.2006.05.001 [89] Kaster, M.P.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2008, 9(1), 46-56. http://dx.doi.org/10.1038/nrn2297 [91] Simen, B.B.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2004, 5(11), 874-885. http://dx.doi.org/10.1038/nrn1536 [93] (a) Airan, R.D.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Science, 2007, 317(5839), 819-823; (http://dx.doi.org/10.1126/science.1144400 b) von Wolff, G.; Avrabos, C.; Stepan, J.; Wurst, W.; Deussing, J.M.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Res., 2011, 45(2), 256-261. http://dx.doi.org/10.1016/ j.jpsychires.2010.06.007 [94] Yang, B.; Treweek, J.B.; Kulkarni, R.P.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Cell, 2014, 158(4), 945-958. http://dx.doi.org/10.1016/ j.cell.2014.07.017 [95] Susaki, E.A.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Cell, 2014, 157(3), 726-739. http://dx.doi.org/10.1016/j.cell.2014.03.042 [96] Chung, K.; Wallace, J.; Kim, S.Y.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Nature, 2013, 497(7449), 332-337. http://dx.doi.org/10.1038/nature12107 [97] Deisseroth, K. Optogenetics.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Methods, 2011, 8(1), 26-29. http://dx.doi.org/10.1038/nmeth.f.324 [98] Tye, K.M.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Neurosci., 2012, 13(4), 251-266. http://dx.doi.org/10.1038/nrn3171 [99] Sparta, D.R.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Brain Res., 2013, 255, 19-25. http://dx.doi.org/10.1016/j.bbr.2013.",OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Biol., 2014, 3(5), 273-279. http://dx.doi.org/10.1021/sb4000838   Received: November 06, 2014 Revised: January 13, 2015 Accepted: January 25, 2015",Non-OADS,/arxiv_data1/oa_pdf/40/e5/CN-13-494.PMC4790405.pdf
"Gen. Psychiatry, 2008, 65(9), 1017-32. http://dx.doi.org/10.1001/archpsyc.65.9.1017 [3] Arnone, D., Cavanagh, J., Gerber, D., Lawrie, S.M., Ebmeier, K.P., and McIntosh, A.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry, 2009, 195(3), 194-201. http://dx.doi.org/10.1192/bjp.bp.108.059717 [4] Hallahan, B., Newell, J., Soares, J.C., Brambilla, P., Strakowski, S.M., Fleck, D.E., Kieseppa, T., Altshuler, L.L., Fornito, A., Malhi, G.S., McIntosh, A.M., Yurgelun-Todd, D.A., Labar, K.S., Sharma, V., MacQueen, G.M., Murray, R.M., and McDonald, C. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2011, 69(4), 326-35. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Res., 2010, 117(1), 1-12. http://dx.doi.org/10.1016/j.schres.2009.12.022 [6] Houenou, J., Frommberger, J., Carde, S., Glasbrenner, M., Diener, C., Leboyer, M., and Wessa, M. Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Disord., 2011, 132(3), 344-55. http://dx.doi.org/10.1016/j.jad.2011.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Biol Psychiatry, 2010, 67(11), 1097-105. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2012, 14(2), 135-45. http://dx.doi.org/10.1111/j.1399-5618.2012.01000.x [9] Beyer, J.L., Young, R., Kuchibhatla, M., and Krishnan, K.R.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2009, 21(4), 394-409. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Acta psychiatrica Scandinavica, 2008, 118(5), 357-62. http://dx.doi.org/10.1111/j.1600-0447.2008.01229.x [11] Vita, A., De Peri, L., and Sacchetti, E. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2009, 11(8), 807-14. http://dx.doi.org/10.1111/j.1399-5618.2009.00759.x [12] De Peri, L., Crescini, A., Deste, G., Fusar-Poli, P., Sacchetti, E. Vita, A.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Des., 2012, 18(4), 486-94. http://dx.doi.org/10.2174/138161212799316253 [13] Marlinge, E., Bellivier, F., and Houenou, J.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2014, 16(2), 97-112. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"35(8), 1820-6. http://dx.doi.org/10.1016/j.pnpbp.2011.05.009 [15] Nortje, G., Stein, D.J., Radua, J., Mataix-Cols, D., and Horn, N. Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Disord., 2013, 150(2), 192-200. http://dx.doi.org/10.1016/j.jad.2013.05.034 [16] Manji, H.K., Moore, G.J., and Chen, G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuropsychobiology, 2010, 62(1), 50-60. http://dx.doi.org/10.1159/000314310 [18] Chiu, C.T., Wang, Z., Hunsberger, J.G., and Chuang, D.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Rev., 2013, 65(1), 105-42. http://dx.doi.org/10.1124/pr.111.005512 [19] Bachmann, R.F., Schloesser, R.J., Gould, T.D., and Manji, H.K.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neurobiol., 2005, 32(2), 173-202. http://dx.doi.org/10.1385/MN: 32:2:173 [20] Chang, Y.C., Rapoport, S.I., and Rao, J.S.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Res., 2009, 34(3), 536-41. http://dx.doi.org/10.1007/s11064-008-9817-3 [21] Abelaira, H.M., Reus, G.Z., Ribeiro, K.F., Zappellini, G., Ferreira, G.K., Gomes, L.M., Carvalho-Silva, M., Luciano, T.F., Marques, S.O., Streck, E.L., Souza, C.T., and Quevedo, J.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Int., 2011, 59(8), 1163-74. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2013, 73(7), 652-7. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuropsychopharmacology, 2005, 30(9), 1649-61. http://dx.doi.org/10.1038/sj.npp.1300710 [25] Vernon, A.C., Natesan, S., Modo, M., and Kapur, S. Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo a n d  p o s t m o r t e m  confirmation.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2011, 69(10), 936-44. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Gen. Psychiatry, 2011, 68(2), 128-37. http://dx.doi.org/10.1001/ archgenpsychiatry.2010.199 [28] Smieskova, R., Fusar-Poli, P., Allen, P., Bendfeldt, K., Stieglitz, R.D., Drewe, J., Radue, E.W., McGuire, P.K., Riecher-Rossler, A., and Borgwardt, S.J.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Des., 2009, 15(22), 2535-49. http://dx.doi.org/10.2174/138161209788957456 [29] van Haren, N.E., Schnack, H.G., Cahn, W., van den Heuvel, M.P., Lepage, C., Collins, L., Evans, A.C., Hulshoff Pol, H.E., and Kahn, R.S., Changes in cortical thickness during the course of illness in schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Arch Gen. Psychiatry, 2011, 68(9), 871-80. http://dx.doi.org/10.1001/archgenpsychiatry.2011.88 [30] Lieberman, J.A., Tollefson, G.D., Charles, C., Zipursky, R., Sharma, T., Kahn, R.S., Keefe, R.S., Green, A.I., Gur, R.E., McEvoy, J., Perkins, D., Hamer, R.M., Gu, H., and Tohen, M. Antipsychotic drug effects on brain morphology in first-episode psychosis.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Gen. Psychiatry, 2005, 62(4), 361-70. http://dx.doi.org/10.1001/archpsyc.62.4.361 [31] Ansell, B.R., Dwyer, D.B., Wood, S.J., Bora, E., Brewer, W.J., Proffitt, T.M., Velakoulis, D., McGorry, P.D., and Pantelis, C. Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuropsychopharmacol., 2009, 19(2), 125-37. http://dx.doi.org/ 10.1016/j.euroneuro.2008.10.001 [33] McDonald, C., Bullmore, E., Sham, P., Chitnis, X., Suckling, J., Maccabe, J., Walshe, M., and Murray, R.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry, 2005, 186, 369-77. http://dx.doi.org/10.1192/bjp.186.5.369 [34] Murray, R.M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., and McDonald, C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Res., 2004, 71(2-3), 405-16. http://dx.doi.org/10.1016/j.schres.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2011, 13(7-8), 604-13. http://dx.doi.org/10.1111/j.1399-5618.2011.00958.x [37] Yip, S.W., Chandler, R.A., Rogers, R.D., Mackay, C.E., and Goodwin, G.M.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"NeuroImage Clin., 2013, 3, 271-8. http://dx.doi.org/10.1016/j.nicl.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Med., 2007, 37(5), 699-704. http://dx.doi.org/10.1017/S0033291706009743 [39] Yip, S.W., Chandler, R.A., Rogers, R.D., Mackay, C.E., and Goodwin, G.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Disord., 2013, 150(2), 499-506. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Res., 2007, 41(10), 821-7. http://dx.doi.org/10.1016/j.jpsychires.2006.07.006 [41] McDonald, C., Bullmore, E.T., Sham, P.C., Chitnis, X., Wickham, H., Bramon, E., and Murray, R.M.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Gen. Psychiatry, 2004, 61(10), 974-84. http://dx.doi.org/10.1001/archpsyc.61.10.974 [42] Matsuo, K., Kopecek, M., Nicoletti, M.A., Hatch, J.P., Watanabe, Y., Nery, F.G., Zunta-Soares, G., and Soares, J.C. New structural brain imaging endophenotype in bipolar disorder.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2012, 17(4), 412-20. http://dx.doi.org/10.1038/mp.2011.3 [43] Hulshoff, P.H.E., van Baal, G.C., Schnack, H.G., Brans, R.G., van der Schot, A.C., Brouwer, R.M., van Haren, N.E., Lepage, C., Collins, D.L., Evans, A.C., Boomsma, D.I., Nolen, W., and Kahn, R.S.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Gen. Psychiatry, 2012, 69(4), 349-59. http://dx.doi.org/10.1001/ archgenpsychiatry.2011.1615 [44] Chaddock, C.A., Barker, G.J., Marshall, N., Schulze, K., Hall, M.H., Fern, A., Walshe, M., Bramon, E., Chitnis, X.A., Murray, R., and McDonald, C. White matter microstructural impairments and genetic liability to familial bipolar I disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry, 2009, 194(6), 527-34. http://dx.doi.org/10.1192/bjp.bp.107.047498 [45] Sprooten, E., Sussmann, J.E., Clugston, A., Peel, A., McKirdy, J., Moorhead, T.W., Anderson, S., Shand, A.J., Giles, S., Bastin, M.E., Hall, J., Johnstone, E.C., Lawrie, S.M., and McIntosh, A.M. White matter integrity in individuals at high genetic risk of bipolar",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2011, 70(4), 350-6. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry, 2013, 170(8), 886-98. http://dx.doi.org/10.1176/appi.ajp.2013.12111448 [47] McIntosh, A.M., Job, D.E., Moorhead, W.J., Harrison, L.K., Whalley, H.C., Johnstone, E.C., and Lawrie, S.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"141(1), 76-83. http://dx.doi.org/10.1002/ajmg.b.30254 [48] Ivleva, E.I., Bidesi, A.S., Keshavan, M.S., Pearlson, G.D., Meda, S.A., Dodig, D., Moates, A.F., Lu, H., Francis, A.N., Tandon, N., Schretlen, D.J., Sweeney, J.A., Clementz, B.A., and Tamminga, C.A.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry, 2013, 170(11), 1285-96. http://dx.doi.org/10.1176/appi.ajp.2013.13010126 [49] Nery, F.G., Monkul, E.S., and Lafer, B.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"New Zealand J. Psychiatry, 2013, 47(12), 1124-35. http://dx.doi.org/10.1177/0004867413496482 [50] Fusar-Poli, P., Howes, O., Bechdolf, A., and Borgwardt, S. Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry Neurosci., 2012, 37(3), 170-84. http://dx.doi.org/10.1503/jpn.110061 [51] Lin, D., Mok, H., and Yatham, L.N.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"CNS Drugs, 2006, 20(1), 29-42. http://dx.doi.org/10.2165/ 00023210-200620010-00003 [52] Versace, A., Almeida, J.R., Hassel, S., Walsh, N.D., Novelli, M., Klein, C.R., Kupfer, D.J., and Phillips, M.L.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Gen. Psychiatry, 2008, 65(9), 1041-52. http://dx.doi.org/10.1001/ archpsyc.65.9.1041 [53] Lyoo, I.K., Dager, S.R., Kim, J.E., Yoon, S.J., Friedman, S.D., Dunner, D.L., and Renshaw, P.F.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuro- psychopharmacology, 2010, 35(8), 1743-50. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2012, 14(4), p. 375-410. http://dx.doi.org/10.1111/j.1399-5618.2012.01023.x [55] Sassi, R.B., Nicoletti, M., Brambilla, P., Mallinger, A.G., Frank, E., Kupfer, D.J., Keshavan, M.S., and Soares, J.C.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Lett., 2002, 329(2), 243-5. http://dx.doi.org/10.1016/ S0304-3940(02)00615-8 [56] van der Schot, A.C., Vonk, R., Brans, R.G., van Haren, N.E., Koolschijn, P.C., Nuboer, V., Schnack, H.G., van Baal, G.C., Boomsma, D.I., Nolen, W.A., Hulshoff Pol, H.E., and Kahn, R.S.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Gen. Psychiatry, 2009, 66(2), 142-51. http://dx.doi.org/10.1001/ archgenpsychiatry.2008.541 [57] Scherk, H., Kemmer, C., Usher, J., Reith, W., Falkai, P., and Gruber, O.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neurosci., 2008, 258(6), 345-9. http://dx.doi.org/10.1007/s00406-007-0801-8 [58] Germana, C., Kempton, M.J., Sarnicola, A., Christodoulou, T., Haldane, M., Hadjulis, M., Girardi, P., Tatarelli, R., and Frangou, S. The effects of lithium and anticonvulsa nts on brain structure in bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Acta Psychiatrica Scandinavica, 2010, 122(6), 481-7. http://dx.doi.org/10.1111/j.1600-0447.2010.01582.x [59] Moore, G.J., Bebchuk, J.M., Wilds, I.B., Chen, G., Manji, H.K., and Menji, H.K.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Lancet, 2000, 356(9237), 1241-2. http://dx.doi.org/10.1016/ S0140-6736(00)02793-8 [60] Moore, G.J., Cortese, B.M., Glitz, D.A., Zajac-Benitez, C., Quiroz, J.A., Uhde, T.W., Drevets, W.C., and Manji, H.K.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2009, 70(5), 699-705. http://dx.doi.org/10.4088/JCP.07m03745 [61] Sapolsky, R.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Gen. Psychiatry, 2000, 57(10), 925-35. http://dx.doi.org/10.1001/archpsyc.57.10.925 [62] Yucel, K., Taylor, V.H., McKinnon, M.C., Macdonald, K., Alda, M., Young, L.T., and MacQueen, G.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuropsychopharmacology, 2008, 33(2), 361-7. http://dx.doi.org/10.1038/sj.npp.1301405 [63] Yucel, K., McKinnon, M.C., Taylor, V.H., Macdonald, K., Alda, M., Young, L.T., and MacQueen, G.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychopharmacology, 2007, 195(3), 357-67. http://dx.doi.org/10.1007/s00213-007-0906-9 [64] Foland, L.C., Altshuler, L.L., Sugar, C.A., Lee, A.D., Leow, A.D., Townsend, J., Narr, K.L., Asuncion, D.M., Toga, A.W., and Thompson, P.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuroreport, 2008, 19(2), 221-4. http://dx.doi.org/10.1097/WNR.0b013e3282f48108 [65] Beyer, J.L., Kuchibhatla, M., Payne, M.E., Moo-Young, M., Cassidy, F., Macfall, J., and Krishnan, K.R.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2004, 12(6), 613-20. http://dx.doi.org/10.1097/ 00019442-200411000-00007 [66] Bearden, C.E., Soares, J.C., Klunder, A.D., Nicoletti, M., Dierschke, N., Hayashi, K.M., Narr, K.L., Brambilla, P., Sassi, R.B., Axelson, D., Ryan, N., Birmaher, B., and Thompson, P.M. Three-dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2008, 47(5), 515-25. http://dx.doi.org/10.1097/CHI.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuroimage, 2010, 49(4), 2966-76. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Brain Mapp., 2012, 33(3), 501-10. http://dx.doi.org/10.1002/hbm.21239 [69] Usher, J., Menzel, P., Schneider-Axmann, T., Kemmer, C., Reith, W., Falkai, P., Gruber, O., and Scherk, H. Increased right amygdala volume in l i t h i u m-treated patients with bipolar I disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Acta psychiatrica Scandinavica, 2010, 121(2), 119-24. http://dx.doi.org/ 10.1111/j.1600-0447.2009.01428.x [70] Hajek, T., Bauer, M., Simhandl, C., Rybakowski, J., O'Donovan, C., Pfennig, A., Konig, B., Suwalska, A., Yucel, K., Uher, R., Young, L.T., MacQueen, G., and Alda, M. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Med., 2014, 44(3), 507-17. http://dx.doi.org/10.1017/S0033291713001165 [71] Doty, T.J., Payne, M.E., Steffens, D.C., Beyer, J.L., Krishnan, K.R., and LaBar, K.S., Age-dependent reduction of amygdala volume in bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"163(1): p. 84-94. http://dx.doi.org/10.1016/j.pscychresns.2007.08.003 [72] Kempton, M.J., Haldane, M., Jogia, J., Grasby, P.M., Collier, D., and Frangou, S. Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neurosci., 2009, 29(35), 10863-8. http://dx.doi.org/ 10.1523/JNEUROSCI.2204-09.2009 [73] Chepenik, L.G., Fredericks, C., Papademetris, X., Spencer, L., Lacadie, C., Wang, F., Pittman, B., Duncan, J.S., Staib, L.H., Duman, R.S., Gelernter, J., and Blumberg, H.P.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuro- psychopharmacology, 2009, 34(4), 944-51. http://dx.doi.org/10.1038/ npp.2008.107 [74] Rimol, L.M., Hartberg, C.B., Nesvag, R., Fennema-Notestine, C., Hagler, D.J., Jr., Pung, C.J., Jennings, R.G., Haukvik, U.K., Lange, E., Nakstad, P.H., Melle, I., Andreassen, O.A., Dale, A.M., and Agartz, I. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2010, 68(1), 41-50. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2006, 19(3), 313-23. http://dx.doi.org/10.1097/ 01.yco.0000218604.63463.cd [76] Becker, S. and Wojtowicz, J.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Sci., 2007, 11(2), 70-6. http://dx.doi.org/10.1016/j.tics.2006.10.013 [77] Bauer, M., Alda, M., Priller, J., Young, L.T.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"http://dx.doi.org/10.1055/s-2003-45138 [78] Adler, C.M., DelBello, M.P., and Strakowski, S.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2005, 10(1), 105-16. http://dx.doi.org/ 10.1038/sj.mp.4001585 [81] Sassi, R.B., Brambilla, P., Hatch, J.P., Nicoletti, M.A., Mallinger, A.G., Frank, E., Kupfer, D.J., Keshavan, M.S., and Soares, J.C.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2004, 56(7), 467-75. http://dx.doi.org/ 10.1016/j.biopsych.2004.07.005 [82] Bearden, C.E., Thompson, P.M., Dalwani, M., Hayashi, K.M., Lee, A.D., Nicoletti, M., Trakhtenbroit, M., Glahn, D.C., Brambilla, P., Sassi, R.B., Mallinger, A.G., Frank, E., Kupfer, D.J., and Soares, J.C.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Affect Disord., 2013, 150(2), 629-33. http://dx.doi.org/10.1016/j.jad.2013.04.020 [87] Javadapour, A., Malhi, G.S., Ivanovski, B., Chen, X., Wen, W., and Sachdev, P. Increased anterior cingulate cortex volume in bipolar I disorder.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"New Zealand J. Psychiatry, 2007, 41(11), 910-6. http://dx.doi.org/10.1080/00048670701634978 [88] Fornito, A., Yucel, M., Wood, S.J., Bechdolf, A., Carter, S., Adamson, C., Velakoulis, D., Saling, M.M., McGorry, P.D., and Pantelis, C. Anterior cingulate cortex abnormalities associated with a first psychotic episode in bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry, 2009, 194(5), 426-33. http://dx.doi.org/10.1192/bjp.bp.107.049205 [89] Kalmar, J.H., Wang, F., Spencer, L., Edmiston, E., Lacadie, C.M., Martin, A., Constable, R.T., Duncan, J.S., Staib, L.H., Papademetris, X., and Blumberg, H.P.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Soc., 2009, 15(3), 476-81. http://dx.doi.org/10.1017/S1355617709090584 [90] Takahashi, T., Malhi, G.S., Wood, S.J., Yucel, M., Walterfang, M., Kawasaki, Y., Suzuki, M., and Pantelis, C. Gray matter reduction of the superior temporal gyrus in patients with established bipolar I disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Affect Disord., 2010, 123(1-3), 276-82. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord, 2013, 15(4):  p. 365-76. http://dx.doi.org/10.1111/bdi.12073 [92] Radenbach, K., Flaig, V., Schneider-Axmann, T., Usher, J., Reith, W., Falkai, P., Gruber, O., and Scherk, H. Thalamic volumes in patients with bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neurosci., 2010, 260(8), 601-7. http://dx.doi.org/10.1007/s00406-010-0100-7 [93] Chang, K., Karchemskiy, A., Barnea-Goraly, N., Garrett, A., Simeonova, D.I., and Reiss, A. R e d u c e d  a m y g d a l a r  g r a y  m a t t e r  volume in familial pediatric bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2005, 44(6), 565-73. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Res., 2010, 44(15), 1106-10. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2011, 13(4), 396-405. http://dx.doi.org/ 10.1111/j.1399-5618.2011.00927.x [96] DelBello, M.P., Zimmerman, M.E., Mills, N.P., Getz, G.E., and Strakowski, S.M.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Three-dimensional mapping of hippocampal and amygdalar structure in euthymic adults with bipolar disorder not t r e a t e d  w i t h  l i t h i u m. Psychiatry Res., 2013, 211(3), 195-201. http://dx.doi.org/10.1016/j.pscychresns.2012.08.",OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Soc., 2011, 17(6), 1080-93. http://dx.doi.org/10.1017/S1355617711001081 [99] Frazier, J.A., Hodge, S.M., Breeze, J.L., Giuliano, A.J., Terry, J.E., Moore, C.M., Kennedy, D.N., Lopez-Larson, M.P., Caviness, V.S., Seidman, L.J., Zablotsky, B., and Makris, N. Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bull., 2008, 34(1), 37-46. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatry, 2009, 33(6), 1050-7. http://dx.doi.org/10.1016/j.pnpbp.2009.05.019 [101] Macritchie, K.A., Lloyd, A.J., Bastin, M.E., Vasudev, K., Gallagher, P., Eyre, R., Marshall, I., Wardlaw, J.M., Ferrier, I.N., Moore, P.B., and Young, A.H. White matter m i c r o s t r u c t u r a l  abnormalities in euthymic bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"J. Psychiatry, 2010, 196(1), 52-8. http://dx.doi.org/10.1192/bjp.bp.108.058586 [102] Sussmann, J.E., Lymer, G.K., McKirdy, J., Moorhead, T.W., Munoz Maniega, S., Job, D., Hall, J., Bastin, M.E., Johnstone, E.C., Lawrie, S.M., and McIntosh, A.M. White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2009, 11(1), 11-8. http://dx.doi.org/10.1111/j.1399-5618.2008.00646.x [103] Benedetti, F., Absinta, M., Rocca, M.A., Radaelli, D., Poletti, S., Bernasconi, A., Dallaspezia, S., Pagani, E., Falini, A., Copetti, M., Colombo, C., Comi, G., Smeraldi, E., and Filippi, M. Tract-specific white matter structural disruption in patients with bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Bipolar Disord., 2011, 13(4), 414-24. http://dx.doi.org/10.1111/ j.1399-5618.2011.00938.x [104] Benedetti, F., Bollettini, I., Barberi, I., Radaelli, D., Poletti, S., Locatelli, C., Pirovano, A., Lorenzi, C., Falini, A., Colombo, C., and Smeraldi, E. Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Neuropsychopharmacology, 2013, 38(2), 313-27. http://dx.doi.org/ 10.1038/npp.2012.172 [105] Gildengers, A.G., Butters, M.A., Aizenstein, H.J., Marron, M.M., Emanuel, J., Anderson, S.J., Weissfeld, L.A., Becker, J.T., Lopez, O.L., Mulsant, B.H., and Reynolds, C.F., 3rd.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"North America, 2012, 21(4), 753-71. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/58/CN-13-445.PMC4790406.pdf
"Psychiatric Sci., 2012, 21 ( 3 ) ,  237-40. http://dx.doi.org/10.1017/S204579601200025X [2] Li, C. T.; Bai, Y. M.; Huang, Y. L.; Chen, Y. S.; Chen, T. J.; Cheng, J. Y.; Su, T. P. A s s o c i a t i o n  b e t w e e n  a n t i d e p r e s s a n t  resistance in unipolar depression and subsequent bipolar disorder: cohort study.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Mental Sci., 2012, 200 (1), 45-51. http://dx.doi.org/10.1192/bjp.bp.110.086983 [3] Brambilla, P.; Perez, J.; Barale, F.; Schettini, G.; Soares, J. C. GABAergic dysfunction in mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Pharmacopsychiatry, 2005, 38 ( 2 ) ,  6 9-77. http://dx.doi.org/ 10.1055/s-2005-837806 [5] Mann, J. J.; Malone, K. M.; Diehl, D. J.; Perel, J.; Cooper, T. B.; Mintun, M. A.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2003, 53 (8), 707-42. http://dx.doi.org/10.1016/S0006-3223(03)00117-3 [7] Sala, M.; Coppa, F.; Cappucciati, C.; Brambilla, P.; d'Allio, G.; Caverzasi, E.; Barale, F.; De Ferrari, G. M. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Med., 2009, 39 (5), 845-53. http://dx.doi.org/10.1017/S0033291708004145 [9] Verdoux, H.; Tournier, M.; Begaud, B. Pharmacoepidemiology of psychotropic drugs: examples of current research challenges on major public health issues.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Learning Memory, 2011, 96 (4), 553-63. http://dx.doi.org/10.1016/j.nlm.2011.06.006 [11] Malykhin, N. V.; Carter, R.; Hegadoren, K. M.; Seres, P.; Coupland, N. J. Fronto-limbic volumetric changes in major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2012, 136 ( 3 ) ,  1 1 0 4-13. http://dx.doi.org/10.1016/j.jad.2011.10.038 [12] Zhang, Y.; Yu, C.; Zhou, Y.; Li, K.; Li, C.; Jiang, T. D e c r e a s e d  gyrification in major depressive disorder.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neuroreport, 2009, 20 (4), 378-80. http://dx.doi.org/10.1097/WNR.0b013e3283249b34 [13] Tu, P. C.; Chen, L. F.; Hsieh, J. C.; Bai, Y. M.; Li, C. T.; Su, T. P. Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 2012, 202 ( 3 ) ,  2 0 6-13. http://dx.doi.org/10.1016/j.pscychresns.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2013, 151 (2), 423-431. http://dx.doi.org/10.1016/j.jad.2013.07.002 [15] Campbell, S.; Marriott, M.; Nahmias, C.; MacQueen, G. M. Lower hippocampal volume in patients suffering from depression: a meta-analysis.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 2004, 161 (4), 598-607. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Brain Mapping, 2009, 30 ( 1 1 ) ,  3 7 1 9-35. http://dx.doi.org/10.1002/hbm.20801 [17] Videbech, P.; Ravnkilde, B. Hippocampal volume and depression: a meta-analysis of MRI studies.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 2004, 161 (11), 1957-66. http://dx.doi.org/10.1176/appi.ajp.161.11.1957 [18] McKinnon, M. C.; Yucel, K.; Nazarov, A.; MacQueen, G. M. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2008, 13 ( 1 1 ) ,  9 9 3-1000. http://dx.doi.org/10.1038/mp.2008.57 [21] Videbech, P. MRI findings in patients with affective disorder: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Acta Psychiatrica Scandinavica, 1997, 96 (3), 157-68. http://dx.doi.org/10.1111/j.1600-0447.1997.tb10146.x [22] Agarwal, N.; Port, J. D.; Bazzocchi, M.; Renshaw, P. F. Update on the use of MR for assessment and diagnosis of psychiatric diseases.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Radiology, 2010, 255 ( 1 ) ,  2 3-41. http://dx.doi.org/10.1148/ radiol.09090339 [23] Andreone, N.; Tansella, M.; Cerini, R.; Rambaldelli, G.; Versace, A.; Marrella, G.; Perlini, C.; Dusi, N.; Pelizza, L.; Balestrieri, M.; Barbui, C.; Nose, M.; Gasparini, A.; Brambilla, P. Cerebral atrophy and white matter disruption in chronic schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neurosci., 2007, 257 (1), 3-11. http://dx.doi.org/ 10.1007/s00406-006-0675-1 [24] Chen, C .",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2012, 73 (5), 625-31. http://dx.doi.org/10.4088/JCP.11m06865 [26] Gaynes, B. N.; Warden, D.; Trivedi, M. H.; Wisniewski, S. R.; Fava, M.; Rush, A. J.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatric Services, 2009, 60 (11), 1 4 3 9-45. http://dx.doi.org/ 10.1176/ps.2009.60.11.1439 [27] Bellani, M.; Dusi, N.; Brambilla, P. Can brain imaging address psychosocial functioning and outcome in schizophrenia?",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"281-290. http://dx.doi.org/10.1002/9781118337981.ch18 [28] Buchsbaum, M. S.; Haznedar, M.; Newmark, R. E., et al.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Res., 2009, 114 (1-3), 161-71. http://dx.doi.org/10.1016/j.schres.2009.07.015 [29] Horga, G.; Bernacer, J.; Dusi, N.; Entis, J.; Chu, K.; Hazlett, E. A.; Haznedar, M. M.; Kemether, E.; Byne, W.; Buchsbaum, M. S. Correlations between ventricular enlargement and gray and white matter volumes of cortex, t halamus, striatum, a nd  internal c apsule  in schizophrenia.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neurosci., 2011, 261 (7), 467-76. http://dx.doi.org/10.1007/s00406-011-0202-x [30] Bellani, M.; Dusi, N.; Brambilla, P. Longitudinal imaging studies in schizophrenia: the relationship between brain morphology and outcome measures.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2011, 35 ( 7 ) ,  1 5 4 4-52. http://dx.doi.org/10.1016/j.pnpbp.2010.11.040 [32] Lavretsky, H.; Roybal, D. J.; Ballmaier, M.; Toga, A. W.; Kumar, A. Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2005, 66 ( 8 ) ,  9 6 4-7. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 1993, 50 ( 1 ) ,  7-16. http://dx.doi.org/10.1001/archpsyc.1993.01820130009002 [34] Dupont, R. M.; Jernigan, T. L.; Heindel, W., et al.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"General Psychiatry, 1995, 52 ( 9 ) ,  7 4 7-55. http://dx.doi.org/10.1001/ archpsyc.1995.03950210041009 [35] Axelson, D. A.; Doraiswamy, P. M.; McDonald, W. M.; Boyko, O.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 1993, 47 ( 2 ) ,  1 6 3-73. http://dx.doi.org/10.1016/0165-1781(93)90046-J [36] Husain, M. M.; McDonald, W. M.; Doraiswamy, P. M.; Figiel, G. S.; Na, C.; Escalona, P. R.; Boyko, O.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 1991, 40 ( 2 ) ,  9 5-9. http://dx.doi.org/10.1016/0925-4927(91)90001-7 [37] Krishnan, K. R.; McDonald, W. M.; Escalona, P. R.; Doraiswamy, P. M.; Na, C.; Husain, M. M.; Figiel, G. S.; Boyko, O.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"General Psychiatry, 1992, 49 (7), 553-7. http://dx.doi.org/10.1001/ archpsyc.1992.01820070047007 [38] Arnone, D.; McIntosh, A. M.; Ebmeier, K. P.; Munafo, M. R.; Anderson, I. M. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 1992, 45 ( 3 ) ,  1 6 9-75. http://dx.doi.org/10.1016/0925-4927(92)90024-X [40] Sassi, R. B.; Brambilla, P.; Nicoletti, M.; Mallinger, A. G.; Frank, E.; Kupfer, D. J.; Keshavan, M. S.; Soares, J.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Sci., 2002, 203–204, 227-233. http://dx.doi.org/10.1016/ S0022-510X(02)00296-4 [42] Grieve, S. M.; Korgaonkar, M. S.; Koslow, S. H.; Gordon, E.; Williams, L. M. Widespread reductions in gray matter volume in depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"NeuroImage Clin., 2013, 3, 332-339. http://dx.doi.org/ 10.1016/j.nicl.2013.08.016 [43] Salvadore, G.; Nugent, A. C.; Lemaitre, H.; Luckenbaugh, D. A.; Tinsley, R.; Cannon, D. M.; Neumeister, A.; Zarate Jr, C. A.; Drevets, W. C. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"NeuroImage, 2011, 54 ( 4 ) ,  2 6 4 3-2651. http://dx.doi.org/ 10.1016/j.neuroimage.2010.11.011 [44] Lai, T.; Payne, M. E.; Byrum, C. E.; Steffens, D. C.; Krishnan, K. R. Reduction of orbital frontal cortex volume in geriatric depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2000, 48 (10), 971-5. http://dx.doi.org/10.1016/S0006-3223(00)01042-8 [45] Drevets, W. C.; Frank, E.; Price, J. C.; Kupfer, D. J.; Holt, D.; Greer, P. J.; Huang, Y.; Gautier, C.; Mathis, C. PET imaging of serotonin 1A receptor binding in depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 1999, 46 ( 1 0 ) ,  1 3 7 5-87. http://dx.doi.org/10.1016/S0006-3223(99) 00189-4 [46] Hirayasu, Y.; Shenton, M. E.; Salisbury, D. F.; Kwon, J. S.; Wible, C. G.; Fischer, I.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"http://dx.doi.org/10.1371/journal.pone.0079055 [49] Frodl, T. S.; Koutsouleris, N.; Bottlender, R.; Born, C.; Jager, M.; Scupin, I.; Reiser, M.; Moller, H. J.; Meisenzahl, E. M. Depression-related variation in brain morphology over 3 years: effects of stress?",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"General Psychiatry, 2008, 65 ( 1 0 ) ,  1 1 5 6-65. http://dx.doi.org/10.1001/archpsyc.65.10.1156 [50] Shah, P. J.; Ebmeier, K. P.; Glabus, M. F.; Goodwin, G. M. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 1998, 172, 527-32. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J.  Psychiatry, 2000, 157 (1), 115-8. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 1997, 42 (1), 69-83. http://dx.doi.org/10.1016/S0165-0327(96)00105-X [53] Caetano, S. C.; Hatch, J. P.; Brambilla, P.; Sassi, R. B.; Nicoletti, M.; Mallinger, A. G.; Frank, E.; Kupfer, D. J.; Keshavan, M. S.; Soares, J. C. Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neuroimaging, 2004, 132 ( 2 ) ,  1 4 1-147. http://dx.doi.org/ 10.1016/j.pscychresns.2004.08.002 [54] van Eijndhoven, P.; van Wingen, G.; Katzenbauer, M.; Groen, W.; Tepest, R.; Fernandez, G.; Buitelaar, J.; Tendolkar, I. P a r a l i m b i c  cortical thickness in first-episode depression: evidence for trait-related differences in mood regulation.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 2013, 170 (12), 1477-86. http://dx.doi.org/10.1176/appi.ajp.2013.12121504 [55] Fallucca, E.; MacMaster, F. P.; Haddad, J.; Easter, P.; Dick, R.; May, G.; Stanley, J.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"General Psychiatry, 2011, 68 ( 5 ) ,  5 2 7-33. http://dx.doi.org/ 10.1001/archgenpsychiatry.2011.36 [56] Krishnan, K. R.; McDonald, W. M.; Tupler, L. A. Neuropathology in affective illness.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J.  Psychiatry, 1993, 150 ( 1 0 ) ,  1 5 6 8-9. http://dx.doi.org/10.1176/ajp.150.10.1568b [57] Parashos, I.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 1996, 153 ( 9 ) ,  1 2 1 2-5. http://dx.doi.org/10.1176/ajp.153.9.1212 [59] Iidaka, T.; Nakajima, T.; Kawamoto, K.; Fukuda, H.; Suzuki, Y.; Maehara, T.; Shiraishi, H. Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neurol.,  1996, 36 (5), 293-9. http://dx.doi.org/10.1159/000117275 [60] Papakostas, G. I.; Iosifescu, D. V.; Renshaw, P. F.; Lyoo, I. K.; Lee, H. K.; Alpert, J. E.; Nierenberg, A.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 2005, 140 (3), 301-307. http://dx.doi.org/10.1016/ j.pscychresns.2005.09.001 [61] Sneed, J. R.; Culang-Reinlieb, M. E.; Brickman, A. M.; Gunning-Dixon, F. M.; Johnert, L.; Garcon, E.; Roose, S. P. MRI signal hyperintensities and failure to remit following antidepressant treatment.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2011, 135 ( 1–3), 315-320. http://dx.doi.org/10.1016/j.jad.2011.06.052 [62] Sheline, Y. I.; Pieper, C. F.; Barch, D. M.; Welsh-Bohmer, K.; McKinstry, R. C.; MacFall, J. R.; D'Angelo, G.; Garcia, K. S.; Gersing, K.; Wilkins, C.; Taylor, W.; Steffens, D. C.; Krishnan, R. R.; Doraiswamy, P. M. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"General Psychiatry, 2010, 67 (3), 277-85. http://dx.doi.org/10.1001/archgenpsychiatry.2009.204 [63] Gunning-Dixon, F. M.; Walton, M.; Cheng, J.; Acuna, J.; Klimstra, S.; Zimmerman, M. E.; Brickman, A. M.; Hoptman, M. J.; Young, R. C.; Alexopoulos, G. S. MRI signal hyperintensities and treatment remission of geriatric d e p r e s s i o n .",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2010, 126 (3), 395-401. http://dx.doi.org/10.1016/j.jad.2010.04.004 [64] Krishnan, K. R.; McDonald, W. M.; Doraiswamy, P. M.; Tupler, L. A.; Husain, M.; Boyko, O.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neurosci., 1993, 243 (1), 41-6. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 2001, 108 (3), 161-8. http://dx.doi.org/10.1016/S0925-4927(01)00123-8 [66] Colla, M.; Kronenberg, G.; Deuschle, M.; Meichel, K.; Hagen, T.; Bohrer, M.; Heuser, I. Hi p p o c a m p a l  v o l u m e  r e d u c t i o n  a n d  H P A-system activity in major depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatric Res., 2007, 41 (7), 553-60. http://dx.doi.org/10.1016/j.jpsychires.2006.06.011 [67] Kronmuller, K. T.; Pantel, J.; Gotz, B.; Kohler, S.; Victor, D.; Mundt, C.; Magnotta, V. A.; Giesel, F.; Essig, M.; Schroder, J.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord.,  2008, 110 (3), 241-7. http://dx.doi.org/10.1016/ j.jad.2008.01.022",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"http://dx.doi.org/ 10.1042/AN20090026 [70] Frodl, T.; Meisenzahl, E. M.; Zetzsche, T.; Hohne, T.; Banac, S.; Schorr, C.; Jager, M.; Leinsinger, G.; Bottlender, R.; Reiser, M.; Moller, H. J. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neuroreport, 1998, 9 (9), 2023-8. http://dx.doi.org/10.1097/00001756-199806220-00021 [72] Sheline, Y. I.; Sanghavi, M.; Mintun, M. A.; Gado, M. H .",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2007, 98 (1-2), 137-42. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 2008, 165 ( 7 ) ,  8 7 2-80. http://dx.doi.org/10.1176/ appi.ajp.2008.07081257 [75] Lorenzetti, V.; Allen, N. B.; Fornito, A.; Yücel, M. Structural brain abnormalities in major depressive disorder: A selective review of recent MRI studies.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2009, 117 ( 1–2), 1-17. http://dx.doi.org/10.1016/j.jad.2008.11.021 [76] Tang, Y.; Wang, F.; Xie, G.; Liu, J.; Li, L.; Su, L.; Liu, Y.; Hu, X.; He, Z.; Blumberg, H. P.  Reduced ventral anterior cingulate and amygdala v o l u m e s  i n  m e d i c a t i o n-naïve females with major depressive disorder: A voxel-based morphometric magnetic resonance imaging study.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 2007, 156 ( 1 ) ,  8 3-86. http://dx.doi.org/10.1016/j.pscychresns.2007.03.005 [77] Kronenberg, G.; Tebartz van Elst, L.; Regen, F.; Deuschle, M.; Heuser, I.; Colla, M. Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatric Res., 2009, 43 ( 1 3 ) ,  1 1 1 2-1117. http://dx.doi.org/ 10.1016/j.jpsychires.2009.03.007 [78] Hastings, R. S.; Parsey, R. V.; Oquendo, M. A.; Arango, V.; Mann, J. J. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Med., 2000, 30 (1), 117-25. http://dx.doi.org/10.1017/S0033291799001567 [80] Munn, M. A.; Alexopoulos, J.; Nishino, T.; Babb, C. M.; Flake, L. A.; Singer, T.; Ratnanather, J. T.; Huang, H.; Todd, R. D.; Miller, M. I.; Botteron, K. N. Amygdala volume analysis in female twins with major depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Bipolar Disord., 2008, 10 ( 1 ) ,  1 0 1-4. http://dx.doi.org/10.1111/j.1399-5618.2008.00476.x [82] Monkul, E. S.; Hatch, J. P.; Nicoletti, M. A.; Spence, S.; Brambilla, P.; Lacerda, A. L.; Sassi, R. B.; Mallinger, A. G.; Keshavan, M. S.; Soares, J. C. Frontolimbic brain structures in suicidal and non-suicidal female patients with major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2007, 12 ( 4 ) ,  3 6 0-6. http://dx.doi.org/10.1038/ sj.mp.4001919 [83] van Eijndhoven, P.; van Wingen, G.; van Oijen, K.; Rijpkema, M.; Goraj, B.; Jan Verkes, R.; Oude Voshaar, R.; Fernández, G.; Buitelaar, J.; Tendolkar, I. Amygdala Volume Marks the Acute State in the Early Course of Depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord.,  2010, 120 (1–3), 112-119. http://dx.doi.org/10.1016/j.jad.2009.04.021 [85] Tebartz van Elst, L.; Woermann, F.; Lemieux, L.; Trimble, M. R. Increased amygdala volumes in female and depressed humans.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Lett., 2000, 281 ( 2-3), 103-6. http://dx.doi.org/10.1016/S0304-3940(00) 00815-6 [86] Frodl, T.; Meisenzahl, E. M.; Zetzsche, T.; Born, C.; Jager, M.; Groll, C.; Bottlender, R.; Leinsinger, G.; Moller, H. J.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2003, 53 (4), 338-44. http://dx.doi.org/10.1016/S0006-3223(02)01474-9 [87] Weniger, G.; Lange, C.; Irle, E. Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord.,  2006, 94 ( 1-3), 219-29. http://dx.doi.org/ 10.1016/j.jad.2006.04.017 [88] Lange, C.; Irle, E. Enlarged amygdala volume and reduced hippocampal volume in young women with major depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychol., Med., 2004, 34 ( 6 ) ,  1 0 5 9-64. http://dx.doi.org/10.1017/ S0033291703001806 [89] Bellani, M.; Baiano, M.; Brambilla, P. Brain anatomy of major depression II.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatric Sci., 2011, 20 (1), 33-6. http://dx.doi.org/10.1017/S2045796011000096 [90] Arnone, D.; McIntosh, A. M.; Tan, G. M.; Ebmeier, K. P. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Res., 2008, 101 (1-3), 124-32. http://dx.doi.org/10.1016/j.schres.2008.01.005 [91] Machino, A.; Kunisato, Y.; Matsumoto, T.; Yoshimura, S.; Ueda, K.; Yamawaki, Y.; Okada, G.; Okamoto, Y.; Yamawaki, S.  Possible involvement of rumination in gray matter abnormalities in persistent symptoms of major depression: An exploratory magnetic resonance imaging voxel-based morphometry study.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2014, 168C, 229-235. http://dx.doi.org/10.1016/ j.jad.2014.06.030 [92] Shah, S. A.; Doraiswamy, P. M.; Husain, M. M.; Escalona, P. R.; Na, C.; Figiel, G. S.; Patterson, L. J.; Ellinwood, E. H., Jr.; McDonald, W. M.; Boyko, O.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Acta Psychiatrica Scandinavica, 1992, 85 (6), 474-9. http://dx.doi.org/10.1111/j.1600-0447.1992.tb03214.x [93] Schlegel, S.; Kretzschmar, K. Computed tomography in affective disorders.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry 1987, 22 ( 1 ) ,  4-14. http://dx.doi.org/10.1016/0006-3223(87)90124-7 [94] Beats, B.; Levy, R.; Forstl, H. Ventricular enlargement and caudate hyperdensity in elderly depressives.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 1991, 30 (5), 452-8. http://dx.doi.org/10.1016/0006-3223(91)90306-7 [95] Rabins, P. V.; Pearlson, G. D.; Aylward, E.; Kumar, A. J.; Dowell, K. Cortical magnetic resonance imaging changes in elderly inpatients with major depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J.  Psychiatry, 1991, 148 (5), 617-20. http://dx.doi.org/10.1176/ajp.148.5.617 [96] Baumann, B.; Bornschlegl, C.; Krell, D.; Bogerts, B.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 1997, 45 (3), 179-88. http://dx.doi.org/10.1016/S0165-0327(97)00073-6 [97] Scott, M. L.; Golden, C. J.; Ruedrich, S. L.; Bishop, R. J. Ventricular enlargement in major depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 1983, 8 (2), 91-3. http://dx.doi.org/10.1016/0165-1781(83)90095-1 [98] Shima, S.; Shikano, T.; Kitamura, T.; Masuda, Y.; Tsukumo, T.; Kanba, S.; Asai, M.  Depression and ventricular enlargement.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Acta Psychiatrica Scandinavica, 1984, 70 ( 3 ) ,  2 7 5-7. http://dx.doi.org/ 10.1111/j.1600-0447.1984.tb01208.x [99] Dolan, R. J.; Calloway, S. P.; Mann, A. H. Cerebral ventricular size in depressed subjects.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Med., 1985, 15 ( 4 ) ,  8 7 3-8. http://dx.doi.org/10.1017/S0033291700005110 [100] Andreasen, N. C.; Swayze, V., 2nd; Flaum, M.; Alliger, R.; Cohen, G. Ventricular abnormalities in affective disorder: clinical and",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 1990, 147 (7), 893-900. http://dx.doi.org/10.1176/ajp.147.7.893 [101] Wurthmann, C.; Bogerts, B.; Falkai, P. Brain morphology assessed by computed tomography in patients with geriatric depression, patients with degenerative dementia, and normal control subjects.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 1995, 61 ( 2 ) ,  1 0 3-11. http://dx.doi.org/10.1016/ 0925-4927(95)02592-L [102] Weinberger, D. R.; DeLisi, L. E.; Perman, G. P.; Targum, S.; Wyatt, R. J. Computed tomography in schizophreniform disorder and other acute psychiatric disorders.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"General Psychiatry, 1982, 39 ( 7 ) ,  7 7 8-83. http://dx.doi.org/10.1001/archpsyc.1982.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Med., 1990, 20 (3), 507-20. http://dx.doi.org/10.1017/S0033291700017025 [105] Lesser, I. M.; Miller, B. L.; Boone, K. B.; Hill-Gutierrez, E.; Mehringer, C. M.; Wong, K.; Mena, I.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord.,  1991, 21 (1), 67-74. http://dx.doi.org/10.1016/0165-0327(91)90020-S [107] Wu, J. C.; Buchsbaum, M. S.; Johnson, J. C.; Hershey, T. G.; Wagner, E. A.; Teng, C.; Lottenberg, S. Magnetic resonance and positron emission tomography imaging of the corpus callosum: size, shape and metabolic rate in unipolar depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 1993, 28 ( 1), 15-25. http://dx.doi.org/10.1016/0165-0327(93)90073-S [108] Lacerda, A. L.; Nicoletti, M. A.; Brambilla, P.; Sassi, R. B.; Mallinger, A. G.; Frank, E.; Kupfer, D. J.; Keshavan, M. S.; Soares, J. C. Anatomical MRI study of basal ganglia in major depressive disorder.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 2003, 124 ( 3 ) ,  1 2 9-40. http://dx.doi.org/10.1016/S0925-4927(03)00123-9 [109] Krishnan, K. R.; Doraiswamy, P. M.; Lurie, S. N.; Figiel, G. S.; Husain, M. M.; Boyko, O.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Metabol., 1991, 72 (2), 256-9. http://dx.doi.org/10.1210/jcem-72-2-256 [110] Sassi, R. B.; Nicoletti, M.; Brambilla, P.; Harenski, K.; Mallinger, A. G.; Frank, E.; Kupfer, D. J.; Keshavan, M. S.; Soares, J. C. Decreased pituitary volume in patients with bipolar disorder.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2001, 50 (4), 271-80. http://dx.doi.org/10.1016/S0006-3223(01)01086-1 [111] Schwartz, P. J.; Loe, J.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Neurosci., 2006, 7 (2), 137-51. http://dx.doi.org/10.1038/nrn1846 [114] Vakili, K.; Pillay, S. S.; Lafer, B.; Fava, M.; Renshaw, P. F.; Bonello-Cintron, C. M.; Yurgelun-Todd, D. A. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2000, 47 ( 1 2 ) ,  1 0 8 7-1090. http://dx.doi.org/10.1016/S0006-3223(99)00296-6 [115] Saylam, C.; Ucerler, H.; Kitis, O.; Ozand, E.; Gonul, A. S. Reduced hippocampal volume in drug-free depressed patients.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J.  Psychiatry, 2005, 186, 197-202. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 2004, 184, 488-95. http://dx.doi.org/10.1192/bjp.184.6.488 [118] Taylor, J. L.; Blanton, R. E.; Levitt, J. G.; Caplan, R.; Nobel, D.; Toga, A.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Res., 2005, 73 ( 2-3), 235-41. http://dx.doi.org/10.1016/j.schres.2004.07.023 [119] Hsieh, M. H.; McQuoid, D. R.; Levy, R. M.; Payne, M. E.; MacFall, J. R.; Steffens, D. C. Hippocampal volume and antidepressant response in geriatric depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Geriatric Psychiatry, 2002, 17 (6), 519-25. http://dx.doi.org/10.1002/gps.611 [120] Neumeister, A.; Wood, S.; Bonne, O.; Nugent, A. C.; Luckenbaugh, D. A.; Young, T.; Bain, E. E.; Charney, D. S.; Drevets, W. C. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2005, 57 ( 8 ) ,  9 3 5-7. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2003, 54 ( 3 ) ,  3 3 8-52. http://dx.doi.org/ 10.1016/S0006-3223(03)00347-0 [122] Vythilingam, M.; Heim, C.; Newport, J.; Miller, A. H.; Anderson, E.; Bronen, R.; Brummer, M.; Staib, L.; Vermetten, E.; Charney, D. S.; Nemeroff, C. B.; Bremner, J. D. Childhood trauma associated with smaller hippocampal volume in women with major depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"BMC Med., 2004, 2, 2. http://dx.doi.org/10.1186/ 1741-7015-2-2 [125] MacQueen, G. M.; Campbell, S.; McEwen, B. S.; Macdonald, K.; Amano, S.; Joffe, R. T.; Nahmias, C.; Young, L. T. Course of illness, hippocampal function, and hippocampal volume in major depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Child Adolescent Psychopharmacol., 2003, 13 (1), 65-73. http://dx.doi.org/10.1089/104454603321666207 [128] Pillay, S. S.; Yurgelun-Todd, D. A.; Bonello, C. M.; Lafer, B.; Fava, M.; Renshaw, P. F. A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: Relationship to treatment response and clinical severity.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 1997, 42 ( 2 ) ,  79-84. http://dx.doi.org/10.1016/S0006-3223(96)00335-6 [129] Pillay, S. S.; Renshaw, P. F.; Bonello, C. M.; Lafer, B. C.; Fava, M.; Yurgelun-Todd, D. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 1998, 84 (2-3), 61-74. http://dx.doi.org/10.1016/S0925-4927(98)00048-1 [130] Hankin, B. L.; Abramson, L. Y.; Moffitt, T. E.; Silva, P. A.; McGee, R.; Angell, K. E. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Abnormal Psychol., 1998, 107 (1), 128-40. http://dx.doi.org/10.1037/0021-843X.107.1.128 [131] Sheline, Y. I.; Disabato, B. M.; Hranilovich, J.; Morris, C.; D'Angelo, G.; Pieper, C.; Toffanin, T.; Taylor, W. D.; MacFall, J. R.; Wilkins, C.; Barch, D. M.; Welsh-Bohmer, K. A.; Steffens, D. C.; Krishnan, R. R.; Doraiswamy, P. M. Treatment course with antidepressant therapy in late-life depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 2012, 169 ( 1 1 ) ,  1 1 8 5-93. http://dx.doi.org/10.1176/appi.ajp.2012.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 2009, 173 (1), 71-76. http://dx.doi.org/10.1016/j.pscychresns.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Disord., 2013, 146 (3), 414-419. http://dx.doi.org/10.1016/j.jad.2012.07.029 [136] Gunning, F. M.; Cheng, J.; Murphy, C. F.; Kanellopoulos, D.; Acuna, J.; Hoptman, M. J.; Klimstra, S.; Morimoto, S.; Weinberg, J.; Alexopoulos, G. S. Anterior cingulate cortical volumes and treatment remission of geriatric depression.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Geriatric Psychiatry, 2009, 24 (8), 829-36. http://dx.doi.org/10.1002/gps.2290 [137] Lai, C. H. Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"http://dx.doi.org/10.1176/jnp.23.2.jnpe40 [138] Pizzagalli, D. A.; Oakes, T. R.; Fox, A. S.; Chung, M. K.; Larson, C. L.; Abercrombie, H. C.; Schaefer, S. M.; Benca, R. M.; Davidson, R. J. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2004, 9 (4), 325, 393-405. http://dx.doi.org/10.1038/sj.mp.4001501 [139] Alexopoulos, G. S.; Murphy, C. F.; Gunning-Dixon, F. M.; Latoussakis, V.; Kanellopoulos, D.; Klimstra, S.; Lim, K. O.; Hoptman, M. J. Microstructural white matter abnormalities and remission of geriatric depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J. Psychiatry, 2008, 165 (2), 238-44. http://dx.doi.org/10.1176/appi.ajp.2007.07050744 [140] Fossati, P.; Radtchenko, A.; Boyer, P. Neuroplasticity: from MRI to depressive symptoms.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"NeuroImage, 2014, 84, 236-244. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry, 2001, 50 ( 3 ) ,  1 7 1-8. http://dx.doi.org/10.1016/S0006-3223(01)01117-9 [144] Brody, A. L.; Saxena, S.; Silverman, D. H.; Alborzian, S.; Fairbanks, L. A.; Phelps, M. E.; Huang, S. C.; Wu, H. M.; Maidment, K.; Baxter, L. R., Jr.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 1999, 91 ( 3 ) ,  1 2 7-39. http://dx.doi.org/10.1016/ S0925-4927(99)00034-7 [145] Little, J. T.; Ketter, T. A.; Kimbrell, T. A.; Dunn, R. T.; Benson, B. E.; Willis, M. W.; Luckenbaugh, D. A.; Post, R. M. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"J.  Geriatric Psychiatry, 2007, 22 ( 5 ) ,  4 6 8-74. http://dx.doi.org/ 10.1002/gps.1790 [149] Lai, C. H.; Wu, Y. T. Duloxetine's modest short-term influences in subcortical structures of first episode drug-naive patients with major depressive disorder and panic disorder.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Psychiatry Res., 2011, 194 (2), 157-62. http://dx.doi.org/10.1016/j.pscychresns.2011.03.011 [150] Ostuzzi, G.; Bighelli, I.; Carrara, B. V.; Dusi, N.; Imperadore, G.; Lintas, C.; Nifosi, F.; Nose, M.; Piazza, C.; Purgato, M.; Rizzo, R.; Barbui, C. Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare.",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Mental Health Systems, 2013, 7 (1), 14. http://dx.doi.org/10.1186/1752-4458-7-14   Received: November 04, 2014 Revised: December 16, 2014 Accepted: December 19, 2014",Non-OADS,/arxiv_data1/oa_pdf/04/d8/CN-13-458.PMC4790407.pdf
"Lancet, 1997, 349 ( 9 0 6 4 ) ,  1 4 9 8-1504. http://dx.doi.org/10.1016/ S0140-6736(96)07492-2 [2] Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J., Vos, T., Whiteford, H. A.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
http://dx.doi.org/10.1371/journal.pmed.1001547 [3] Diagnostic and Statistical Manual IV.,Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Psychiat., 2005, 62(6), 617-627. http://dx.doi.org/10.1001/archpsyc.62.6.617 [6] American Psychiatric Association.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Sleep Med., 2 0 0 6, 7(2), 123-130. http://dx.doi.org/10.1016/j.sleep.2005.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Rev., 2002, 6(2), 97-111. http://dx.doi.org/10.1053/smrv.2002.0186 [9] Taylor, D. J., Lichstein, K. L., Durrence, H. H. Insomnia as a health risk factor.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Sleep Med., 2003, 1(4), 227-247. http://dx.doi.org/10.1207/S15402010BSM0104_5 [10] Baxter, A. J., Scott, K. M., Ferrari, A. J. Norman, R.E., Vos, T., Whiteford, H. A.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"http://dx.doi.org/10.1002/da.22230 [11] Kessler, D., Bennewith, O., Lewis, G., Sharp, D. Detection of depression and anxiety in primary care: follow up study.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"J. Psychiatry, 2000, 157(11), 1851-1857. http://dx.doi.org/10.1176/appi.ajp.157.11.1851 [13] Knaudt, P. R., Connor, K. M., Weisler, R. H., Churchill, L. E., Davidson, J. R. Alternative therapy use by psychiatric outpatients.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Dis., 1999, 187(11), 692-695. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Psychiat., 2001, 158(2), 289-294. http://dx.doi.org/ 10.1176/appi.ajp.158.2.289 [15] Pearson, N. J., Johnson, L. L., Nahin, R. L. Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Med., 2006, 166(16), 1775-1782. http://dx.doi.org/10.1001/archinte.166.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Disord., 2008, 111(2), 360-365. http://dx.doi.org/10.1016/j.jad.2008.03.010 [17] Tindle, H. A., Davis, R. B., Phillips, R. S., Eisenberg, D. M. Trends in use of complementary and alternative medicine by US adults: 1997-2002.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"JAMA, 1998, 280(18), 1569-1575. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"J. Chinese Med., 2009, 37(02), 207-213. http://dx.doi.org/10.1142/ S0192415X09006771 [22] Yeung, W. F., Chung, K. F., Ng, K. Y., Yu YM., Ziea ET., Ng BF.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Res., 2014, 57, 165-175. http://dx.doi.org/10.1016/j.jpsychires.2014.05.016 [23] Yeung, W. F., Chung, K. F., Man-Ki Poon, M., Ho FY., Zhang SP., Zhang ZJ., Ziea ET., Wong VT. Chinese herbal medicine for insomnia: A systematic review of randomized controlled trials.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Rev., 2012, 16(6), 497-507. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Disord., 2013, 150(3), 707-719. http://dx.doi.org/10.1016/j.jad.2013.05.042 [25] Belmaker, R. H., Agam, G. Major depressive disorder.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Sci., 1962, 96(1), 279-288. http://dx.doi.org/10.1111/j.1749-6632.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Psychopharmacol., 2001, 16(3), 203-218. http://dx.doi.org/10.1002/hup.288 [28] Lanni, C., Govoni, S., Lucchelli, A., Boselli, C. Depression and antidepressants: molecular and cellular aspects.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Life Sci., 2009, 66(18), 2985-3008. http://dx.doi.org/10.1007/s00018-009-0055-x [29] Lopez-Munoz, F., and Alamo, C. Monoaminergic neuro- transmission: the history of the discovery of antidepressants from 1950s until today.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Design, 2009, 15(14), 1563-1586. http://dx.doi.org/10.2174/138161209788168001 [30] Xu, C., Teng, J., Chen, W., Ge, Q., Yang, Z, Yu, C., Yang, Z., Jia, W. 20 (S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuro-Psychoph., 2012, 34(8), 1402-1411. http://dx.doi.org/10.1016/j.pnpbp.2010.07.010 [31] Zhang, M. Z., Zhang, Q. Y., Cui, G. B.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2009, 124(2), 316-320. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuropsychoph., 1999, 2(04), 327-331. http://dx.doi.org/10.1017/ S1461145799001662 [37] Kim, J. H., Kim, S. Y., Lee, S. Y., Jang, C. G. Antidepressant-like effects of Albizzia julibrissin in mice: Involvement of the 5-HT1A receptor system.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Be, 2007, 87(1), 41-47. http://dx.doi.org/10.1016/j.pbb.2007.03.018 [38] Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch AJ, Gold SJ, Monteggia LM.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuron, 2002, 34(1), 13-25. http://dx.doi.org/10.1016/S0896-6273(02)00653-0 [39] Arborelius, L., Owens, M. J., Plotsky, P. M., Nemeroff, C. B.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Endocrinol., 1999, 160(1), 1-12. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Be, 2011, 98(2), 273-278. http://dx.doi.org/10.1016/j.pbb.2011.01.008 [41] Kim, D. H., Moon, Y. S., Jung, J. S., Min, SK, Son, BK, Suh, HW, Song, DK.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Lett., 2003, 343(1), 62-66. http://dx.doi.org/10.1016/S0304-3940(03) 00300-8 [42] Duman, R. S., Heninger, G. R., Nestler, E. J.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Psychiat., 1997, 54(7), 597-606. http://dx.doi.org/10.1001/archpsyc.1997.01830190015002 [43] Altar, C. A. Neurotrophins and depression.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Sci., 1999, 20(2), 59-62. http://dx.doi.org/10.1016/S0165-6147(99)01309-7 [44] Murakami, S., Imbe, H., Morikawa, Y., Kubo, C., Senba, E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Res., 2005, 53(2), 129-139. http://dx.doi.org/10.1016/j.neures.2005.06.008 [45] Smith, M. A., Makino, S., Kvetnansky, R., Post, R. M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neurosci., 2001, 24, 677. http://dx.doi.org/10.1146/annurev.neuro.24.1.677 [47] Castrén, E., Rantamäki, T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neurobiol., 2010, 70(5), 289-297. http://dx.doi.org/10.1002/dneu.20758 [48] Shirayama, Y., Chen, A. C. H., Nakagawa, S., Russell, D. S., Duman, R. S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"J. ECT, 1998, 14(3), 181-193. http://dx.doi.org/10.1097/00124509-199809000-00004 [50] Yi, L. T., Li, J., Geng, D., Liu, BB., Fu, Y., Tu, J. Q., Liu, Y., Weng LJ.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2013, 147(1), 245-253. http://dx.doi.org/10.1016/j.jep.2013.03.015 [51] Xue, W., Zhou, X., Yi, N., Jiang, L., Tao, W., Wu, R., Wang, D,.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2008, 117(2), 339-344. http://dx.doi.org/10.1016/j.jep.2008.02.004 [53] Wei, X. H., Xu, X. D., Shen, J. S., Wang, Z. T. Antidepressant effect of Yueju ethanol extract and its constituents in mice models of despair.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Sci., 2012, 120(4), 280-287. http://dx.doi.org/10.1254/jphs.12163FP [57] Antonijevic, I.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Psychoneuroendocrinology, 2006, 31(1), 1-15. http://dx.doi.org/10.1016/j.psyneuen.2005.04.004 [58] Raison, C. L., Capuron, L., Miller, A. H. Cytokines sing the blues: inflammation and the pathogenesis of depression.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Trends Immunol., 2006, 27(1), 24-31. http://dx.doi.org/10.1016/j.it.2005.11.006 [59] Ressler, K. J., Nemeroff, C. B.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Phytomedicine, 2009, 16(9), 830-838. http://dx.doi.org/10.1016/j.phymed.2009.03.011 [62] Panossian, A., Hambardzumyan, M., Hovhanissyan, A., Wikman, G. The adaptogens Rhodiola and Schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"http://dx.doi.org/10.1371/journal.pone.0088617 [64] Hosseinzadeh, H., Karimi, G., Niapoor, M. Antidepressant effect of Crocus sativus L. stigma extracts and their constituents, crocin and safranal, in mice.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Brain Res., 1998, 787(1), 132-138. http://dx.doi.org/10.1016/S0006-8993(97)01505-9 [67] Lechtenberg, M., Schepmann, D., Niehues, M., Hellenbrand N., Wünsch B., Hensel A.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Planta Med., 2008, 74(7), 764. http://dx.doi.org/ 10.1055/s-2008-1074535 [68] Nutt, D. J., Ballenger, J. C., Sheehan, D., Wittchen, H. U. Generalized anxiety disorder: comorbidity, comparative biology and treatment.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuropsychoph., 2002, 5(04), 315-325. http://dx.doi.org/10.1017/S1461145702003048 [69] Tyrer, P. and Baldwin, D. Generalised anxiety disorder.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Lancet, 2006, 368(9553), 2156-2166. http://dx.doi.org/10.1016/S0140-6736(06)69865-6 [70] Toriizuka, K., Kamiki, H., Ohmura, N. Y., Fujii, M., Hori, Y., Fukumura, M., Hirai, Y., Isoda, S., Nemoto, Y., Ida, Y. Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan (KSS), a Japanese traditional Kampo medicine.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Life Sci., 2005, 77(24), 3010-3020. http://dx.doi.org/ 10.1016/j.lfs.2004.12.054 [71] Krishnakumar, A., Nandhu, M. S., Paulose, C. S. Up regulation of 5-HT 2C receptors in hippocampus of pilocarpine-induced epileptic rats: Antagonism by Bacopa monnieri.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Epilepsy Behav., 2009, 16(2), 225-230. http://dx.doi.org/10.1016/j.yebeh.2009.07.031 [72] Dirks, A., Groenink, L., Westphal, K. G., Olivier JD, Verdouw PM, van der Gugten J, Geyer MA, Olivier B.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuropsychopharmacology, 2003, 28(10), 1790-1798. http://dx.doi.org/10.1038/sj.npp.1300256 [73] Groenink, L., Pattij, T., De Jongh, R., Van der Gugten, J., Oosting, RS., Dirks, A., Olivier ,B.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Pharmacol., 2003, 463(1), 185-197. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"http://dx.doi.org/10.1016/S0367-326X(00)00180-5 [75] Van Gaalen, M. M., Stenzel‐Poore, M. P., Holsboer, F., Steckler, T. Effects of transgenic overproduction of CRH on anxiety‐like behaviour.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"CR  Biol., 2005, 328(2), 199-212. http://dx.doi.org/10.1016/j.crvi.2005.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"http://dx.doi.org/10.1055/s-2003-45132 [78] Heilig, M. The NPY system in stress, anxiety and depression.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuropeptides, 2004, 38(4), 213-224. http://dx.doi.org/10.1016/ j.npep.2004.05.002 [79] Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Asberg, M., Ekman, R., Wahlestedt, C., Agren, H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with pre pro NPY gene polymorphism.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Res., 2004, 38(2), 113-121. http://dx.doi.org/10.1016/ S0022-3956(03)00101-8 [80] Awad, R., Levac, D., Cybulska, P., Merali, Z., Trudeau, V.L., Arnason, J.T.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Pharm., 2007, 85(9), 933-942. http://dx.doi.org/10.1139/ Y07-083 [81] Pearl, P. L., Gibson, K. M. Clinical aspects of the disorders of GABA metabolism in children.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neurol., 2004, 17(2), 107-113. http://dx.doi.org/10.1097/00019052-200404000-00005 [82] Deng, S., West, B. J., Palu, A. K., Zhou, B. N., Jensen, C. J. Noni as an anxiolytic and sedative: A mechanism involving its gamma-aminobutyric acidergic effects.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Phytomedicine, 2007, 14(7), 517-522. http://dx.doi.org/10.1016/j.phymed.2007.04.005 [83] Murphy, K., Kubin, Z. J., Shepherd, J. N., Ettinger, R. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Phytomedicine, 2010, 17(8), 674-678. http://dx.doi.org/ 10.1016/j.phymed.2009.10.020 [84] Dietz, B. M., Mahady, G. B., Pauli, G. F., Farnsworth, N. R. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Brain Res., 2005, 138(2), 191-197. http://dx.doi.org/10.1016/j.molbrainres.2005.04.009 [85] Peng, Z. C. and Zhu, J. J.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Be, 2009, 92(2), 206-213. http://dx.doi.org/ 10.1016/j.pbb.2008.11.012 [87] Kumar, D., Bhat, Z.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Med., 2013, 11(3), 240-244. http://dx.doi.org/10.1016/s1875-5364(13) 60022-9 [88] Kumar, D., Bhat, Z.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuro-Psychoph., 2013, 40, 180-186. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2010, 132(1), 334-339. http://dx.doi.org/10.1016/j.jep.2010.08.045 [90] Shaw, D., Annett, J. M., Doherty, B., Leslie, J. C. Anxiolytic effects of lavender oil inhalation on open-field behaviour in rats.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Phytomedicine, 2007, 14(9), 613-620. http://dx.doi.org/10.1016/ j.phymed.2007.03.007 [91] Park, J. H., Cha, H. Y., Seo, J. J., Hong JT., Han K., Oh KW.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuro-Psychoph., 2005, 29(6), 895-900. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Rev., 2007, 11(1), 71-79. http://dx.doi.org/10.1016/j.smrv.2006.06.002 [94] Sateia, M.J., Nowell, P.D.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Lancet, 2004, 364, 1959-1973. http://dx.doi.org/10.1016/S0140-6736(04)17480-1 [95] Shou, C. H., Wang, J., Zheng, X. X., Guo, D. W. Inhibitory effect of jujuboside A on penicillin sodium induced hyperactivity in rat hippocampal CA1 area in vitro.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Sin., 2007, 28(3), 334-338. http://dx.doi.org/ 10.1111/j.1745-7254.2007.00497.x [97] Yi, P. L., Lin, C. P., Tsai, C. H., Lin, J. G., Chang, F. C. The involvement of serotonin receptors in suanzaorentang-induced sleep alteration.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2010, 128(2), 419-423. http://dx.doi.org/10.1016/j.jep.2010.01.034 [99] Abourashed, E. A., Koetter, U., Brattström, A.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Phytomedicine, 2004, 11(7), 633-638. http://dx.doi.org/10.1016/ j.phymed.2004.03.005 [100] Bown, D. The Royal Horticultural Society encyclopedia of herbs & their uses.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"J. Gen. Med, 2011, 4, 451. http://dx.doi.org/10.2147/IJGM.S21529 [102] Hosseinzadeh, H., Noraei, N. B. Anxiolytic and hypnotic effect of Crocus sativus a q u e o u s  e x t r a c t  a n d  i t s  c o n s t i t u e n t s ,  c r o c i n  a n d  safranal, in mice.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2010, 128(2), 482-489. http://dx.doi.org/10.1016/j.jep.2010.01.016 [104] Kwon, S., Lee, B., Kim, M., Lee, H., Park, H. J., Hahm, D. H. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Neuro-Psychoph., 2010, 34(2), 265-270. http://dx.doi.org/10.1016/j.pnpbp.2009.11.015 [105] Xiuping, S., Zhe, S., Tengfei, L., et al.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Plants Res., 2012, 6(26), 4308-4316. http://dx.doi.org/10.5897/ jmpr12.338 [106] Li, X. Q., Song, A. H., Li, W., Chen, X. H., Bi, K. S. Analysis of the fatty acid from Bupleurum chinense DC in China by GC-MS and GC-FID.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Bull., 2005, 53(12), 1613-1617. http://dx.doi.org/10.1248/cpb.53.1613 [107] Yen, M. H., Lin, C. C., Chuang, C. H., Liu, S. Y.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Fitoterapia, 2009, 80(1), 35-38. http://dx.doi.org/10.1016/j.fitote.2008.09.007 [109] Zhu, Z., Liang, Z., Han, R., Dong, J. E. Growth and saikosaponin production of the medicinal herb Bupleurum chinense DC.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Prod., 2009, 29(1), 96-101. http://dx.doi.org/10.1016/j.indcrop.2008.04.010 [110] Seo, M. K., Song, J. C., Lee, S. J., et al.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Plants Res., 2012, 6(26), 4308-4316. http://dx.doi.org/10.5897/ jmpr12.338 [115] Li, Z. Y., Guo, Z., Liu, Y. M., Liu X. M., Chang, Q., Liao, Y. H., Pan, R. L. Neuroprotective effects of Total Saikosaponins of Bupleurum yinchowense o n  c o r t i c o s t e r o n e-induced apoptosis in PC12 cells.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Drug Res., 1991, 20, 167-217. http://dx.doi.org/10.1016/B978-0-12-013320-8.50007-1 [117] Handley, S. L., McBlane, J. W., Critchley, M. A. E., Njung'e, K. Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Brain Res., 1993, 58(1), 203-210. http://dx.doi.org/10.1016/0166-4328(93) 90104-X [118] Chatterjee, S. S., Gabard, B.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Life Sci, 1986, 39(24), 2327-2334. http://dx.doi.org/10.1016/0024-3205(86) 90663-6 [120] Shih, J. C., Chen, K., Ridd, M. J., Seif, I. Ginkgo biloba abolishes aggression in mice lacking MAO A. Antioxid.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Redox Sign, 2000, 2(3), 467-471. http://dx.doi.org/10.1089/15230860050192242 [121] White, H. L., Scates, P. W., Cooper, B. R. Extracts of Ginkgo biloba l e a v e s  i n h i b i t  m o n o a m i n e  o x i d a s e .",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Life Sci., 1996, 58(16), 1315-1321. http://dx.doi.org/10.1016/0024-3205(96)00097-5 [122] Taylor, J.E.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Res., 2007, 41(6), 472-480. http://dx.doi.org/10.1016/j.jpsychires.2006.05.004 [124] Xie, Z.W.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2000, 72(3), 435-441. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Bull., 2000, 23(1), 76-79. http://dx.doi.org/10.1248/bpb.23.76 [129] Shiyi, L. Some basic features of the new sleep-aid tea (SAT) for the treatment of insomnia.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2 0 0 8, 117(2), 318-324. http://dx.doi.org/ 10.1016/j.jep.2008.02.006 [131] Wang, L. E., Bai, Y. J., Shi, X. R., Cui XY., Cui SY., Zhang F., Zhang QY., Zhao YY., Zhang YH.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Be, 2008, 90(3), 399-403. http://dx.doi.org/10.1016/j.pbb.2008.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Biomed., 2008, 48(5), 1467-1470. http://dx.doi.org/10.1016/j.jpba.2008.09.022 [134] Cao, J. X., Zhang, Q. Y., Cui, S. Y., Cui, X. Y., Zhang, J., Zhang, Y. H., Bai, Y. J., Zhao, Y. Y. Hypnotic effect of jujubosides from Semen Ziziphi Spinosae.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2010, 130(1), 163-166. http://dx.doi.org/10.1016/j.jep.2010.03.023 [135] Feng, Z. Y., Guo, D. W., Su, S., Zhao, H., Zheng, X. X. Sedative and anticonvulsant effect of jujuboside A. J. Zhejiang Uni.Med.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Res., 1978, 1(1), 7-11. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2011, 137(1), 236-244. http://dx.doi.org/10.1016/j.jep.2011.05.016 [138] Xiong, J .",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Chinese Materia Medica, 2007, 23, 3-5. http://dx.doi.org/10.1016/j.jep.2011.06.024 [139] Gao, X., Zheng, X., Li, Z.,  Zhou, Y., Sun, H., Zhang, L., Guo, X., Du, G., Qin, X. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromato- graphy coupled with mass spectrometry.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Med., 2010, 8(11), 1075-1079. http://dx.doi.org/10.3736/jcim20101112 [144] Pharmacopoeia Committee of China (Eds.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"A, 2007, 1142(2), 115-122. http://dx.doi.org/10.1016/j.chroma.2006.09.098 [146] Wang, X., Wang, Y., Geng, Y., Li, F., Zheng, C .",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"A, 2004, 1036(2), 171-175. http://dx.doi.org/10.1016/ j.chroma.2004.02.073 [147] Li, J.M., Kong, L.D.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Ethnopharmacol., 2000, 73(1), 277-281. http://dx.doi.org/10.1016/S0378-8741(00)00242-7 [150] Guo, Y., Kong, L., Wang, Y., Huang, Z. Antidepressant evaluation of polysaccharides from a Chinese herbal medicine Banxia‐houpu decoction.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Res., 2004, 18(3), 204-207. http://dx.doi.org/ 10.1002/ptr.1394 [151] Maruyama, Y., Kuribara, H., Morita, M., Yuzurihara, M., Weintraub, S. T. Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine.",Non-OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Prod., 1998, 61(1), 135-138. http://dx.doi.org/10.1021/np9702446 [152] Kuribara, H., Kishi, E., Hattori, N., Yuzurihara, M., Maruyama, Y.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Res., 1999, 13(7), 593-596. http://dx.doi.org/10.1002/(SICI)1099-1573(199911)13:7<593::AID-PTR520>3.0.CO;2-F [153] Kuribara, H., Stavinoha, W. B., Maruyama, Y. Behavioural Pharmacological Characteristics of Honokiol, an Anxiolytic Agent Present in Extracts of Magnolia Bark, Evaluated by an Elevated Plus‐maze Test in Mice.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Pharmacol., 1998, 50(7), 819-826. http://dx.doi.org/10.1111/j.2042-7158.1998.tb07146.x [154] Ku, T. H., Lee, Y. J., Wang, S. J., Fan, C. H., Tien, L. T. Effect of honokiol on activity of GAD 65 and GAD 67 in the cortex and hippocampus of mice.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Phytomedicine, 2011, 18(13), 1126-1129. http://dx.doi.org/10.1016/j.phymed.2011.03.007 [155] Owen, A.",OADS,/arxiv_data1/oa_pdf/51/94/CN-13-481.PMC4790408.pdf
"Disord., 2011, 135(1-3), 10-19. http://dx.doi.org/10.1016/j.jad.2011.01.011  [3] He, Y.C.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Rev., 2013, 37(10, Part 1), 2 3 7 2-2374. http://dx.doi.org/10.1016/j.neubiorev.2013.01.008 [5] Tian, J.S.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Neurosci., 2005, 255(6), 381-386. http://dx.doi.org/10.1007/s00406-005-0578-6 [8] Heim, C.; Newport, D.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Psychoneuroendocrinology, 2008, 33(6), 693-710. http://dx.doi.org/10.1016/j.psyneuen.2008.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Ethnopharmacol., 1984, 12(1), 35-74. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Ethnopharmacol., 1980, 2(1), 37-41. http://dx.doi.org/10.1016/0378-8741(80)90028-8 [12] Perry, T.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Neurol., 1975, 32(2), 108-113. http://dx.doi.org/10.1001/archneur.1975.00490440058009 [13] Sullivan, P.F.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"J. Psychiatry, 2000, 157(10), 1552-1562. http://dx.doi.org/10.1176/appi.ajp.157.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Neurobiol., 2005, 25(2), 297-312. http://dx.doi.org/10.1007/s10571-005-3061-z [15] Maes, M.; Yirmyia, R.; Noraberg, J.; Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Brain Dis., 2009, 24(1), 27-53. http://dx.doi.org/10.1007/s11011-008-9118-1 [16] Deakin, J.W.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Psychopharmacol., 1991, 5(4), 305-315. http://dx.doi.org/10.1177/ 026988119100500414 [17] Altar, C.A.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Sci., 1999, 20(2), 59-62. http://dx.doi.org/10.1016/S0165-6147(99)01309-7 [18] Martinowich, K.; Manji, H.; Lu, B.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Neurosci., 2007, 10(9), 1089-1093. http://dx.doi.org/10.1038/nn1971 [19] Karege, F.; Perret, G.; Bondolfi, G.; Schwald M, Bertschy G, Aubry JM.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Psychiatry Res., 2002, 109(2), 143-148. http://dx.doi.org/10.1016/S0165-1781(02)00005-7 [20] Shirayama, Y.; Chen, A.C.H.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Behav., 1997, 56(1), 131-137. http://dx.doi.org/10.1016/S0091-3057(96)00169-4 [22] Monteggia, L.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Trends Neurosci., 2008, 31(9), 464-468. http://dx.doi.org/10.1016/j.tins.2008.06.006 [24] Stokes, P.E.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Women's Mental Health, 2006, 9(4), 187-196. http://dx.doi.org/10.1007/s00737-006-0131-2 [26] Gotlib, I.H.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Brain Dis., 2009, 24(1), 2 7-53. http://dx.doi.org/10.1007/s11011-008-9118-1 [28] Maes, M. Evidence for an immune response in major depression: A review and hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Psychiatry, 1995, 19(1), 11-38. http://dx.doi.org/10.1016/0278-5846(94)00101-M [29] Maes, M.; Bosmans, E.; De Jongh, R.;  Kenis, G.; Vandoolaeghe, E.; Neels, H .",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Cytokine, 1 9 9 7, 9(11), 853-858. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Cardiol., 2002, 90(12), 1279-1283. http://dx.doi.org/10.1016/S0002-9149(02)02863-1 [33] Kop, W.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Cardiol., 2002, 89(4), 419-424. http://dx.doi.org/10.1016/S0002-9149(01)02264-0 [34] Suarez, E.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Med., 2003, 65(3), 362-368. http://dx.doi.org/10.1097/01.PSY.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Immun., 2003, 17(4), 276-285. http://dx.doi.org/10.1016/S0889-1591(03)00057-6 [36] Zhang, F.X.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Bio Systems, 2010, 6(5), 852-861. http://dx.doi.org/10.1039/b914751a [37] Shi, B.Y.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Brain Res., 2013, 241(0), 86-91. http://dx.doi.org/10.1016/j.bbr.2012.11.036 [38] Zheng, P.; Wang, Y.; Chen, L.; Yang, D., Meng, H., Zhou, D., Zhong, J., Lei, Y., Melgiri, N.D., Xie, P. Identification and validation of urinary metabolite biomarkers for major depressive disorder.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Proteom., 2013, 12(1), 207-214. http://dx.doi.org/10.1074/ mcp.M112.021816 [39] Zheng, P.; Gao, H.C.; Li, Q.; Shao, W. H.; Zhang, M. L.; Cheng, K.; Yang, de Y.; Fan, S. H.; Chen, L.; Fang, L.; Xie, P. Plasma Metabonomics as a Novel Diagnostic Approach for Major Depressive Disorder.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"J. Proteome Res., 2012, 11(3), 1741-1748. http://dx.doi.org/10.1021/pr2010082 [40] Li, Z.Y.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Mass Spectrometry, 2010, 24(24), 3539-3546. http://dx.doi.org/ 10.1002/rcm.4809 [41] Chen, G.H.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Pharmacol., 1969, 5(4), 357-366. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"J. Neural Trans., 1979, 46(2), 85-103. http://dx.doi.org/10.1007/BF01250331 [46] Lucki, I.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Pharmacol.,1997, 8(6-7), 523-532. http://dx.doi.org/10.1097/ 00008877-199711000-00010 [47] Papakostas, G.I.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Psychiatry, 2007, 62(11), 1217-1227. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Med., 2010, 64(1), 24-30. http://dx.doi.org/10.1007/s11418-009-0360-6 [50] Chatterjee, S.S.; Bhattacharya, S.K.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Life Sci., 1998, 63(6), 499-510. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Ethnopharmacol., 2006, 106(1), 76-81. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Brain Res., 2008, 194(1), 108-113. http://dx.doi.org/10.1016/j.bbr.2008.06.030 [53] Linde, K .",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Psychiatry, 2009, 33(1), 1 1 8-127. http://dx.doi.org/10.1016/j.pnpbp.2008.10.018 [55] Butterweck, V .",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"M e c h a n i s m  o f  a c t i o n  o f  S t  J o h n ’ s  w o r t  i n  depression.CNS Drugs, 2003, 17(8), 5 3 9-562. http://dx.doi.org/ 10.2165/00023210-200317080-00001 [57] Sarris, J.; Kavanagh, D.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Med., 2000, 160(2), 152-156. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Analysis, 2011, 55(3), 533-539. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Neurobiol., 2008, 28(5), 745-755. http://dx.doi.org/10.1007/s10571-007-9169-6 [61] Dai, Y.T.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Ethnopharmacol., 2010, 128(2), 482-489. http://dx.doi.org/10.1016/j.jep.2010.01.016 [62] Gao, X.X.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Ethnopharmacol., 2011, 137(1), 690-699. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Pharmacol., 2012, 64(4), 578-588. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Ethnopharmacol., 2014, 158,1-10. http://dx.doi.org/10.1016/j.jep.2014.10.005 [65] Kim, S.H.",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"Life Sci., 2005, 76(11), 1297-1306. http://dx.doi.org/10.1016/j.lfs.2004.10.022   Received: September 01, 2014 Revised: January 19, 2015 Accepted: January 25, 2015",OADS,/arxiv_data1/oa_pdf/bc/e1/CN-13-514.PMC4790409.pdf
"We conservatively calculated costs with use of the average wholesale price for TXA (US$50.40 per 1000 mg/10 mL ampoule of Cyklokapron ® injection; Red  Book Online, Truven Health Analytics, http://sites.truven-health.com/redbook/index.html; accessed 23 February 2015) and the published mean cost for packed red blood cell (pRBC) transfusions in surgical patients with accounting for acquisition, processing, testing, and direct and indirect over - head expense (US$761 per unit in 2010 US dollars).",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/10.1177_2050312116637024.PMC4790417.pdf
"Simulationswere run using the Victorian Life Sciences Computa-tion Initiative (VLSCI) supercomputing facility.Analysis was performed in the open-source environ-ment, R ( http://www.r-project.org/ , in the public domain), using RStudio (version 0.98.501, RStudio, Inc.).",OADS,/arxiv_data1/oa_pdf/8b/bd/i2164-2591-5-2-7.PMC4790418.pdf
"Mental health, 2014,  http://www.who.int/mental_health/management/schizophre-nia/en/ (accessed 5 November 2014).",Non-OADS,/arxiv_data1/oa_pdf/74/94/10.1177_2050312116637026.PMC4790419.pdf
"Daily foreign exchange rates, 2014, http://www.bot.or.th/English/Statistics/FinancialMarkets/ ExchangeRate/_layouts/Application/ExchangeRate/ ExchangeRate.aspx (accessed 8 January 2014).",Non-OADS,/arxiv_data1/oa_pdf/74/94/10.1177_2050312116637026.PMC4790419.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8e/31/10.1177_2325967116633419.PMC4790424.pdf
"Secondary Remicade prescribing information.Available at: http://www.remicade.com/shared/ product/remicade/prescribing-information.pdf.Access March 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0a/7a/i2164-2591-5-2-11.PMC4790433.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/3a/77/epi-07-813.PMC4790440.pdf
"http://bioinformaticstools.mayo.edu  45 Lin X, Sun D, Rodriguez B et al.",OADS,/arxiv_data1/oa_pdf/3a/77/epi-07-813.PMC4790440.pdf
"Duralweakness could be secondary to an unde rlying connective tissue disorder, meningeal diverticula, or because of mechanical disruption of the dura,Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/d2/0a/tre-06-366-7522-1.PMC4790469.pdf
"Contrast- enhanced brain MRI shows diffuse and linear meningeal enhancement that involves the pachymeninges of both the infra- and supratentorial compartmen ts without evidence of involvement of the leptomeninges (i.e., no abnormal enhancement around the brainstem, within the depth of the cerebral sulci or the Sylvi an fissures) (segment 2 ).Salazar R Intracranial Hypotension Associated with Kinetic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/d2/0a/tre-06-366-7522-1.PMC4790469.pdf
"Social Issues: Frequently Asked Questions, 2015, http://www.girlscouts.org/en/faq/faq/social-issues.html (2015, accessed 7 September 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://www.hrc.org/campaigns/corporate- equality-index (2015, accessed 10 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://schools.nyc.gov/RulesPolicies/Transgender StudentGuidelines/default.htm (2015, accessed 11 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"The Boston Globe , 5 March 2015. https://www.bostonglobe.com/ metro/2015/03/05/wellesley/1a3eDzywpzF4QAznRuOw3L/story.html (2015, accessed 10 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
https://www.congress.,Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://www.defense.gov/News/News-Releases/News-Release-View/Article/612778 (2015, accessed 12 October 2015).",OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://www.ynetnews.com/arti- cles/0,7340,L-4169089,00.html (2011, accessed 10 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://www.transbirth.com (2015, accessed 10 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://www.transgen- derparentsdoc.com (2012, accessed 12 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://lgbtqpn.ca/wp-con-tent/uploads/woocommerce_uploads/2014/09/TFL-Fact-Sheet.pdf (2014, accessed 10 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://www.milkjunkies.net/2012/03/ tips-for-transgender-breastfeeders-and.html (2012, accessed 10October 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://transhealth.ucsf.edu/video/story.html (2014, accessed 7 September 2015).",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"http://www.lgbthealtheducation.org/training/learning- modules/ (2015, accessed 10 October 2015).8 Obstetric Medicine 9(1)",Non-OADS,/arxiv_data1/oa_pdf/6c/d0/10.1177_1753495X15612658.PMC4790470.pdf
"We used ImageJ (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA) and a computing environment (MATLAB; Math- Works, Inc., Natick, MA, USA) to quantify the digital images.",OADS,/arxiv_data1/oa_pdf/e4/63/i1552-5783-57-3-1106.PMC4790472.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/97/pcw016.PMC4790474.pdf
"NP_199704 .1/At5g48930) and PpHCT1 (http://www.cosmoss.org, acces- sion No.",OADS,/arxiv_data1/oa_pdf/28/97/pcw016.PMC4790474.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 283–290Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  283OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10171 7Public opinion on community-based education  and exercise programs for managing hip and knee  osteoarthritis-like symptoms: results of a survey Aileen M Davis1–5 Marvilyn Palaganas1 linda c li6,7 1Division of health care and  Outcomes research, 2Arthritis  community research and  evaluation Unit, Krembil research  institute, University health  network, 3Department of Physical  Therapy, institute of health Policy,   4Management and evaluation, 5institute  of rehabilitation science, University  of T oronto, T oronto, On , 6Arthritis  research canada, richmond,   7Department of Physical Therapy,   University of British columbia,   Vancouver, Bc , canadaIntroduction:  In North America, delivery of targeted exercise and education programs by  health professionals for people with hip and knee osteoarthritis (OA) poses challenges related  to cost and access.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"For example,  OA affects one in six adult Canadians.1 Based on the US data, the estimated lifetime  risk of knee OA alone is 45% by 85 years.2 Two of three people are under 65 years3  with 10% reporting symptomatic knee OA by 60 years of age.4 Poorly managed hip  and knee OA results in severe chronic pain, limited mobility, and disability5–11 and  is associated with cardiovascular disease, diabetes, and obesity.12,13 High health care  usage, total joint replacement,14–16 and increased mortality12,13 are hallmarks of poorly correspondence: Aileen M Davis Division of health care and Outcomes  research, Krembil research institute,  MP11-322, 399 Bathurst street, Toronto,  On M5T 2s8, canada Tel +1 416 603 5543 Fax +1 416 603 6288 email adavis@uhnresearch.c a Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Davis et al Running head recto: Osteoarthritis exercise programs in community centers DOI: http://dx.doi.org/10.2147/PPA.S101717",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Available from: http://www.phac-aspc.gc.ca/cd-mc/arthritis- arthrite/lwaic-vaaac-10/pdf/arthritis-2010-eng.pd f. Accessed March  2,  2014.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Available from:  http://boneandjointcanada.com/wp-content/uploads/2014/05/BJC-OA- Meeting-Report-Final.pd f. Accessed November 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Available from: https://www.glaid.dk/pdf/English%20 Summary%20annual%20report%202014%20GLAD.pd f. Accessed  November 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Available from:  http://www.aci.health.nsw.gov.au/models-of-care/musculoskeletal/ osteoarthritis-chronic-care-progra m. Accessed November 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
Available from: http://www.vch.ca/locations-and- services/find-health-services/?program_id =2654.,Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
Available from: http://ymcahbb.ca/Locations/Hamilton/ Neighbourhood-One/Les-Chater-Family-YMCA/Programs?category 1=1089&category2 =1108&category3 =0&categoryid =1108.,Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Available from: http://www1.toronto.ca/wps/portal/   contentonly?vgnextoid =7fc0dada600f0410VgnVCM10000071d60f89 RCRD&vgnextfmt =defaul t. Accessed March 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Available from: http://www.abilitiescentre.org/ membershi p. Accessed November 16, 2015.",OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Available from: http://www.statcan.gc.ca/ daily-quotidien/131028/dq131028a-eng.ht m. Accessed December 29,  2015.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/ppa-10-283.PMC4790486.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/55/cia-11-287.PMC4790487.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 287–292Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  287OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9969 8Periprocedural temporary pacing in primary  percutaneous coronary intervention for patients  with acute inferior myocardial infarction Y ou Mi hwang1 Chul-Min Kim2 Keon-Woong Moon2 1Department of Cardiology, Asan  Medical Center, University of  Ulsan College of Medicine, seoul,   2Department of Internal Medicine,   st Vincent’s hospital, The Catholic  University of Korea, suwon,   south KoreaObjective:  High-degree atrioventricular block (AVB), including complete AVB in acute  inferior ST-elevation myocardial infarction (STEMI), is not uncommon.",Non-OADS,/arxiv_data1/oa_pdf/45/55/cia-11-287.PMC4790487.pdf
"However, in previous reports,  the presence of HAVB was a significant prognostic factor for survival.16,17 Although Correspondence: Chul-Min Kim Department of Internal Medicine,  st Vincent’s hospital, The Catholic  University of Korea, #93-6, Ji-dong,  Paldal-gu, suwon, gyeonggi-do 442-723,  south Korea Tel +82 31 249 7139 Fax +82 31 247 7139 email cmkim@cmcnu.or.k r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hwang et al Running head recto: Periprocedural TP in primary PCI DOI: http://dx.doi.org/10.2147/CIA.S99698",Non-OADS,/arxiv_data1/oa_pdf/45/55/cia-11-287.PMC4790487.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/45/55/cia-11-287.PMC4790487.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/45/55/cia-11-287.PMC4790487.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Biologics: Targets and Therapy 2016:10 33–52Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  33Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S7167 9Selective biologics for ulcerative colitis and  Crohn’s disease – clinical utility of vedolizumab Jill M v Petkau Bertus eksteen Snyder institute for Chronic Diseases,   Cumming School of Medicine,   University of Calgary, Calgary, AB,   Canada Correspondence: Bertus eksteen   Snyder institute for Chronic Diseases,  Cumming School of Medicine, University  of Calgary, 4AC66-3280 Hospital Drive  Nw, Calgary, AB T2N 4N1, Canada   Tel +1 403 220 3719   Fax +1 403 210 9146   email b.eksteen@ucalgary.c aAbstract:  Inflammatory bowel disease (IBD) encompasses a cluster of different disease  phenotypes which are broadly classified into ulcerative colitis and Crohn’ s disease.",Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
Available from: http://www.isupportibd.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
"Available from:  http://isupportibd.ca/pdf/ccfc.ca-impact-report-fast-facts.pd f. Accessed  July 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
Available  from: http://www.janssen.ca/subcategory_docdownload?id=226 3.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
"Available  from: http://www.abbvie.ca/content/dam/abbviecorp/ca/english/docs/ HUMIRA_PM_EN.pd f. Accessed July 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
Available  from: http://www.janssen.ca/subcategory_docdownload?id=227 8.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
"Available from: http://www.ucb-canada.ca/_up/ucbpharma_ca_en/ documents/cimzia_pm_en_15jan2014.pd f. Accessed July 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
Avail able from: http://www.biogen.ca/Admin/Public/ DWSDownload.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8e/47/btt-10-033.PMC4790488.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/03/jpr-9-123.PMC4790489.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain Research 2016:9 123–127Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  123ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S10060 7acetaminophen for analgesia following  pyloromyotomy: does the route of administration  make a difference?",Non-OADS,/arxiv_data1/oa_pdf/6d/03/jpr-9-123.PMC4790489.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/6d/03/jpr-9-123.PMC4790489.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/03/jpr-9-123.PMC4790489.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nephrology and Renovascular Disease 2016:9 53–64International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  53RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S8970 4Efficacy and safety of iron isomaltoside  (Monofer®) in the management of patients with  iron deficiency anemia Philip A Kalra1 Sunil Bhandari2,3 1Department of Renal Medicine,   Salford Royal NHS Foundation Trust,   Salford, UK; 2Hull and east Yorkshire  Hospitals NHS Trust, Hull, UK; 3Hull  Y ork Medical School, Hull, UK Correspondence: Philip A Kalra   Department of Renal Medicine, Salford  Royal NHS Foundation Trust, Stott Lane,  Salford M6 8HD, UK   T el +44 161 206 0509   Fax +44 161 206 5713   email philip.kalra@srft.nhs.u kAbstract:  New intravenous (IV) iron preparations should ideally be capable of delivering a  wide dosing range to allow iron correction in a single or low number of visits, a rapid infusion  (doses up to 1,000 mg must be administered over more than 15 minutes and doses exceeding  1,000 mg must be administered over 30 minutes or more), and minimal potential side effects  including low catalytic/labile iron release with minimal risk of anaphylaxis.",Non-OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
Available from: http://kdigo.org/home/ guidelines/anemia-in-ckd /.,Non-OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
"Available from: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008- 4337b1-01-fda.pd f. Accessed November 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
"Available from:  http://evs.nci.nih.gov/ftp1/CTCAE/Archive/CTCAE_4.02_2009-09- 15_QuickReference_8.5x11.pd f. Accessed November 13, 2015.",OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
Available from: https://www.nice.org.uk/guidance/ng 8.,Non-OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/6e/ijnrd-9-053.PMC4790490.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/1e/dddt-10-1101.PMC4790491.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1101–1110Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1101Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10342 3Formulation and clinical evaluation of silymarin  pluronic-lecithin organogels for treatment of  atopic dermatitis Fatma M Mady1,2 hanaa essa2 Tarek el-ammawi3 hamdy abdelkader2 amal K hussein2 1Department of Pharmaceutics and  Pharmaceutical Technology, Faculty  of Pharmacy, Taibah University,   Medina, saudi arabia; 2Department of  Pharmaceutics, Faculty of Pharmacy,   Minia University, Minia, egypt;   3Department of Dermatology, sTDs,   and andrology, Minia University  hospital, Minia, egyptAbstract:  Silymarin is a naturally occurring flavonoid drug; evidence from recent research has  highlighted its use as a potential treatment for atopic dermatitis (AD).",Non-OADS,/arxiv_data1/oa_pdf/c4/1e/dddt-10-1101.PMC4790491.pdf
"It  has long been used as a traditional herbal hepatoprotective agent.13 It is one of the most  widely used compounds of flavonoids because of its extensive therapeutic properties.correspondence: amal K hussein Department of Pharmaceutics,  Faculty of Pharmacy, Minia University,  Minia 61519, egypt Tel +20 102 051 051 Fax +20 86 236 9075 email amal.hus sein@mu.edu.e g Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Mady et al Running head recto: Formulation and clinical evaluation of silymarin PLOs DOI: http://dx.doi.org/10.2147/DDDT.S103423",Non-OADS,/arxiv_data1/oa_pdf/c4/1e/dddt-10-1101.PMC4790491.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c4/1e/dddt-10-1101.PMC4790491.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/1e/dddt-10-1101.PMC4790491.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and Investigational Dentistry Clinical, Cosmetic and Investigational Dentistry 2016:8 35–50Dove press submit your manuscript | www.dovepress.co m Dove press  RevIewopen access to scientific and medical research Open Access Full T ext Article 35 http: //dx.doi.org/10.2147/CCIDE.S6362 6Strategies to manage patients with dental anxiety  and dental phobia: literature review Deva Priya Appukuttan Department of Periodontics, Sri  Ramakrishna Mission Dental College  and Hospital, Chennai, India Correspondence: Deva Priya Appukuttan   Department of Periodontics,   Sri Ramakrishna Mission Dental College  and Hospital, Bharathi Salai, Ramapuram,  Chennai, Tamil Nadu 600 089, India   Tel +91 9840 197 121   email devapriyamds@gmail.co mAbstract:  Dental anxiety and phobia result in avoidance of dental care.",Non-OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
2007;7:1 ( http://creativecommons.org/licenses/by/2.0 /).14,Non-OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
"Available from: https://www.dentistry.utoronto.ca/ system/files/x3eblreport-2009.pd f. Accessed November 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
"Available from: http://www.baos.org.uk/resources/ BDAGuidanceconscious_sedation_ -_nov_11.pd f. Accessed  November 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7b/21/ccide-8-035.PMC4790493.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/dc/a3/bctt-8-039.PMC4790494.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/dc/a3/bctt-8-039.PMC4790494.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Breast cancer: Targets and Therapy 2016:8 39–45submit your manuscript | www.dovepress.co m Dove press  39 http: //dx.doi.org/10.2147/BCTT .S10259 8astym therapy improves function and range of  motion following mastectomy claire c Davies1 Dorothy Brockopp2 Krista Moe2 1Baptist health rehabilitation,   2research Department, Baptist health  lexington, lexington, KY, Usa correspondence: claire c Davies   Baptist health rehabilitation, Baptist  health lexington,   1800 nicholasville road, lexington,   KY 40503, Usa   T el +1 859 260 6673   Fax +1 859 260 6431   email claire.davies@bhsi.co mAbstract:  Hypersensitive scar tissue formation along the incision line and drain site is a  common side effect following mastectomy.",Non-OADS,/arxiv_data1/oa_pdf/dc/a3/bctt-8-039.PMC4790494.pdf
Available from: http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/dc/a3/bctt-8-039.PMC4790494.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/dc/a3/bctt-8-039.PMC4790494.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/98/ott-9-1291.PMC4790503.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1291–1302OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1291Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8063 5Role of gefitinib in the targeted treatment of non- small-cell lung cancer in Chinese patients Meng-Jiao Li Qing He Mei Li Feng Luo Y ong-Song Guan Department of Oncology, Center  of Oncology, West China Hospital  of Sichuan University, Chengdu,   People’s  Republic of ChinaAbstract:  Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/9b/98/ott-9-1291.PMC4790503.pdf
"Although the median OS and 1-year Correspondence: Yong-Song Guan Center of Oncology, West China  Hospital of Sichuan University, Chengdu  610041, People’s Republic of China email yongsongguan@yahoo.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Role of gefitinib in NSCLC treatment DOI: http://dx.doi.org/10.2147/OTT.S80635",Non-OADS,/arxiv_data1/oa_pdf/9b/98/ott-9-1291.PMC4790503.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9b/98/ott-9-1291.PMC4790503.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/98/ott-9-1291.PMC4790503.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 489–501International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  489OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9766 5Whakawhanaungatanga: the importance of  culturally meaningful connections to improve  uptake of pulmonary rehabilitation by Ma ˉori with  COPD – a qualitative study William MM levack Bernadette Jones rebecca grainger Pauline Boland Melanie Brown Tristram r Ingham Department of Medicine, University  of Otago, Wellington, new ZealandBackground:  Pulmonary rehabilitation is known to improve function and quality of life for  people with chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
"Keywords:  COPD, pulmonary rehabilitation, health care access, cultural safety, indigenous  peoples, qualitative research Introduction It is now well established that indigenous peoples in colonized countries, an estimated  370 million people worldwide,1 endure significantly poorer health than their nonindig - enous counterparts.2 Compared to others in their native lands, indigenous peoples suffer Correspondence: William MM levack Department of Medicine, University  of Otago, Wellington, PO Box 7343,  Wellington 6242, new Zealand Tel +64 4 918 6279 Fax +64 4 389 5427 email william.levack@otago.ac.n z Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Levack et al Running head recto: Experiences of pulmonary rehabilitation by Ma ˉori in New Zealand DOI: http://dx.doi.org/10.2147/COPD.S97665",Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
Available from: http://www.who.int/ topics/health_services_indigenous/en /.,Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
Available from: http://www.stats.govt.nz/browse_for_stats/ health/life_expectancy/NZLifeTables_HOTP12-14/Commentary.,Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
Available from: http://www.goldcopd.com /.,Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/b3/copd-11-489.PMC4790504.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ea/de/ott-9-1135.PMC4790505.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1135–1143OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1135Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9587 1combined action of egFr tyrosine kinase  inhibitors and whole-brain radiotherapy on EGFR- mutated non-small-cell lung cancer patients with  brain metastasis Yunyun lu Yun Fan The Key laboratory of Diagnosis and  Treatment T echnology for Thoracic  Oncology (esophagus and lung),   Zhejiang cancer hospital, Zhejiang,   People’s republic of chinaBackground:  Lung cancer is the most common type of cancer to spread to the brain (brain  metastasis [BM]).",Non-OADS,/arxiv_data1/oa_pdf/ea/de/ott-9-1135.PMC4790505.pdf
"For such patients, platinum-based chemotherapy is often  used as the first-line treatment; however, such treatments may not significantly reduce  NSCLC mortality and the 5-year survival rate remains less than 5% with median correspondence: Yun Fan The Key laboratory of Diagnosis and  Treatment Technology for Thoracic  Oncology (esophagus and lung), Zhejiang  cancer hospital, 38 guangji road,  hangzhou, Zhejiang 310022, People’s  republic of china Tel +86 571 8812 2091 Fax +86 571 8812 2589 email fanyunzj@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lu and Fan Running head recto: Effect of EGFR TKIs with WBRT on NSCLC patients with BM DOI: http://dx.doi.org/10.2147/OTT.S95871",Non-OADS,/arxiv_data1/oa_pdf/ea/de/ott-9-1135.PMC4790505.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ea/de/ott-9-1135.PMC4790505.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/de/ott-9-1135.PMC4790505.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0b/22/ijnrd-9-045.PMC4790506.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/0b/22/ijnrd-9-045.PMC4790506.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).international Journal of Nephrology and Renovascular Disease 2016:9 45–52submit your manuscript | www.dovepress.co m Dove press  45 http: //dx.doi.org/10.2147/IJNRD.S7591 6Renal cell carcinoma: links and risks Reena Kabaria Zachary Klaassen Martha K T erris Department of Surgery, Section of  Urology, Augusta University, Augusta,   GA, USA Correspondence: Reena Kabaria   Section of Urology, Augusta University,   1120 15th Street, BA 8415, Augusta,  GA 30912, USA   T el +1 770 265 2148   Fax +1 706 721 2548   email rkabaria@gru.ed uAbstract:  This review provides an overview of the incidence of renal cell carcinoma (RCC)  and a summary of the most commonly associated risk factors.",Non-OADS,/arxiv_data1/oa_pdf/0b/22/ijnrd-9-045.PMC4790506.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/0b/22/ijnrd-9-045.PMC4790506.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/22/ijnrd-9-045.PMC4790506.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/fa/ott-9-1319.PMC4790507.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1319–1325OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1319Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9664 6a prospective comparison of acute intestinal  toxicity following whole pelvic versus small field  intensity-modulated radiotherapy for prostate  cancer Yeon Joo Kim Jin-hong Park in-ha Yun Y oung seok Kim Department of radiation Oncology,   asan Medical center, college of  Medicine, University of Ulsan, seoul,   republic of KoreaPurpose:  To compare the acute intestinal toxicity of whole pelvic (WP) and small field (SF)  intensity-modulated radiotherapy (IMRT) for prostate cancer using dosimetric and metabolic  parameters as well as clinical findings.",Non-OADS,/arxiv_data1/oa_pdf/ec/fa/ott-9-1319.PMC4790507.pdf
"Several studies have correspondence: Young seok Kim Department of radiation Oncology, asan  Medical center, college of Medicine,  University of Ulsan, 88, Olympic-ro  43-gil, songpa-gu, seoul 05505, republic  of Korea Tel +82 2 3010 5614 Fax +82 2 3010 6950 email ysk@amc.seoul.k r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kim et al Running head recto: Acute intestinal toxicities following IMRT for prostate cancer DOI: http://dx.doi.org/10.2147/OTT.S96646",Non-OADS,/arxiv_data1/oa_pdf/ec/fa/ott-9-1319.PMC4790507.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ec/fa/ott-9-1319.PMC4790507.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/fa/ott-9-1319.PMC4790507.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/ee/tcrm-12-387.PMC4790508.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 387Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/9e/ee/tcrm-12-387.PMC4790508.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 387CoRRigenduMopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10516 9Cone-beam computed tomography study of the root and canal morphology  of mandibular permanent anterior teeth in a Chongqing population  [Corrigendum] Journal name: Therapeutics and Clinical Risk Management Article Designation: Corrigendum Y ear: 2016 Volume: 12 Running head verso: Zhengyan et al Running head recto: Cone-beam computed tomography study DOI: http://dx.doi.org/10.2147/TCRM.S105169 Zhengyan Y, Keke L, Fei W, Yueheng L, Zhi Z. Ther Clin  Risk Manag .",Non-OADS,/arxiv_data1/oa_pdf/9e/ee/tcrm-12-387.PMC4790508.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/42/ott-9-1205.PMC4790509.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1205–1219OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1205Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9379 0combination of vatalanib and a 20-heTe synthesis  inhibitor results in decreased tumor growth in an  animal model of human glioma adarsh shankar1 Thaiz F Borin2 asm iskander1 nadimpalli rs Varma3 Bhagelu r achyut1 Meenu Jain1 T om Mikkelsen4 austin M guo5 Wilson B chwang3 James r ewing6 hassan Bagher-ebadian6 ali s arbab1 1T umor angiogenesis laboratory,   cancer center, georgia regents  University, augusta, ga, Usa;   2laboratory of Molecular investigation  of cancer (liM c), Faculty of Medicine  of sao Jose do rio Preto, sao Jose  do rio Preto, Brazil; 3Department  of radiology, cellular and Molecular  imaging laboratory, 4Department of  neurosurgery, henry Ford health  system, Detroit, M i, 5Department  of Pharmacology, new Y ork Medical  college, Valhalla, nY, 6Department of  neurology and radiology, henry Ford  health system, Detroit, M i, UsaBackground:  Due to the hypervascular nature of glioblastoma (GBM), antiangiogenic  treatments, such as vatalanib, have been added as an adjuvant to control angiogenesis and  tumor growth.",Non-OADS,/arxiv_data1/oa_pdf/6b/42/ott-9-1205.PMC4790509.pdf
"Keywords:  magnetic resonance imaging, glioblastoma, antiangiogenic treatments, HET0016,  vascular parameters, protein array Introduction Glioblastoma (GBM) is a hypervascular malignant brain tumor with poor prognosis,  even with the best combination of treatments.1 The hypervascular nature of GBM has  made antiangiogenic treatment (AAT) a popular adjuvant to inhibit angiogenesis and  tumor growth.2–5 However, clinical results indicate transient beneficial effects of AAT correspondence: ali s arbab Tumor angiogenesis laboratory, cancer  center, georgia regents University,  1410 laney Walker Boulevard, room  cn3141, augusta, ga 30912, Usa Tel +1 706 721 8909 Fax +1 706 434 6406 email aarbab@gru.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Shankar et al Running head recto: Antitumor effect of HET0016 DOI: http://dx.doi.org/10.2147/OTT.S93790",Non-OADS,/arxiv_data1/oa_pdf/6b/42/ott-9-1205.PMC4790509.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/42/ott-9-1205.PMC4790509.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/42/ott-9-1205.PMC4790509.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8c/82/jpr-9-115.PMC4790511.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/82/jpr-9-115.PMC4790511.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain research 2016:9 115–122submit your manuscript | www.dovepress.co m Dove press  115 http: //dx.doi.org/10.2147/JPR.S9895 6Effect of verbal persuasion on self-efficacy  for pain-related diagnostic sensory testing in  individuals with chronic neck pain and healthy  controls – a randomized, controlled trial anne söderlund1 Michele sterling2 1Physiotherapy, School of Health,   care and social Welfare, Mälardalen  University, Västerås, Sweden;   2centre for national research on  Disability and Rehabilitation Medicine  (cOnr OD), Menzies health institute  Queensland, Griffith University,   Parklands, australia correspondence: anne söderlund   Physiotherapy, School of Health, Care  and Social Welfare, Mälardalen University,  Box 883, SE-721 23, Västerås, Sweden   T el +46 73 66 20 567   email anne.soderlund@mdh.s eAbstract:  The aim of this study was to investigate the differences in cold pain threshold (CTh),  pressure pain threshold (PPT), cold pain tolerance (CPTo) tests, and the level of self-efficacy  when self-efficacy for diagnostic sensory testing was manipulated by verbal persuasion before  a testing situation in persons with neck pain and in healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/8c/82/jpr-9-115.PMC4790511.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/8c/82/jpr-9-115.PMC4790511.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/82/jpr-9-115.PMC4790511.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/82/ott-9-1311.PMC4790519.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1311–1317OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1311Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9858 3Diagnostic value of two-dimensional shear wave  elastography in papillary thyroid microcarcinoma shao-Bo Duan1,2 Jie Yu2 Xin li2 Zhi-Yu han2 hong-Yan Zhai2 Ping liang2 1Department of interventional  Ultrasound, Medical center  Tsinghua University, 2Department  of interventional Ultrasound, P la  general hospital, Beijing, People’s  republic of chinaObjective:  The purpose of this study was to evaluate the predictability of two-dimensional  shear wave elastography (2D-SWE) for papillary thyroid microcarcinoma (PTMC).",Non-OADS,/arxiv_data1/oa_pdf/e6/82/ott-9-1311.PMC4790519.pdf
"The feature of firmness and hardness on palpation is known  to be associated with a higher risk of malignancy.5 Two-dimensional shear wave elastography (2D-SWE) uses the acoustic radiation  force induced by a focused US beam to reach underlying tissues, and an ultrafast US correspondence: Ping liang Department of interventional Ultrasound,  Pla general hospital, 28 Fuxing road,  Beijing 100853, People’s republic  of china email liangping301@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Duan et al Running head recto: Diagnostic value of 2D-SWE in PTMC DOI: http://dx.doi.org/10.2147/OTT.S98583",Non-OADS,/arxiv_data1/oa_pdf/e6/82/ott-9-1311.PMC4790519.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/82/ott-9-1311.PMC4790519.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/82/ott-9-1311.PMC4790519.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/61/d3/jpr-9-129.PMC4790520.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/61/d3/jpr-9-129.PMC4790520.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain Research 2016:9 129–135Journal of Pain Research Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/61/d3/jpr-9-129.PMC4790520.pdf
"Or use: http://youtu.be/cY6VWcoaOz 4Dove press submit your manuscript | www.dovepress.co m Dove press  129ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S9827 3Opioids for chronic pain: a knowledge assessment  of nonpain specialty providers amy cs Pearson Jason s eldrige susan M Moeschler W Michael hooten Department of anesthesiology,    Mayo clinic, Rochester, M n, Usa correspondence: W Michael hooten   Department of anesthesiology, Mayo  clinic, 200 First st sW, charlton 1-145,  Rochester, Mn 55905, Usa   T el +1 507 266 9977   email hooten.william@mayo.ed uIntroduction:  Although the majority of opioids in the US are prescribed by nonpain special - ists, these providers often report inadequate training in chronic pain management and opioid  prescribing.",Non-OADS,/arxiv_data1/oa_pdf/61/d3/jpr-9-129.PMC4790520.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/61/d3/jpr-9-129.PMC4790520.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/d3/jpr-9-129.PMC4790520.pdf
"Available from: http://www.hhs.gov/ohrp/humansubjects/ guidance/45cfr46.htm l. Accessed December 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/61/d3/jpr-9-129.PMC4790520.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/42/hiv-8-047.PMC4790521.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).HIV/AIDS - Research and Palliative Care 2016:8 47–65HIV/AIDS - Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  47ReVIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S9906 3evaluating the role of atazanavir/cobicistat   and darunavir/cobicistat fixed-dose combinations  for the treatment of HIV-1 infection Rustin D Crutchley1 Rakesh C Guduru2 Amy M Cheng1 1Department of Pharmacy Practice  and Translational Research, College  of Pharmacy, University of Houston,   2CompanionDX, Houston, TX, USA Correspondence: Rustin D Crutchley   Department of Pharmacy Practice and  Translational Research, College of  Pharmacy, University of Houston,  1441  Moursund St, Houston, TX  77030, USA   Tel +1 832 842 8379  Fax +1 832 842 8383  email rdcrutchley@uh.ed uAbstract:  Atazanavir/cobicistat (ATV/c) and darunavir/cobicistat (DRV/c) are newly approved  once daily fixed-dose protease inhibitor combinations for the treatment of HIV -1 infection.",Non-OADS,/arxiv_data1/oa_pdf/cf/42/hiv-8-047.PMC4790521.pdf
Available from: https://aidsinfo.nih.gov/guidelines/html/1/ adult-and-adolescent-treatment-guidelines/ 0.,Non-OADS,/arxiv_data1/oa_pdf/cf/42/hiv-8-047.PMC4790521.pdf
"Available from: http://www.bhiva.org/ documents/Guidelines/Treatment/2015/2015-treatment-guidelines.pd f.  Accessed October  21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/cf/42/hiv-8-047.PMC4790521.pdf
"Available from: http://www.HIV - druginteractions.or g. Accessed October  22, 2015.",Non-OADS,/arxiv_data1/oa_pdf/cf/42/hiv-8-047.PMC4790521.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/cf/42/hiv-8-047.PMC4790521.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/42/hiv-8-047.PMC4790521.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/21/ott-9-1339.PMC4790522.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1339–1350OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1339Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9854 0association of thymidylate synthase expression  and clinical outcomes of gastric cancer patients  treated with fluoropyrimidine-based chemotherapy:  a meta-analysis Yunhe gao* Jianxin cui* hongqing Xi* aizhen cai Weisong shen Jiyang li Kecheng Zhang Bo Wei lin chen Department of general surgery,   Chinese People’s Liberation Army  general hospital, Beijing, People’s  Republic of China *These authors contributed equally  to this workPurpose:  Although several studies have suggested an association between thymidylate synthase  (TS) expression and outcomes of gastric cancer (GC) patients treated with fluoropyrimidine- based chemotherapy (FUC), the predictive value of TS for response and survival in this setting  is unclear.",Non-OADS,/arxiv_data1/oa_pdf/ac/21/ott-9-1339.PMC4790522.pdf
"As a cor - nerstone of gastrointestinal cancer chemotherapy, single or combined chemotherapy with  these two drugs is recommended for both localized and advanced GC patients.2 Moreover,  newly developed FU-based chemotherapies (FUCs) including capecitabine and S-1 have  improved antitumor effects and reduced side effects.3 However, as drug resistance due  to tumor heterogeneity is still a major obstacle to ideal clinical outcomes,4 more precise  predictors of outcomes for patients who undergo FUC regimens are needed.correspondence: lin chen Department of general surgery, chinese  People’s Liberation Army General  hospital, 28 Fuxing road, Beijing 100853,  People’s Republic of China Tel +86 10 6693 8128 email chenlinbj@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gao et al Running head recto: Association of TS and gastric cancer patients’ clinical outcomes DOI: http://dx.doi.org/10.2147/OTT.S98540",Non-OADS,/arxiv_data1/oa_pdf/ac/21/ott-9-1339.PMC4790522.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/21/ott-9-1339.PMC4790522.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/ott-9-1339.PMC4790522.pdf
